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ABSTRACT  
 
This thesis reports the effects in vivo of the sympathetic nervous system (SNS) in 
human subcutaneous abdominal white adipose tissue (WAT) and other tissues 
involved in energy storage and utilisation.  
 
Cannulation of superficial veins draining skin, abdominal subcutaneous WAT and 
deep forearm muscle combined with isotope turnover methodology and tissue 
blood flow estimation was used to investigate the behaviour of these tissues under 
varying experimental conditions. 
 
Glucose infusion study:   
 
This examined differential substrate uptake and utilisation in the three tissues.  
WAT was responsible for only a small amount of glucose disposal and deep 
forearm muscle took up but did not release NEFA.  Skin was a net exporter of 
lactate.  Results confirm the relative purity of the venous effluent from these 
tissues.  
 
Sympathetic Nervous System study:   
 
This examined whole body, WAT and forearm muscle SNS activity in lean and 
obese individuals under fasting and postprandial conditions.  Whereas whole body 
SNS activity was increased in the obese, regional heterogeneity of SNS activity 
was evidenced by reduced SNS activity in WAT.  Adipose tissue blood flow was 
significantly reduced in the obese.  This may underlie abnormal lipolysis and/or 
blood flow regulation in obesity.  
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Pulsatility Studies:   
 
These studies examined whether lipolysis and leptin production in human WAT is 
uniform or pulsatile.  Novel control datasets were used to test the robustness of a 
widely used pulse detection algorithm.  Whereas NEFA release appeared truly 
pulsatile, apparent leptin ‘pulses’ occurred with similar frequency in the control 
datasets and appear likely simply to reflect variability. 
 
Anatomical studies:   
 
Confocal immuno-fluorescence microscopy was used to demonstrate innervation 
of WAT in man for the first time.  Such innervation appears confined to the 
microvasculature and suggests that the defective SNS activity within WAT is 
likely to affect adipose tissue biology primarily through defective regulation of 
adipose tissue blood flow. 
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INTRODUCTION 
 
The prevalence of obesity and of its complications is rising at an alarming rate not 
only in this country (where over one in five males are now obese according to the 
National Audit Office) but also in the USA and worldwide (Kopelman, 2000).   
 
The importance of Sympathetic Nervous System (SNS) innervation of white 
adipose tissue (WAT) in myriad physiological and pathological processes is 
increasingly gaining recognition.  Not only does the SNS have the potential to 
influence overall body mass through effects on energy expenditure but it may also 
directly or indirectly influence abnormalities of  lipolysis, glucose homeostasis 
and blood pressure control which together form the cornerstones of the metabolic 
syndrome.  It may therefore contribute not only to the development of obesity but 
also to its complications (Astrup & Macdonald 1998, Macdonald, 1995, Snitker et 
al, 2000, Webber et al, 1994).   
 
Abnormalities of fat distribution as well as of total fat mass are now recognised to 
be important in obesity, particularly in relation to the development of visceral 
adiposity and consequent risk of insulin resistance.  The observed variability in 
regional fat distribution between the sexes and between different ethnic groups 
convincingly demonstrates the regional and functional heterogeneity of adipose 
tissue, independent of its total mass, and the potential importance of 
understanding how this diverse tissue is regulated on a regional as well as whole 
body level (Arner, 1999). 
 
The current state of knowledge relating to the contribution of the sympathetic 
nervous system (SNS) to the regulation of WAT physiology will be reviewed, 
touching upon some of the problems implicit in attempting to unravel its role.  It 
will emerge that the presence of species differences makes assessment of SNS 
activity in humans particularly desirable.  Unfortunately, however, obtaining good 
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in vivo human data has in the past been beset with important methodological 
limitations and conflicting conclusions have resulted (Grassi & Esler 1999, 
Young & Macdonald 1992, Snitker et al, 2000).   
 
The purpose underlying the studies presented in this thesis has been to develop, 
and apply robust anatomical and physiological techniques for use in humans to 
help unravel the role of the sympathetic nervous system in regulating this often 
neglected but metabolically pivotal tissue. 
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LITERATURE REVIEW 
 
The role of the SNS in the regulation of adipose tissue physiology. 
 
The review presented in this section will consider the evidence that the SNS is in 
a position to have an important influence on the regulation of body weight both 
directly through its innervation and regulation of WAT (and its microvascular 
environment) and also indirectly through its effects on other endocrine organs and 
metabolically active tissues such as skeletal muscle, the pancreas and the gut.   
 
Discussion of its effects on lipolysis, thermogenesis, recruitment and 
differentiation of pre-adipocytes as well as consideration of the origins and 
destination of afferent and efferent signals to and from WAT will be presented 
leading to an evaluation of the evidence that SNS innervation of this tissue has 
relevance to the understanding and treatment of human obesity.   
 
It will emerge from this discussion that: - 
 
1. The SNS is potentially in a position to be able to regulate lipolysis, 
thermogenesis, adipose tissue endocrine function and pre-adipocyte 
recruitment and differentiation.  
2. The role of the SNS in human obesity remains unclear. 
3. Techniques for unravelling this complex system in humans are evolving but 
remain subject to important limitations. 
4. Heterogeneity between different species and tissues and between the SNS 
innervation and catecholamine sensitivity of different adipose tissue depots 
may explain some of the divergence in the current literature relating to the 
role of the SNS in human obesity.
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The SNS and regulation of body weight 
 
The SNS is in a position both anatomically and physiologically to regulate 
virtually all aspects of nutrient partitioning, substrate disposal and, therefore, 
body weight homeostasis (Figure 1.1). 
 
 
Fig. 1.1:  The regulation of the adipocyte and its endocrine, nutrient and vascular 
microenvironment by the SNS.  
 
 
 
 
Legend to Figure 1.1 
 
Nutrients and hormones regulating WAT activity include catecholamines, insulin, 
glucose, triglycerides, sex steroids and gut-peptides.  The SNS is potentially able 
to influence adipocytes not only by direct innervation but also by its modulation 
of signals from the pancreas, gut, liver and other endocrine organs as well as by 
regulation of its vascular perfusion.   
 30
 
In addition to this, the SNS may exert a further level of control by its effects on 
local vascular tone and permeability which may influence both the concentration 
and rate of presentation of such substrates (Samra et al, 1996).  Not surprisingly, 
such levels of complexity have proved exceedingly difficult to unravel, 
particularly in humans, and a rather confusing literature has resulted (Snitker et al, 
2000, Young et al, 1992).   
 
Despite the complexities referred to above, there is now a substantial body of 
evidence that changes in SNS activity underpin many forms of obesity in animals 
(Bray 1989, Bray 1990, Bray 1991, Bray & York 1998,  Bray 2000) and, 
furthermore, evidence of significant abnormalities in the local activity of the SNS 
in obesity that have long been described in animals are now finding correlates in 
human obesity.  These include effects on lipolysis (Astrup & Macdonald 1998), 
thermogenesis (Schwartz et al, 1987) and futile cycling (Mercer & Williamson 
1988), transcriptional regulation of uncoupling proteins (UCPs) (Berraondo et al, 
2000), metabolic rate (Saad et al, 1991) and the novel effect on the ‘re-
awakening’ of human brown AT (Weyer et al,1999) as well as possible effects on 
appetite (Leibowitz et al, 1984) and spontaneous physical activity (Christin et al, 
1993). 
 
Receptor Physiology and Regulation of Lipolysis 
 
An important feature of the SNS innervation of WAT is the fact that it involves 5 
distinct adrenoceptor subtypes which are differentially recruited by epinephrine, 
norepinephrine (NE) and their synthetic agonists and antagonists (Lafontan et al, 
1997).  These receptors often display opposing effects on adipocytes in response 
to ligand binding and their relative cell membrane densities not only show marked 
regional heterogeneity (Arner 1999) but are also subject to rapid changes in 
response to different metabolic and endocrine/paracrine influences.  Thus, insulin 
(Engfeldt et al, 1988), leptin (Breslow et al, 1997) and tumour necrosis factor-α 
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(TNF-α) (Berkowitz et al, 1998) can modulate the expression of adrenergic 
receptors in WAT.  Catecholamine-induced lipolysis in human visceral WAT is 
increased in obesity due to increased function of β3-adrenoceptors, decreased 
function of α2-adrenoceptors and increased ability of cyclic AMP to stimulate 
lipolysis (Lafontan & Berlan 1980, Lafontan et al, 1997).  When associated with 
reduced lipolysis in other depots, this leads to a relative redistribution of lipolysis 
to visceral depots and consequent exposure of the liver, via the portal vein, to 
increased concentrations of compounds known to induce a state of insulin 
resistance.  Studies in rodent models have been able to demonstrate marked 
increases in insulin sensitivity following surgical removal of visceral WAT 
(Barzilai et al, 1999).  Studies by Richelsen and colleagues (Richelsen et al, 1991) 
have demonstrated that the differential (up to five fold) responsiveness of visceral 
and subcutaneous adipose tissue to catecholamine induced lipolysis could be 
blocked in the peripheral fat by yohimbine, an α2-antagonist, implying that there 
is high activity of inhibitory α2-adrenoceptors in the subcutaneous depot.   
 
In addition to the release of catecholamines, most sympathetic nerve terminals 
also co-secrete Neuropeptide Y (NPY) (Lundberg et al, 1985) which appears to 
have complex effects on SNS signalling.  Whereas there is evidence for 
augmentation of catecholamine effects at the target receptor, it seems that its 
release may also act pre-synaptically to reduce the amount of NE released per 
action potential.  It has been suggested that this might serve as a mechanism to 
conserve NE at times of maximal stimulation of the SNS (Potter 1988).  To what 
extent this mechanism operates in human white adipose tissue (WAT) has not 
been determined although it may be of some potential interest given both the 
central role of NPY in the hypothalamic regulation of appetite and also that most 
attempts to assess the activity of the SNS in man use measurements of NE 
spillover into the circulation, the validity of which could be affected if this 
putative system is indeed operational in man.  The other implication of the 
findings discussed above is that the concentration of catecholamines achieved 
within an adipose tissue depot could, through differential sensitivity of the 5 
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adrenoceptor sub-types for differing catecholamine concentrations, determine 
whether the net effect is one of inhibition or stimulation of lipolysis.   
 
The SNS Regulation of Thermogenesis 
 
The differential regulation of adrenoceptor-dependent effects both within 
adipocytes and also in other tissues is strikingly demonstrated in the induction of 
uncoupling proteins (UCPs).  These appear to be involved in the dissipation of 
proton gradients and thus the ‘wasting’ of surplus energy in the form of heat 
(some of which ‘obligatory’ and some ‘adaptive’ or ‘facultative’), a concept with 
potential implications in the regulation of body weight (Ricquier 2006). 
 
Facultative thermogenesis is mediated by at least two separate components, diet-
induced thermogenesis and cold-induced thermogenesis.  Both of these 
components appear to depend at least in part on the activity of the SNS in 
modulating UCP expression in a tissue-specific manner.  Thus, the administration 
of a β3-agonist to KK-Ay mice for 21 days resulted in large (14-, 6- and 16-fold) 
increases in UCP 1, 2 and 3 respectively in the brown adipose tissue of these 
animals but there was no detectable change at all in WAT UCP 2 mRNA levels.  
Furthermore, UCP 3 mRNA levels in skeletal muscle and heart were reduced to 
approximately 10% of their baseline values (Yoshitomi et al, 1998).  Similar 
increases in UCP 1 and 2 have been found in rats after cold exposure but they 
were reduced by prior denervation suggesting direct SNS involvement in this 
adaptive response although UCP3 appeared not to be under direct sympathetic 
control in this particular model (Denjean et al, 1999).  There is also a rodent 
model with reduced levels of BAT which develops significant obesity (Lowell 
1993) presumably as a result of reduced UCP1 mediated thermogenesis.   
 
Thermogenesis in man is likely to be relatively more dependent on skeletal 
muscle as demonstrated by the fact that infusion of epinephrine into forearm 
tissues causes an approximately 90% increase in O2 consumption which, if 
 33
representative of skeletal muscle throughout the body, extrapolates to 
approximately 40% of the total thermic response to the dose of epinephrine they 
administered (Simonsen et al, 1992).  However, evidence is emerging to suggest 
that functional brown adipose tissue (BAT) exists in adult humans and is also 
inducible by the activation of the SNS.  Patients with phaeochromocytomas for 
example develop adipose tissue with the morphological characteristics of BAT 
(Lean et al, 1986, Ricquier et al, 1982).  Pharmacological studies of β3-
adrenoceptor agonists such as CL 316,243 have resulted in recruitment of such 
cells in adult primates, a phenomenon referred to as the ‘re-awakening’ of 
dormant BAT (Weyer et al, 1999).  Humans given synthetic β3-agonists showed 
several potentially important beneficial effects in terms of lipolysis, insulin 
sensitivity and fat oxidation without any untoward effects on the cardiovascular 
system, making such agents and the mechanisms upon which they act promising 
targets for further research and development (Weyer et al, 1999).   
 
The clinical importance of energy dissipation in the form of heat is apparent in the 
observation that food restriction sufficient to maintain a 10% reduction in body 
weight is associated with a highly significant reduction in energy expenditure 
(Leibel et al, 1995) measured as resting metabolic rate.  Acute starvation may 
reduce this by as much as 40% (Saris 1995).  Whilst this homeostatic mechanism 
may usefully defend body weight in times of famine, it is highly 
counterproductive during attempts to lose weight by dietary modification and is 
probably at least partly responsible for the dismal failure of this strategy in 
clinical practice.   
 
Thus, whilst uncertainty exists as to the actual role played by both obligatory and 
facultative thermogenesis in the regulation of body weight in humans, its further 
understanding and potential pharmacological manipulation may be a matter of 
some importance.   
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SNS Regulation of Adipose Tissue Microcirculation 
 
Activation of the SNS may be able to influence lipolysis not only directly via β-
adrenoceptor mediated amplification of the cAMP second messenger system but 
also indirectly via an effect on capillary permeability and blood flow regulation 
(Samra et al, 1996).  An increase in capillary permeability and blood flow will 
tend to remove lipolytic end products, bound to plasma proteins, from the 
immediate vicinity of the adipocyte thus reducing any inhibition of lipolysis 
caused by local increases in NEFA concentrations (Burns et al, 1978).  There are 
important although not fully characterised changes in AT blood flow following 
meal ingestion which differ between lean and obese humans.  Whether these are 
predominantly related to differences in tissue insulin or SNS sensitivity is not 
currently clear (Summers et al, 1996).  The SNS may play a longer term 
regulatory role in vascular tissue via the potent angiogenic stimulating factor, 
vascular endothelial growth factor (VEGF) which has been shown to be directly 
regulated by cold stress (which increases SNS activity) in rat BAT and also by β-
adrenoceptor agonists and NE (Asano et al, 1997).  Other aspects of the complex 
issue of AT microcirculation have been reviewed elsewhere (Crandall et al, 1997) 
in detail and are discussed further in relation to the studies presented in Chapter 
VII.   
 
Trophic effects of the SNS 
 
It is becoming increasingly acknowledged that the SNS appears to have trophic, 
anti-apoptotic and possibly differentiating effects on pre-adipocytes.  This is 
implied by reports of reduced BAT apoptosis in the presence of cold stress or 
directly applied NE (Briscini et al, 1998) and doubling of fat cell number in intact 
rodent fat pads following sympathetic denervation (Youngstrom & Bartness, 
1998).  More recent work has identified a possible mechanism for these 
observations (Valet et al, 1998, Pages et al, 2000) by demonstrating that the 
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release of lysophosphatidic acid (LPA), an adipogenic factor in WAT, appears to 
be subject to control by α2-adrenoceptor activation.  The role of adipocyte 
recruitment in the regulation of the overall fat cell mass in humans and some of 
the mechanisms underlying this has also been reviewed recently by O'Rahilly 
(Prins & O’Rahilly 1997).  Further discussion of the role of the SNS in fat cell 
recruitment and differentiation is presented in chapter VII.   
 
Anatomy 
 
The precise ultra-structural anatomy of the innervation of WAT by the SNS is far 
from being fully characterised (Bartness & Bamshad 1998, Bartness & Song 
2007) and is the subject of the studies reported in chapter VII.  The only semi-
quantitative estimate available from animal studies of the number of adipocytes 
that are actually innervated by SNS terminals reported a figure of 3% despite rich 
innervation of surrounding vascular tissue (Slavin & Ballard 1978).  Such a low 
innervation density appears intriguing in the light of preliminary data suggesting 
that peripheral, but not visceral WAT, is rather unresponsive, at least in terms of 
lipolysis, to the effects of physiological levels of circulating catecholamines 
(Richelsen et al, 1991).  Thus it may be speculated either that current methods 
lack the power to detect all of the synaptic interactions that exist (for example, en 
passant contacts lacking classical pre- and post-synaptic morphology) or that the 
innervated cells represent a pool of the most metabolically active adipocytes or 
that the SNS regulates these adipocytes largely via control of their perfusing 
vasculature and local tissue microenvironment.   
 
The SNS reaches AT from diverse brain regions via ganglia in the spinal cord.  
Studies using the retrograde trans-synaptic pseudo-rabies virus (PRV) tracer 
method in rodent and Siberian hamster WAT (Bartness & Ballard 1998) reveal 
projections from the spinal cord, brainstem (nucleus of the solitary tract, C1 and 
A5 regions, and the rostroventro-lateral, rostroventro-medial and caudal raphe 
nuclei), forebrain hypothalamic nuclei (arcuate nucleus, dorsal and lateral 
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hypothalamic areas, zona incerta and paraventricular, suprachiasmatic and 
dorsomedial nuclei) and forebrain non-hypothalamic nuclei (zona incerta, medial 
amygdala, medial preoptic area, septum and bed nucleus of the stria terminalis).  
A particularly salient insight into the direct relationship between WAT and the 
SNS in vivo has been obtained recently by the work of Niijima (Niijima 1999) 
who dissected out and cut the afferent sympathetic nerve to white and brown AT 
depots in the rat.  Electrical recordings of neuronal activity were made from the 
cut ends of these nerve trunks both before and after the local injection of leptin 
directly into the AT depot which they innervated.  Recordings were also taken 
from the autonomic supplies to liver, pancreas and adrenal medulla.  The results 
demonstrated that the effect of the leptin on AT was to increase the afferent SNS 
activity to that depot and also to the pancreas, liver and adrenal glands whilst at 
the same time reducing the parasympathetic tone to these organs.  These findings 
would appear to demonstrate a direct link between local AT leptin receptors and 
the autonomic nervous system innervation of these tissues as part of a reflex arc. 
 
Human Studies-Limitations and Results 
 
It emerges from the above that the SNS is ideally placed in many ways to be an 
important regulator of body weight although at present the literature relating to its 
actual function in man, particularly in obesity, is sometimes conflicting (Grassi & 
Esler 1999, Young & Macdonald 1992, Snitker et al, 2000).  No studies to date 
have actually demonstrated the presence of SNS axons in human white adipose 
tissue.  The conflicting reports have undoubtedly arisen in part due to the 
difficulty that exists in assessing the local as opposed to whole body activity of 
the SNS and the assumptions that such methods must necessarily make.  
Historically, the main methods employed to this end in humans (Grassi & Esler 
1999) have been measurement of whole body indices of SNS activity such as 
plasma or urine NE concentrations.  Such methods are constrained by the 
assumption that NE release into the circulation and then into the urine bears a 
linear relationship to SNS activity and, furthermore, are able to take account of 
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neither the regional heterogeneity of SNS activity nor of the fact that there may 
exist post-receptor modifications of adrenoceptor-mediated signals.  A refinement 
of this method has been to combine superficial abdominal vein catheterisation 
with Esler’s radio-labelled tracer methods (Esler et al, 1984) to study specific 
subcutaneous AT depots in man (Frayn et al, 1989).  This too remains constrained 
by the assumption of a linear relationship between SNS activity and the spillover 
of NE into the circulation, albeit local circulation, but represents probably the best 
single currently available method.  Yet even with this refinement, spillover 
methods remain unable to address the fundamental problem that it may not be 
possible to define the influence of the SNS on AT purely in terms of the amount 
of NE released into the circulation.  It may be, for example, that changes in the 
innervation density, number of adrenoceptors, response to neurotransmitter 
binding, the relative contribution of often opposing effects of α- and β-subtypes, 
not to mention changes in NE reuptake and metabolism and even blood flow 
modulation (Rongen et al, 2000) may all cause dissociation of the measured NE 
concentrations from the actual effects exerted upon AT.   
 
Another method which attempts to measure local SNS activity directly is muscle 
sympathetic nerve activity (MSNA) which records activity in SNS axons within 
the peroneal nerve.  Whether MSNA activity in the peroneal nerve truly reflects 
SNS regulation of adipose tissue is debated.  Thus for many reasons, human 
studies are subject to a number of limitations and must be interpreted with some 
degree of caution.   
 
Notwithstanding the limitations discussed above, there is now a growing body of 
evidence to suggest that local abnormalities of the SNS may have relevance to 
obesity in humans.  In order to circumvent the problem of deciding whether 
detected differences in SNS activity are cause or consequence of obesity, Pima 
Indians have been subjected to intense study as their very high propensity to 
develop obesity provides fertile ground for prospective study.  The alternative 
method is to study people in the post-obese state although not only is this 
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notoriously difficult given the low success of weight reduction in the majority of 
studies but also due to problems related to the known metabolic perturbations 
associated with relative under-feeding and weight loss, including, for example, 
the previously described changes in metabolic rate associated with this (Leibel et 
al, 1995).   
 
In a prospective study of male Pima Indians, lower levels of 24h urinary NE and 
epinephrine excretion were highly correlated with increased subsequent weight 
gain (Tataranni et al, 1997) and further studies by the same group have also 
demonstrated both lower β-adrenoceptor sensitivity to the administration of 
isoprenaline in Pima Indians relative to Caucasian controls (Tataranni et al, 1998) 
and also lower levels of SNS activity, estimated by muscle sympathetic nerve 
activity (MSNA) (Tataranni et al, 1999). 
 
Genetic disturbances in the SNS have also been identified in this population 
which has a high rate of mis-sense mutations of the β3-adrenoceptor gene.  Those 
with the mutation are prone to the development of obesity, type 2 diabetes, and 
diastolic hypertension (Silver et al, 1997).  Studies of this mutation in other 
populations has yielded variable and sometimes contradictory results with no 
effects on obesity or insulin sensitivity in a German population (Buettner et al, 
1998), effects on obesity only in Chinese women with type 2 diabetes (Xiang et 
al, 1998) and over-representation amongst older Australian obese women but not 
men (Kurabayashi et al, 1996).  One study though has shown that the mutation is 
a predictor of the failure to lose weight in obese Caucasian women with type 2 
diabetes (Sakane et al, 1997). 
 
Studies in age and fat-free body mass matched lean and obese Caucasian women 
using tracer balance methodology applied to subcutaneous AT have been able to 
demonstrate reduced levels of local AT, but not systemic, NE spillover into the 
circulation in the obese subjects (Coppack et al, 1998) and there is some recent 
evidence to suggest that the lipolytic response to infused catecholamines may also 
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be blunted in obese humans both under basal conditions (Horowitz et al, 2000) 
and after exercise (Borsheim et al, 2000).  Studies in formerly obese humans 
again have yielded sometimes divergent results although Astrup has produced 
convincing evidence of a defect in the SNS in a study of obese patients before and 
after weight loss where the thermic response to glucose and the arterial NE 
concentrations were significantly reduced (by a factor of 4) in the obese relative 
to lean controls and remained abnormal (by a factor of 2) after a mean 30 Kg 
weight reduction (Astrup et al, 1990). 
 
It is clear from the review above that under-activity of the sympathetic nervous 
system (SNS) in AT has the potential to cause obesity through several 
mechanisms including reductions in lipolysis, thermogenesis and also possibly 
appetite modulation (Astrup et al, 1998).  It has been proposed that most animal 
forms of obesity, including even that of the ob/ob mouse, are characterised by 
SNS under-activity (Bray & York 1998, Bray 1991, Bray 1990, Breslow et al, 
1997).  To what extent this applies to humans has been hotly debated with some 
investigators citing raised plasma catecholamine levels and obesity-associated 
hypertension as evidence that obesity is, in fact, a state of increased rather than 
decreased SNS activity (Rumantir et al, 1999, Grassi 1999).   
 
The motivation for the studies presented in this Thesis was to study aspects of the 
metabolism of a human WAT depot compared to other tissues (Chapter III), its 
SNS outflow compared to lean controls under fasting and post-prandial conditions 
(Chapter IV), its co-ordination in terms of lipolysis (Chapter V) and leptin 
production (Chapter VI) and its anatomical pattern of SNS innervation (Chapter 
VII) in order to address some of these questions.  We anticipated that increased 
understanding of depot and tissue-specific heterogeneity of function would help to 
reconcile some of the divergent conclusions reached in the previous literature.   
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CORE EXPERIMENTAL METHODS 
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NOREPINEPHRINE SPILLOVER METHODOLOGY 
 
We applied Esler’s tracer balance approach which is based on the concept that the 
rate of entry of the SNS neurotransmitter, norepinephrine (NE), into venous blood 
(norepinephrine spillover, NEspillover) is an index of local sympatho-neuronal 
activity over a wide range of firing rates (Grassi & Esler 1999).  Figure 2.1 
illustrates in diagrammatic form the key physiological principles of method used 
to assess SNS nerve activity within adipose tissue.  The cannulations used, 
isotopes, experimental measurements, assumptions and calculations are described 
in the following sections.   
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Figure 2.1: Illustration of the source and fate of NE within adipose tissue 
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Legend to Figure 2. 1 
 
Schematic illustration of the principals used to measure NE spillover.  In essence, 
NE is released as a neurotransmitter at SNS terminals (a) but is also present in 
circulating blood.  Following release, most is taken up in the terminal by 
monoamine oxidase (MAO, uptake 1) (b) or in the tissue by catechol-o-methyl 
transferase (COMT, uptake 2) (c).  Some (perhaps 15%) will ‘spill-over’ 
(NEspillover) into the vasculature having evaded these uptake mechanisms (d).  
NEspillover is a measure of NE added to the vasculature as a result of release from 
SNS terminals.   
 
NEflux is the net tissue uptake or release of NE.  It is calculated as the product of 
the veno-arterial difference in NE ([NE]v-[NE]a) and adipose tissue plasma flow 
(ATPF).   
 
However, NE transit is bi-directional and a quantitatively large proportion of the 
NE present in the arterial inflow leaves the vasculature and is cleared in the tissue 
(NEclearance) (e).  NEclearance is quantitatively larger than spillover, typically in the 
order of 50% depending on flow rates and other circumstances.   
 
NEspillover is therefore the sum of NEflux and NEclearance and is expressed in 
pmol.100g adipose tissue-1.min-1 
 
NEclearance is calculated as the product of the fractional extraction of tritiated NE 
(3H-NE), arterial NE concentration [NE]a and ATPF under steady state infusion 
conditions.  This relies on the assumption that infused 3H-NE is not released by 
SNS axons within the time course of the experiment and that it behaves in all 
other ways as unlabelled NE.  Please see text for details of calculations of these 
quantities and for details of the assumptions made in using this methodology.   
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Cannulations 
 
Following consent, screening and baseline anthropomorphic measurements, 
subjects were taken to a clinical area in which the temperature was maintained 
between approximately 18 and 220C and cannulae were inserted into a superficial 
abdominal vein for WAT venous effluent sampling, radial artery (following an 
Allen test to confirm the presence of a viable ulnar arterial supply to the hand), 
and deep forearm vein (retrograde cannulation of the median cubital vein at the 
elbow).  Additional cannulae were sited in order to maintain isotope infusions.   
 
The abdominal vein cannulations were performed by means of the Seldinger 
technique whereby a paediatric 22/F gauge 20cm long cannula was passed over a 
guide wire inserted into a visible superficial abdominal vein and advanced so that 
its tip was positioned just above the confluence of the external epigastric vein and 
the sapheno-femoral junction in the groin as judged by surface anatomy.  It has 
been previously shown that the venous blood from this site contains a mixture of 
effluent from superficial abdominal WAT and a lesser contribution from 
abdominal skin and does not contain any significant contribution from muscle as 
there are no known branches that perforate the barrier of the external oblique 
aponeurosis (Frayn et al, 1989).  This cannulation was carried out under strict 
aseptic technique (using chlorhexidine surgical skin prep) and the initial puncture 
site (always at least 10cm from the actual sampling site due to the length of the 
catheter) was infiltrated with 1% lignocaine as local anaesthesia.  In cases where 
veins were difficult to cannulate, a cold light source (Brian Reece Scientific Ltd, 
Berks, UK) and/or heating device (a small electric blanket placed on the 
abdomen) were used to aid visualisation/induce local vasodilatation but again, the 
illuminated or slightly warmed areas were anatomically distinct from the actual 
sampling site.  Radial artery cannulation was performed in a standard manner 
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with a 20 gauge cannula using a minimal amount of 1% lignocaine local 
anaesthetic and an aseptic technique.   
 
Forearm vein cannulation was designed so that the venous blood would be as far 
as possible obtained from forearm muscular elements rather than skin or hand 
circulation.  Cannulation was therefore performed retrogradely using an 18 gauge 
cannula into a deep branch of the median cubital vein using the methods of Coles 
et al (Coles et al, 1958).  All samples were taken with the hand circulation having 
been excluded for at least 2 minutes by the inflation of a blood pressure cuff to 
supra-systolic pressures at the wrist.  The placement of the line was checked by 
blood gas analysis and accepted if the saturation of blood withdrawn was less than 
60% (Møller et al, 1989).  This is because blood draining the hand or skin is 
known typically to have saturations of greater than 70% and often as much as 80 
or 90% due to higher flow rates, lower metabolic activity in the resting state and 
the presence of multiple functional or anatomical arterio-venous fistulae.  
However, despite the precautions described for both the forearm and abdominal 
vein cannulations, a degree of contamination of these effluents by blood draining 
skin and other tissues is impossible to exclude altogether.   
 
Flow calculations 
 
Forearm blood flow was determined by venous plethysmography (Hokanson 
Instruments, Bellevue, WA) (Greenfield et al, 1963).  A mercury strain gauge was 
placed around the relaxed and supported forearm with hand circulation excluded 
for at least 2 minutes by a cuff inflated to supra-systolic pressures at the wrist.  A 
further pressure cuff instantaneously inflated to a predetermined level 
intermediate between arterial and venous pressure (in practice, set at 40mmHg) 
was placed on the upper arm above the elbow.  The change in electrical resistance 
in the mercury strain gauge was recorded for 3 cardiac cycles following the upper 
cuff inflation and the peak slope (in %/s) of the resulting trace recorded using 
Chart for Windows software (AD instruments, Hastings, UK).  This figure 
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represents the volume expansion of the forearm per unit time at the level of the 
strain gauge when arterial inflow but not venous outflow is permitted relative to 
the resting volume of that part of the forearm.  As one ml of blood and one ml of 
forearm muscle by definition occupy the same volume, the percentage volume 
increase due to arterial blood influx may be referred to as mls blood per 100mls of 
forearm tissue.  As forearm tissue comprises mostly muscle with a fixed 
contribution from bone which will not expand, this figure is considered as blood 
flow per 100g forearm muscle.  Some inaccuracy in these assumptions is 
inevitable given differences in forearm tissue composition between muscular and 
less muscular individuals and between those with relatively greater amounts of 
subcutaneous forearm adipose tissue.   
 
Adipose tissue blood flow was quantified using the 133Xe dispersion method 
(Larsen et al, 1966, Coppack et al, 1990, Quaade et al, 1967, Nielsen 1972, Prinz 
et al, 1986).  Approximately 150µCi of 133Xe (Mallinckrodt Medical, Le Petten, 
Holland) dissolved in a volume of approximately 0.05 to 0.15 mls saline 
depending on the specific activity of the isotope was injected using a 26 gauge 
needle into superficial abdominal AT approximately 3 cm lateral to the umbilicus 
using a minimally traumatic technique and no local anaesthetic.  The injecting 
needle was carefully withdrawn over at least 45 seconds to avoid leakage along 
the needle track and the 133Xe depot allowed to equilibrate with AT for at least an 
hour before measurements were taken.  This is to allow the complete dissolution 
of the 133Xe into AT according to its partition coefficient, λ (Jansson & Lonroth 
1995).  It has been shown that the gradient of the mono-exponential washout 
curve detected by a caesium iodide detector (Oakfield Instruments, Eynsham, 
UK) reflects the blood supply to that area of AT and the results have been 
validated in animals with micro-spheres and in humans with microdialysis and 
colour doppler techniques (Nielsen 1972).  Prior to calculating the mono-
exponential washout curve, the raw counts were corrected against a standard 
curve of the form  
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y=x / {1-(n/x)}  
 
supplied by the manufacturer where y denotes corrected counts, x raw counts and 
n the maximum raw count detection rate when a highly active source is placed 
close to the detector (determined experimentally as 40,000).  This correction is 
necessary due to the fact that the number of counts that the Cs iodide cell can 
detect is finite and the error increased in importance as the maximum level of 
detection is reached.   
 
The dose of 133Xe administered was chosen as a compromise between this and the 
introduction of errors from random count variation and background radiation if 
too small a count rate were attempted.  Values of approximately 5000-10,000 
counts/s were typically obtained.  A typical curve with the natural log of the 
corrected count rate plotted against time is presented in figure 2.2 below. 
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Figure 2.2:  Loge corrected 133Xe count vs. time in a representative subject over 1 
hour. 
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Legend to Figure 2.2 
 
Shows natural logarithm (Ln) decay in dpm over time in a representative subject 
plotted in ‘Microsoft Excel’ to obtain the gradient of the mono-exponential decay 
curve.  For calculations and assumptions used, please refer to text. 
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It may be shown that the rate constant k of the mono-exponential decay curve of 
the form y=a+be-kt may be calculated according to the formula  
 
k = (ln y2 - ln y1)/t2 – t1   
 
where y1 and y2 were the counting rates at times t2 and t1 min respectively.  In 
practice, k is taken as the gradient of the line of best fit of a plot of ln 133Xe (dpm) 
vs. time as shown above.  This experimentally derived rate constant may then be 
used to calculate the adipose tissue blood flow (ATBF, mls. 100g-1 adipose tissue. 
min-1) using the formula 
 
ATBF = -100kλ   
 
where λ is the AT-to-blood partition coefficient for 133Xe.  The value for λ was 
taken to be 10 ml/g as this has been shown to represent a close approximation in 
both lean and obese subjects (Jansson & Lonroth 1995). 
 
Subcutaneous adipose tissue plasma flow (ATPF) was calculated as  
 
ATPF = ATBF·x (1-hematocrit). 
 
Although well validated, this technique is subject to a number of possible sources 
of error which are not possible to quantify exactly.  These include the fact that 
some of the measured blood flow will be partitioned to skin, the counting 
geometry of the Xenon depot may vary over time or between individuals, the 
count rate is determined over a 30 minute period and the actual blood flow may 
not be entirely static over this time, tissue distortion by the presence of the 
volume of saline and/or damage caused by the injection may all influence local 
blood flow and diffusion of the Xenon may be influenced by unknown local 
anatomical differences such as the lobular structure of the AT and its 
microcirculation and interstitial fluid content.   
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Isotopes 
 
Once the cannulae were in place, the 133Xe was injected as described above and a 
constant rate infusion of 3H-Norepinephrine (3H-NE) was started, the subject 
being allowed to rest during the equilibration of these isotopes.  The tritiated 
norepinephrine was necessary for the reasons discussed in the legend to figure 
2.1.  SNS activity was to be quantitated by measurement of a-v differences in NE 
concentrations multiplied by the appropriate tissue blood flow.  This is possible 
because NE is released from SNS terminals and undergoes one of a number of 
fates (Esler et al, 1990).  Much of it is taken back up into the nerve terminal that 
released it by a process (uptake 1) which results in its metabolism by the intra-
neuronal enzyme, monoamine oxidase (MAO).  NE that escapes this reuptake 
mechanism is subject to degradation elsewhere in the tissue (uptake 2) by non-
neuronal catechol-o-methyl transferase (COMT).  However, a small proportion 
(estimated at around 15%) escapes both of these processes and diffuses into the 
perfusing blood allowing the measurement of a-v differences.  It has been shown 
that the proportion of NE that ‘spills over’ (norepinephrine spillover) into blood is 
directly proportional to that released at SNS terminals over a wide range of SNS 
activity (Esler et al, 1990) thus permitting semi-quantitative assessment of SNS 
activity locally within a tissue by measurement of the NE flux (product of a-v 
difference and flow) from that tissue.  However, this calculation alone is not 
sufficient as in a single passage through the human forearm, for example, a 
variable amount (up to 50%) of circulating NE is removed.  Thus NE is both 
taken up from and simultaneously released into blood in passage through tissues 
and this will render assessment of NE production on the basis of net flux alone 
inadequate.  However, the proportion of tissue uptake of NE may be calculated 
from the assessment of the simultaneous uptake of radio-labelled infused 3H-NE.  
This is then converted into tissue clearance of NE by taking the product of 
perfusing arterial concentration and fractional uptake of NE.  The net flux may 
then be converted into a true NE spillover measurement according to the formula 
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NEspillover = Net NEflux + Tissue NEclearance 
 
If [NE]v and [NE]a represent venous and arterial NE concentrations respectively 
and ATPF is adipose tissue plasma flow,   
 
Net NEflux = ([NE]v – [NE]a) x ATPF 
 
and 
 
Tissue NEclearance = NEfractional extraction x [NE]a x ATPF 
 
NE fractional extraction (fexNE) is calculated with the use of the isotope enrichment and 
represents the fractional amount of isotope activity removed from the arterial 
plasma in a passage through the tissue.  Thus, where SAa and SAv are NE specific 
activities in arterial and venous samples, respectively, 
 
fexNE = ([NE]a x·SAa ) - ([NE]v x·SAv)  
[NE]a x SAa 
 
Adipose tissue NE spillover rate, AT [NE]spillover, was therefore calculated as 
 
([NE]a.SAa ) - ([NE]v.SAv) 
[NE]a.SAa). 
 
Some of the assumptions inherent in these calculations include the fact that radial 
artery [NE] concentration may not be exactly equal to that in the arteries actually 
perfusing abdominal AT and the possibility that isotope effects may exist (i.e. that 
the fact that the labelled NE is physically different to the ‘native’ molecule may 
affect its tissue metabolism).  It must further assume that labelled NE is not taken 
up, transported and released by SNS axons.  However, in addition to permitting 
[NE]spillover = x ATPF ([NE]v - [NE]a) + ([NE]a  x
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estimates of tissue clearance, this technique does permit assessment of 
contributions to NE metabolism by uptakes 1 and 2 if labelled moieties of 
metabolites are measured in subsequent assays as the intermediate and end 
products of these pathways are quite distinct (Esler et al, 1990).   
 
The isotope used was levo-[ring-2,5,6-3H] (New England Nuclear, Boston, MA) 
provided in acetic acid/ethanol (9:1) with specific activity range 40-80 Ci/mmol, 
purity >97%, optical purity>99%, MW 169.2.  This was diluted into aliquots with 
ascorbic acid preservative under aseptic conditions and the vials defrosted 
immediately prior to infusion.  Whole body kinetics for NE are calculated 
according to the formula  
 
Whole body rate of appearance = [3H]-NE isotope infusion rate (dpm/min)  
specific activity (dpm/nmol) 
 
 
Rongen (Rongen et al, 2000) has observed that spillover assumptions appear to 
hold under steady conditions but may be affected by changes in blood flow in 
non-steady state conditions.  He proposed a mathematical correction of spillover, 
namely appearance rate (AR), which appears robust to this where 
 
AR = Spillover  
(1- fexNE) 
 
and calculations made using this correction are presented where appropriate 
alongside those using the assumptions of Esler (Grassi & Esler 1999).   
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Sampling and assays 
 
Once all the isotope infusions have been allowed to reach steady state, samples 
were drawn simultaneously from all three sampling sites and were taken directly 
into cooled lithium-heparin tubes (Monovet, Sarstedt, Germany).  They were 
stored on ice until centrifugation for 15 minutes at 3000 rpm whereupon the 
plasma was separated and aliquoted within 30 minutes of being drawn and plasma 
stored at –700C until assay.  All assays were performed in a single batch in the lab 
of Prof G Eisenhofer (NIH, Bathesda, Washington, USA) and appropriate internal 
controls and standards used.  Plasma [NE] concentration was determined by a 
single isotope derivative radio-enzymatic method and plasma [3H]-NE specific 
activity was determined after organic extraction (Shah et al, 1985, Eisenhofer et 
al, 1986).  Samples of the infusates were taken in order to measure specific 
activities and the rates of isotope infusion noted in order to permit calculation of 
whole body kinetics. 
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METHODS FOR OTHER STUDIES 
 
 
Cannulations were used in the other studies and the techniques used were similar 
to those outlined above.  A euglycaemic hyperinsulinaemic clamp was employed 
to obviate spontaneous insulin pulses in the studies described in chapters V and 
VI.   
 
Insulin Clamp Methodology 
 
A hyperinsulinaemic-euglycemic clamp was established by infusing insulin, using 
a primed-constant infusion protocol (DeFronzo et al, 1979) with the final infusion 
rate 35 mU. m-2. min-1.   
 
Histological Techniques 
 
These are integral to the relevant chapter and are therefore described fully in 
Chapter VII. 
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CHAPTER III 
 
 
 
 
 
 
 
GLUCOSE AND KETONE BODY METABOLISM IN 
HUMAN DEEP AND SUPERFICIAL FOREARM AND 
SUBCUTANEOUS ABDOMINAL TISSUE 
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INTRODUCTION 
 
Peripheral (non-splanchnic) tissues are important sites of uptake of oxidative fuels 
such as glucose and ketone bodies.  Skeletal muscle, brain and myocardium are 
regarded as the major sites of oxygen uptake (Ferrannini & DeFronzo 1997) but 
even in healthy lean subjects (e.g. ~70 kg man) the skin (~6 kg) and adipose tissue 
(~12 kg) are large organs which could contribute significantly to glucose and 
ketone body uptake, as well as lactate production (Ferrannini & Groop 1989, 
Buchalter et al, 1989).  There are relatively few data in vivo about the uptake of 
oxidative fuels by skin and adipose tissue.  
 
The Fick principle, or arterio-venous difference method, has been extensively 
used to study metabolism in vivo in man (Zierler 1961).  However, arterio-venous 
differences studies require identification of suitable vascular beds for use as 
models of the tissue of interest.  Both the deep forearm and the leg have been used 
to study skeletal muscle metabolism (Andres et al, 1956, Coles et al, 1958, 
Mottram & Butterfield 1961, Wahren 1966, Kaijser & Rössner 1975, Rössner et 
al, 1976, Jackson et al, 1986, Møller et al, 1989).  For the study of subcutaneous 
adipose tissue, Zierler’s group (Baltzan et al, 1961) proposed that the superficial 
forearm tissue was a suitable bed, and this model was used extensively (Andres et 
al, 1956, Wahren 1966, Kaijser & Rössner 1975, Rössner et al, 1976, Jackson et 
al, 1986, Jackson et al, 1987).  Frayn suggested that a subcutaneous abdominal 
vein yields samples more closely reflecting adipose tissue metabolism (Frayn et 
al, 1989).   
 
In many resting tissues glucose is utilised as a substrate for anaerobic glycolysis, 
lactate being the end-product released by the tissue (Buchalter et al, 1989, Andres 
et al, 1956, Kreisberg 1972).  Both skin and adipose tissue appear to use 
anaerobic glycolysis more than resting muscle.  Lactate production by skin has 
been shown by studies in vitro (Hsia 1971, Johnson & Fusaro 1972).  Similarly, in 
vitro (Crandall et al, 1983, Newby et al, 1990) and microdialysis studies (Jansson 
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et al, 1990, Hagström et al, 1990, Simonsen et al, 1994) show lactate production 
by adipose tissue.  Arterio-venous difference studies both of the superficial 
forearm (Kaijser & Rössner 1975, Jackson et al, 1987) and of subcutaneous 
abdominal tissue (Simonsen et al, 1994, Coppack et al, 1990a, Coppack et al, 
1990b) show lactate production. However the quantitative importance of these 
peripheral tissues for whole body lactate production remains uncertain 
(Kerckhoffs et al, 1998, Coppack et al, 1996).   
 
Although the superficial forearm has little subcutaneous adipose tissue and 
relatively thick skin compared to the superficial abdominal site, previous authors 
have considered the oxidative fuel uptake of adipose tissue and skin to be 
generally similar (Jackson et al, 1987, Johnson & Furaso 1972).  The aim of our 
study was to examine glucose and ketone body metabolism in deep forearm and 
superficial tissues and in particular to compare the characteristics of the 
superficial forearm tissues and subcutaneous abdominal tissues as described by 
Zierler (Baltzan et al, 1961) and Frayn (Frayn et al, 1989), respectively.  We 
therefore undertook a study combining arterio-venous difference techniques 
across superficial forearm tissue, subcutaneous abdominal tissue and deep 
forearm tissue (Andres et al, 1956, Coles et al, 1958, Mottram & Butterfield 
1961, Wahren 1966, Kaijser & Rössner 1975, Jackson et al, 1986) in normal 
healthy subjects.  Measurements were made in the post-absorptive state and 
during hyper-insulinaemia induced by glucose infusion.  We wished to test the 
hypothesis that these two superficial tissue beds would have similar patterns of 
metabolism.
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METHODS 
 
Subjects  
 
Approval for the study was given by the Local Research Ethics Committee. 
Thirteen healthy male volunteers gave written, informed consent. All volunteers 
were non-smokers and taking no medications. Subject data is shown in Table 3.1.  
All subjects were well nourished, weight stable and had normal biochemical 
screen, haematology screen and urinalysis. 
 
Table 3.1:  Characteristics of volunteer subjects 
 
Characteristic Median (inter-quartile range) 
Age (years) 26 (23, 29) 
Weight (kg) 73.0 (70.0, 82.6 ) 
Body mass index (kg.m-2) 23.6 (22.8, 24.8) 
Percentage body fat 17.4 (15.8, 17.8) 
Total body muscle mass (kg) 31.5 (29.7, 32.5) 
Total body skin mass (kg) 5.84 (5.59, 6.61) 
Total body fat mass (kg) 13.0 (10.5, 14.7) 
 
 
Legend to Table 3.1:   
 
Baseline characteristics of the study subjects.  Please see Methods for details of 
deriving body composition data. 
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Protocol 
 
The subjects came to the Clinical Research Centre at 1700 h and on arrival ate a 
standard meal providing 20 kcal•kg lean body mass (LBM)-1 with 50% of calories 
as carbohydrate, 30% as fat, and 20% as protein. Thereafter the subjects ate 
nothing and consumed only clear (decaffeinated and calorie-free) fluids. Body 
composition was determined by dual energy X-ray absorptiometry (Lunar 
Instruments, Madison, WI). We chose to study healthy, non-obese, young males 
since it was expected that they would have a relatively consistent thickness of 
subcutaneous tissue deep to the skin of the anterior forearm. This was the case, as 
skin fold thickness in this region was 2-4 mm in all subjects. 
 
Subjects awakened at 0700 h.  Blood sampling cannulae were inserted (using 
local anaesthesia) into a radial artery, a subcutaneous abdominal vein (Frayn et al, 
1989), a superficial forearm vein (Wahren 1966, Rössner et al, 1976, Jackson et 
al, 1986, Baltzan et al, 1961, Jackson et al, 1987) and a deep forearm vein 
(Andres et al, 1956, Coles et al, 1958, Mottram & Butterfield 1961, Wahren 
1966, Kaijser & Rössner 1975, Rössner et al, 1976, Jackson et al, 1986).  The 
subcutaneous abdominal vein was sampled from a cannula whose tip was just 
inferior to the inguinal ligament (by surface anatomy) (Frayn et al, 1989, Coppack 
et al, 1989).  The forearm sampling cannulae were contralateral to the arterial 
cannulae. The median antebrachial vein or another tributary of the basilic vein 
(Gelfand & Barrett 1987) was cannulated to obtain superficial drainage from the 
forearm, the cannula tip being 4-12 cm inferior to the medial epicondyle (Andres 
et al, 1956, Wahren 1966, Kaijser & Rössner 1975, Baltzan et al, 1961, Heaf et 
al, 1977).  In 2 subjects superficial veins did not permit drawing of adequate 
samples and the superficial veins of these subjects were excluded from further 
consideration.  Deep forearm (antecubital, usually the median cubital) veins were 
cannulated retrogradely (Andres et al, 1956, Coles et al, 1958, Mottram & 
Butterfield 1961, Wahren 1966, Kaijser & Rössner 1975, Rössner et al, 1976, 
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Jackson et al, 1986, Møller et al, 1989).  In one subject, no anatomically suitable 
deep antecubital vein could be cannulated.  Samples from forearm veins were 
always taken after exclusion of hand circulation for 2 minutes by applying a 
sphygmomanometer cuff inflated to 60-100 mmHg above arterial pressure.  
Oxygen saturation was measured in each vein.  If initial deep forearm venous O2 
was above 60 % (Møller et al, 1989) the cannula was moved in an attempt to 
achieve acceptable values.  If subsequent deep venous O2 saturations were not 
below 60 % then these samples were not considered further as recommended by 
Møller (Møller et al, 1989).  The samples from an additional superficial vein were 
discarded because oxygen O2 saturation was not consistently >70%. 
 
An infusion cannula was inserted in a forearm vein, ipselateral to the cannulated 
artery.  All cannulae were kept clear with constant infusions of sterile 150 mM 
NaCl at 30 mL.h-1.  
 
After inserting the cannulae (at -90 min), 50 µCi 133Xe in sterile saline was 
injected into the subcutaneous abdominal adipose tissue in the drainage of the 
abdominal vein being sampled to estimate adipose tissue blood flow as described 
in chapter 2 ‘Methods’ (Coppack et al, 1990, Quaade et al, 1967, Nielsen 1972, 
Prinz et al, 1986).   
 
Blood samples were drawn from all sampling cannulae at -30, -20, -10 and -1 
min.  At time ‘0’ an infusion of sterile 50% glucose was infused at 8 mg.min-1.kg 
body weight-1.  In some subjects, this infusion rate was associated with discomfort 
near the infusion site, and the rate was reduced when necessary.  Infusion rates 
actually achieved were between 6-8 mg.min-1.kg body weight-1 for all subjects. 
 
At 60 minutes a sample was taken from the arterial cannula.  All cannulae were 
sampled at 90, 100, 110 and 120 min.  
 
Adipose tissue blood flow was estimated between -30 and -1 min as well as 
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between 90 and 120 min.  This was done by measuring the washout of 133Xenon 
from the tissue depot, assuming a tissue partition co-efficient of 0.82 ml/g 
(Coppack et al, 1999, Nielsen 1972). 
 
Forearm blood flow was measured using venous occlusion strain-gauge 
plethysmography (Hokansen, Bellview, WA) (Coppack et al, 1999, Whitney 
1953, Cooper et al, 1955).  Blood flow was apportioned to superficial and deep 
forearm tissues according to the data of Cooper who examined the effect of 
‘switching’ off superficial flow with iontophoresed vasoconstrictor (Cooper et al, 
1955). 
 
Sample handling and analyses 
 
Blood samples were collected in heparinized blood-gas syringes and kept on ice.  
Oxygen content was subsequently measured on a co-oximeter (Instrumentation 
Laboratories 282, Lexington KY).  Blood pH was determined on a blood gas 
analyzer (Instrumentation Laboratories 1302).  An aliquot was taken into 1% 
perchloric acid for analysis of ketone bodies and pyruvate. 
 
Other blood samples were taken and immediately transferred to pre-cooled tubes 
containing EDTA and kept on ice until centrifuged at 4°C, which was done within 
30 minutes of the sample being drawn.  Plasma was then stored at -70°C. 
 
Glucose, lactate, pyruvate, ß-hydroxybutyrate and acetoacetate were measured by 
enzyme-linked fluorimetric analyses (Frayn et al, 1990). 
 
Plasma insulin concentration was determined by radioimmunoassay (Coppack et 
al, 1999) and haematocrit by centrifugation.  Assay results are reported in the 
fluid assayed e.g. plasma for NEFA, whole blood for oxygen.  Conversions 
between plasma and whole blood are used for whole-body estimates, and other 
derived values (e.g. percentage of oxygen consumption accounted for by fuels). 
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Calculations and Statistics 
 
Net arterio-venous difference was calculated by subtraction of the venous 
concentration from the arterial concentration.  Thus a negative arterio-venous 
difference indicates net release, and a positive arterio-venous difference indicates 
net uptake.  Net fluxes were calculated by multiplication of the arterio-venous 
difference by the tissue whole blood or plasma flow, depending upon which was 
appropriate. 
 
We estimated, by extrapolation, the lactate production that could be accounted for 
by the whole-body muscle mass (WBMM), whole-body skin (WBS) and whole-
body fat mass (WBFM) in these subjects. To do this we measured the WBFM by 
DEXA and took the WBMM to be 50% fat free mass (Elia et al, 1988).  We 
assumed that the whole of the WBMM behaved the same as the deep forearm 
tissue studied here and that the whole of the WBFM behaved the same as the 
subcutaneous abdominal tissue studied here.  These assumptions are considered in 
the Discussion.  The density of muscle was taken as 1.10 g.ml-1 (Clasey et al, 
1999). 
 
Because we could not be sure that the observed values were normally distributed, 
results are given as medians (interquartile range).  Comparisons between groups 
were done using Mann-Witney and Wilcoxon’s tests for unpaired and paired data 
respectively.  A probability value of p<0.05 was taken to be statistically 
significant.
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RESULTS 
 
Blood oxygen content 
 
In all 13 subjects, the oxygen saturations always ranked arterial (highest), 
abdominal vein, superficial forearm vein, deep vein (lowest) at all time points 
(Table 3.2).  However, since O2 saturations were not consistently below 60% in 
the deep vein samples of 3 subjects, and not consistently above 70% in the 
superficial forearm vein samples of 1 subject, these venous samples were not 
analysed further and are excluded from further presentation.  Thus data presented 
relate to n=13 for arteries and abdominal veins, n= 9 for deep forearm veins and 
n=10 for superficial forearm veins. 
 
The oxygen contents of the arterial blood and the arterio-venous differences 
across deep forearm, superficial forearm and subcutaneous abdominal tissue are 
shown in Table 3.2. 
 
Post-absorptive conditions 
 
Arterial concentrations were steady during the post-absorptive measurement 
period (time -30 to -1 in Figure 3.1) 
 
Net arterio-venous differences in the post-absorptive state are shown in Table 3.2 
and the fluxes (i.e. arterio-venous difference multiplied by the blood/plasma flow) 
in Figures 3.2 and 3.3.  Subcutaneous abdominal tissue tended to take up less 
glucose than deep forearm (p =0.07), but there were no significant differences in 
the post-absorptive glucose uptake between tissues.  Lactate output was seen 
consistently in all subjects for the two superficial tissue beds in the post-
absorptive state, being significantly greater from superficial forearm than from 
either of the other two depots (p<0.05).  Deep forearm lactate metabolism showed 
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net release in some subjects and net uptake in others.  Pyruvate flux was 
significantly different (p<0.05) between deep forearm tissue (net uptake in most 
subjects) and the two superficial tissues (which released pyruvate in all subjects).  
Pyruvate release was not significantly different between the superficial forearm 
and subcutaneous abdominal tissue beds. 
 
From the results shown in Table 3.3, it can be calculated that the net proportion of 
glucose uptake that was released as lactate (i.e. anaerobic glycolysis) was 95.2 
(50.9,137) % for superficial forearm tissue, a significantly higher fraction 
(p<0.05) than those for deep forearm (24.6 (3.7, 52.4) %) or subcutaneous 
abdominal tissue (20.9 (10.0, 40.0)%).  Net glucose uptake (allowing for lactate 
and pyruvate balance) could account for only 5.3 (-6.2, 36.0) % of superficial 
forearm oxygen uptake.  The equivalent value for deep forearm tissue and 
subcutaneous abdominal tissue tended to be greater at 27.8 (16.5, 49.1)% and 66.3 
(17.3, 110)%, respectively (not significant). 
 
Post-absorptive NEFA efflux was significantly different between all three tissues 
(i.e. deep forearm less than both other tissue beds (p<0.02), superficial forearm 
release was less than subcutaneous abdominal tissue (p<0.01)).  Ketone body 
uptake was greater in both forearm tissues than in subcutaneous abdominal tissue 
(p<0.05). 
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Table 3.2:  Arterio-venous differences during the Post-absorptive state 
 
 
 
Legend to Table 3.2: 
 
A positive value indicates uptake. A negative uptake value indicates release. All 
values are medians (interquartile range) and in µmol.l-1.  NEFA are plasma 
concentrations, all other values are whole blood concentrations.  
 
* = significantly different from forearm muscle, p<0.05 
† = significantly different from forearm skin, p<0.05 
  Net a-v differences 
 
Arterial 
concentration 
Forearm  
muscle 
Forearm  
skin 
Adipose  
tissue 
Glucose 
 
4338 
(4025, 4408) 
195 
(163, 351) 
151 
(57, 263) 
121 
(23, 368) 
Lactate 
 
869 
(705, 1050) 
-152 
(-240,-14) 
-214 
(-426,-167)* 
-118 
(-194,-65) 
Pyruvate 
 
30 
(27, 50) 
2 
(-5, 19) 
-8 
(-14,11) 
-4 
(14,-2)* 
NEFA 
521 
(381, 651) 
24 
(7, 62) 
-209 
(-69, -326)* 
-665 
(-379, -870)*†
β-Hydroxy-
butyrate 
153 
(61, 249) 
44 
(21, 80) 
40 
(12, 51) 
7 
(2, 10)*† 
Aceto- 
acetate 
81 
(48, 103) 
29 
(-7, 58) 
19 
(-2, 35) 
10 
(3, 20) 
Oxygen 
 
8092 
(7387, 8674) 
3949 
 (3213, 4532) 
1437 
(1098, 1747)* 
575 
(488, 653)*† 
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Figure 3.1:  Changes in NEFA, Ketones, Glucose and Insulin in response to 
Glucose infusion 
 
 
 
 
Legend to Figure 3.1: 
 
Changes with time in concentrations of plasma non-esterified fatty acids (∆), 
whole blood ketone bodies (•),whole blood glucose (▲) and plasma insulin (ο). 
Glucose infusion (6-8 mg.kg body weight-1.min-1) commenced at time zero. 
Values are medians (± interquartile range).   
 
For glucose, values are in mmol.l-1. For NEFA and ketone bodies, values are in 
µmol.l-1.  For insulin, values are in pmol.l-1. 
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Change during glucose infusion 
 
As expected, arterial glucose, lactate, pyruvate and insulin concentrations rose in 
all subjects whereas NEFA and ketone body concentrations declined (p<0.02 for 
all).  Figure 3.1 shows the changes of arterial glucose, total ketone bodies and 
insulin with time during glucose infusion.  For ketone bodies, the values were 
near to the limits of assay detection, so caution is necessary for interpretation of 
these results. 
 
Adipose tissue blood flow declined significantly (p<0.05) from 4.67 (3.79, 6.03) 
to 3.33 (2.53, 5.35) ml.min-1.100g tissue during the glucose infusion.  Estimated 
muscle blood flow and skin blood flow changed little from the post-absorptive 
value of 3.27 (3.04, 3.44) to 3.64 (2.99, 3.94) ml.min-1.100 ml tissue and from 
7.09 (3.77, 8.20) to 8.20 (4.40, 11.04) ml•min-1•100 ml tissue-1, respectively, 
during the glucose infusion. 
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Table 3.3:  Arterio-venous concentration differences during glucose infusion 
 
 
  Net a-v differences 
 Arterial 
concentration 
Forearm  
muscle 
Forearm  
skin 
Adipose  
tissue 
Glucose 11523 
(11227, 12796) 
1174 
(782, 2120) 
697 
(216, 1231) 
447 
(167, 1450)* 
Lactate 
 
1105 
(935, 1311) 
-46 
(-6, -86) 
-204 
(-135, -263)* 
-104 
(-58, -229)* 
Pyruvate 
 
78 
(57, 105) 
15 
(-3, 30) 
-1 
(-14, 9) 
-3 
(0, 13)* 
NEFA 
 
182 
(104, 275) 
32 
(-27, 98) 
-63 
(-1, -75) 
-12 
(9, -43) † 
β-hydroxy 
butyrate 
7 
(6, 13) 
-1 
(-2, 2) 
-3 
(-4, -2) 
-1 
(-3, 1) 
Aceto- 
acetate 
15 
(11, 22) 
2 
(-4, 11) 
-2 
(-7,9)* 
-3 
(-8, 3) 
 
 
Legend to Table 3.3:   
 
A positive value indicates uptake. A negative value indicates release.  All values 
are medians (interquartile range) and in µmol.l-1.  NEFA are plasma 
concentrations, all other values are whole blood concentrations. 
 
* = significantly different from forearm muscle, p<0.05 
† = significantly different from forearm skin, p<0.05 
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The arterio-venous differences during glucose infusion are shown in Table 3.3 
and the fluxes during glucose infusion in Figures 3.2 and 3.3.  As indicated, the 
glucose flux for deep forearm and superficial forearm tissue increased 
significantly, whilst the fluxes for fatty acids and ketone bodies declined across 
all tissues.  Notably, in subcutaneous abdominal tissue, the glucose flux across 
subcutaneous abdominal tissue tended to increase, but the change did not reach 
statistical significance.  During the glucose infusion, deep and superficial forearm 
tissues both took up significantly more glucose than did subcutaneous abdominal 
tissue (p<0.05). 
 
The suppression of fatty acid release was greater (p<0.02) in subcutaneous 
abdominal tissue than in the superficial forearm tissue both in absolute and 
percentage terms (Figure 3.2). 
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Figure 3.2:  NEFA and Ketone fluxes in the 3 tissues before and during glucose 
infusion 
 
 
 
Legend to Figure 3.2:   
 
Median (± interquartile range) values of fluxes (in nmol.100 g-1.min-1) for non-
esterified fatty acids (upper panel) and ketone bodies (lower panel).  The open 
bars indicate results during the post-absorptive state, the hatched bars indicate 
results during glucose infusion. Positive flux values indicate uptake, negative 
values indicate release.  Values during glucose infusion that are significantly 
different (p<0.05) from post-absorptive are indicated (*). 
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Figure 3.3:  Glucose, Pyruvate and Lactate Fluxes in the 3 tissues before and 
during Glucose infusion 
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Legend to Figure 3.3:   
 
Median (± interquartile range) values of fluxes (in nmol.100 g-1.min-1) for glucose 
(upper panel), pyruvate (middle panel) and lactate (lower panel).  The open bars 
indicate results during the post-absorptive state, the hatched bars indicate results 
during glucose infusion.  Positive flux values indicate uptake, negative values 
indicate release.  Values during glucose infusion that are significantly different 
(p<0.05) from post-absorptive are indicated (*). 
 
 
Whole body extrapolations 
 
Assuming the whole body muscle mass behaved like the deep forearm tissue in 
these subjects, the whole body muscle mass would consume 186 (154, 272) 
µmol.min-1 of glucose and release 127 (14, 252) µmol.min-1 of lactate.  
Extrapolation of the current superficial forearm tissue results to the whole body 
skin mass would suggest that skin consumes less glucose (33 (25, 96) µmol.min-1) 
than whole body muscle (p<0.05), but produces a comparable amount of lactate 
(84 (44, 198) µmol.min-1).  Likewise, whole body estimates of glucose 
consumption by adipose tissue 53 (8, 220) µmol.min-1 were less (p<0.05) than 
those of whole body muscle mass.  The estimated whole body fat mass lactate 
production rate was 70 (32, 120) µmol.min-1.
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DISCUSSION 
 
As expected, the deep forearm tissue, which has been extensively studied as a 
model for muscle metabolism (Andres et al, 1956, Coles et al, 1958, Mottram & 
Butterfield 1961, Wahren 1966, Kaijser & Rössner 1975, Jackson et al, 1986), 
behaves differently from the two superficial tissue beds.  The novelty of the 
current study is in the differences seen between these superficial tissues, notably 
(a) in the post-absorptive state the superficial forearm tissue tended to take up 
more glucose than the subcutaneous abdominal tissue; (b) superficial forearm 
glucose uptake was mostly converted to lactate; (c) superficial forearm glucose 
uptake increased more during glucose infusion and became significantly greater 
than that in the abdominal tissue; (d) conversely, the superficial forearm tissue 
released less fatty acids post-absorptively; but (e) this release was less completely 
suppressed during glucose infusion. 
 
Results in this study are consistent with the interpretation that forearm superficial 
tissue in lean men drains primarily skin with little contribution from subcutaneous 
fat, whilst the subcutaneous abdominal tissue is predominantly adipose tissue 
with a proportionately smaller amount of skin. This supports previous suggestions 
(Kaijser & Rössner 1975, Simonsen et al, 1994), although a direct comparison 
has not been reported.   
 
As mentioned above, in the post-absorptive state, the glucose arterio-venous 
differences and fluxes were not significantly different between the three sites but 
the superficial abdominal tissue tended to take up least glucose (Table 3.2 & 
Figure 3.3).  Previous work has consistently reported a lower uptake (usually 
significantly lower) of glucose by abdominal subcutaneous tissue compared to 
deep forearm tissue (Coppack et al, 1990, Coppack et al, 1996, Horowitz et al, 
2001).  Previous studies showed lactate production by superficial forearm tissue 
(Kaijser & Rössner 1975, Jackson et al, 1987).  The current study showed this 
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lactate production by superficial forearm tissue was higher than that of the other 
two tissues (Table 3.2, Figure 3.3).  This superficial forearm lactate production 
could account for most of that tissue’s glucose uptake which would be compatible 
with the high conversion rates of glucose to lactate seen in studies in vitro of skin 
(Newby et al, 1990, Newby et al, 1988, Mårin et al, 1987).  As expected from 
previous work (Baltzan et al, 1961, Coppack et al, 1999), both superficial tissues 
released significant amounts of fatty acids (NEFA), whilst the deep forearm took 
up NEFA.  The NEFA arterio-venous difference and NEFA flux were both 
significantly greater (p<0.02) in abdominal subcutaneous than forearm superficial 
tissue (Table 3.2, Figure 3.2), reinforcing the idea that this depot contains more 
adipose tissue than skin.   
 
During glucose infusion, the glucose uptake of both the forearm tissues increased 
significantly (p<0.05), whilst that of the subcutaneous abdominal tissue did not.  
This led to the glucose arterio-venous difference in deep forearm and the glucose 
fluxes for both deep and superficial forearm tissue being greater (p<0.05) than 
that of the abdominal tissue during glucose infusion (Table 3.3, Figure 3.3).  It is 
well-known that hyperglycaemia and hyperinsulinaemia increases deep forearm 
glucose uptake.  The lack of such an increase in the abdominal tissue that we 
believe to represent mostly adipose tissue is surprising in relation to some 
previous in vitro work (Green & Newsholme 1979, Zeuzem & Taylor 1985).  
However, this observation is in line with previous arterio-venous difference 
findings (Coppack et al, 1996, Coppack et al, 1989) and other studies suggesting 
that insulin produces only a modest increase in glucose uptake by adipose tissue 
(Mårin et al, 1987, Hjöllund et al, 1985).   
 
Also as expected (Kerckhoffs et al, 1998, Coppack et al, 1999, Coppack et al, 
1989, Frayn et al, 1994), the insulinaemic response to glucose infusion reduced 
lipolysis in subcutaneous abdominal tissue.  During the same period the release of 
NEFA from superficial forearm tissue also declined significantly (p<0.05).  
However the inhibition of NEFA release in both absolute and percentage terms 
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was less in forearm than abdominal tissue.  This observation perhaps parallels the 
observation that lipolysis in the upper-body is more resistant to insulin’s anti-
lipolytic effect than is lipolysis in the lower-body (Jensen 1991, Martin & Jensen 
1991, Roust & Jensen 1993).   
 
The importance of these tissues to whole body glucose metabolism can be 
estimated by extrapolation.  Our data suggest that postabsorptive skin and adipose 
tissue are only minor consumers of glucose (≈ 4% and ≈ 7% of whole body, 
respectively).  Such assumptions should be interpreted conservatively because of 
heterogeneity between adipose tissue depots (Jensen 1991, Jansson et al, 1992).  
Estimates of adipose tissue glucose uptake based upon uptake of 14C-labelled 
glucose into a single adipose depot are low (Mårin et al, 1987, Mårin et al, 1992).  
However, that method may underestimate glucose uptake because it only 
measures 14C-glucose remaining in the tissue at the time of biopsy and takes no 
account of isotope taken up and then re-released as lactate, glycerol or CO2.  
Previous arterio-venous estimates of post-absorptive whole body adipose tissue 
glucose uptake have been 11 ± 2% for lean female subjects (Horowitz et al, 2001) 
and ~5% in lean subjects of mixed sex (Coppack et al, 1996).  In obese sex-
matched groups, the equivalent estimates were 21 ± 4% and ~7% (Coppack et al, 
1996, Horowitz et al, 2001), but those studies share the same limitation as the 
current one in terms of extrapolation from a single depot to the whole body.   
 
Transport of monocarboxylates such as lactate and pyruvate across the plasma 
membrane has a role in the metabolism and pH regulation of most cells 
(Manoharan et al, 2006).  Monocarboxylate transport is mediated by a family of 
monocarboxylate transporters (MCTs) of which there are now known to be 14 
members, although only for members 1–4 has lactate and pyruvate transport been 
demonstrated directly (Halestrap & Meredith 2004).  To be translocated correctly 
to the plasma membrane, MCTs 1–4 require the ancillary protein basigin (also 
known as CD147) or its homologue, embigin (also known as gp70) (Fanelli et al, 
2003).  Adipose tissue and skin have been proposed (Jansson et al, 1990, 
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Hagström et al, 1990, Kerckhoffs et al, 1998, Mårin et al, 1987) as important 
sources of lactate production.  Our data confirm that these two tissues do produce 
lactate.  However, whole-body extrapolation suggests that net adipose tissue 
production is a small proportion (~ 8%) of whole body lactate production (as 
reviewed by Buchalter (Buchalter et al, 1989)).  The equivalent contribution of 
skin would be only slightly greater (~ 9%).  The hyperlactatemia seen after 
glucose infusion is accompanied by no significant change in the lactate release by 
either superficial tissue.  The lactate output by deep forearm tissue was reduced 
during glucose infusion.  This was also seen following an oral glucose load in 
Jackson’s study (Jackson et al, 1987) but not in other studies (Coppack et al, 
1990, Kerckhoffs et al, 1998). 
 
The subcutaneous abdominal tissue had the largest arterio-venous difference for 
NEFA and appeared the better tissue bed for study of a relatively pure adipose 
tissue depot.  Superficial forearm tissue contains some lipolytic elements 
(presumably adipose) but showed the greatest arterio-venous difference for lactate 
and pyruvate production, suggesting skin elements are predominant in the arterio-
venous differences seen. 
 
In summary, these findings suggest that superficial forearm veins drain a 
predominantly cutaneous (rather than adipose) bed with modest NEFA release 
and high conversion of glucose to lactate (~90%).  During glucose infusion, skin 
glucose uptake increases significantly and NEFA release is reduced (by ∼70%).  
In contrast the superficial abdominal vein drains a predominantly adipose tissue 
bed with greater lipolysis but less conversion of glucose to lactate.  During 
glucose infusion adipose glucose uptake changes little whereas NEFA release is 
markedly (>90%) inhibited.  Whole body extrapolations suggest that both skin 
and adipose tissue are each minor (<10%) contributors to whole body glucose 
uptake and lactate production. 
 
These studies confirmed the relative purity of venous drainage from 3 
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metabolically distinct body tissues.  We then sought to examine the role of the 
SNS as a putative mechanism underlying the different metabolic characteristics of 
two of these tissues, adipose tissue and deep forearm skeletal muscle under post 
absorptive and postprandial conditions in individuals of differing body 
composition.  The Sympathetic Nervous System (SNS) is thought to regulate 
lipolysis (and thereby, ketogenesis (Bahnsen et al, 1984)), adipose tissue blood 
flow (Ardilouze et al, 2004) and secretion of cytokines from adipose tissue 
(Haynes 2000).  Dysfunction of both skeletal muscle and adipose tissue 
metabolism is described in insulin resistant states and obesity.  Catecholamine 
infusions elevate blood glucose levels, suppress plasma insulin and differentially 
affect glucose metabolism to lactate or pyruvate (Pernet et al, 1984).  We 
therefore hypothesised that abnormalities of the SNS innervation of these tissues 
may be found in human obesity and have the potential either to cause or maintain 
the obese state or to underlie some of its metabolic consequences.   
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CHAPTER IV 
 
 
 
 
 
 
 
DYSFUNCTION OF SYSTEMIC AND REGIONAL 
SYMPATHETIC NERVOUS SYSTEM OUTFLOW IN 
HUMAN OBESITY 
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INTRODUCTION 
 
The sympathetic nervous system contributes to body weight regulation via 
influences on appetite (Bray 2000, Tsujii & Bray 1998), resting energy 
expenditure (Webber & Macdonald 2000) and thermogenesis (Bachman et al, 
2002, Yoshitomi et al, 1998).  Sympathetic nerves innervating adipose tissue also 
regulate lipolysis (Collins & Surwit 2001, Youngstrom & Bartness 1998, Christin 
et al, 1989, Carey 1998) and other endocrine/paracrine functions, such as 
secretion of leptin and other cytokines (Trayhurn et al, 1996, Rayner 2001, 
Trayhurn et al, 1998, Lu et al, 1998, Orban et al, 1999), as well as adipocyte 
differentiation (Loncar 1991) and apoptosis (Valet et al, 1998).  Since the above 
actions influence overall energy balance and adipose tissue behaviour, it seems 
plausible that dysfunction of the sympathetic nervous system (SNS) might result 
in a tendency for weight gain.  Indeed, as pointed out by Bray (Bray 1991), this 
view is supported by many animal models of obesity.   
 
Conversely, a number of clinical studies have shown that the SNS is systemically 
activated in obesity and it is widely thought that sympathetic activation may be a 
major factor in obesity-related hypertension (Daly & Landsberg 1991, Landsberg 
2001, Carlson et al, 2000, Corry & Tuck 1999, Esler 2000, Kunz et al, 2000, 
Masuo et al, 2000, Vaz et al, 1997).  This view is corroborated by the observation 
that SNS traffic is reduced after weight loss and this is accompanied by a 
reduction in blood pressure (Grassi et al, 1998).   
 
Despite this, many of the changes in the behaviour of adipose tissue seen in 
obesity would be better explained in terms of reduced rather than increased 
sympathetic drive to this tissue.  For example, increased leptin secretion, 
increased fat depot size and decreased lipolysis per unit fat mass (Klein et al, 
1988) are all features of obesity yet each of these changes can also be caused by 
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measures that reduce sympathetic activity such as surgical sympathectomy 
(Youngstrom & Bartness 1998) or adrenergic receptor blockade (Rayner 2001). 
 
Despite the advent of a new generation of sympathomimmetic anti-obesity agents 
with specificity for the ß3 adrenoceptor (Weyer et al, 1999), little is known about 
the function of sympathetic nerves innervating white adipose tissue, the principal 
location of this receptor in man.  The need for specific information on the 
innervation of adipose tissue is further underlined by the fact that many studies 
(Vaz et al, 1997, Esler et al, 1984, Cox et al, 1995, Muntzel et al, 1994) have 
demonstrated that the SNS shows considerable regional and tissue specific 
heterogeneity.   
 
We therefore hypothesized that sympathetic outflow to adipose tissue would be 
reduced in obesity independent of the systemically increased SNS outflow 
previously reported in this condition.   
 
We examined differences in sympathetic outflow after an overnight fast and in 
response to feeding in 11 obese subjects (BMI>30 Kg.m-2) and 11 lean controls 
(BMI<25 Kg.m-2).  Sympathetic outflow was assessed systemically and 
regionally using radiotracer-dilution methodology, involving intravenous 
infusions of 3H-labelled norepinephrine and measurements of the rate of entry of 
endogenous norepinephrine into the general circulation and into blood draining 
subcutaneous abdominal adipose tissue and forearm skeletal muscle. 
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METHODS 
 
A detailed account of the methods, assumptions and calculations is available in 
Chapter II ‘Core Experimental Methods’.   
 
Subjects 
 
Eleven obese (BMI>30kg.m-2) and 11 lean (BMI<25kg.m-2) age and sex-matched 
controls (Table 4.1) were recruited for the study.  Full, informed and written 
consent was obtained from each volunteer prior to participation.  Medical history 
and physical examination (including an Allen test- digital occlusion of the radial 
artery to ensure adequate ulnar arterial blood supply to the hand before radial 
artery cannulation) were performed and routine laboratory blood tests sent for 
analysis (including full blood count, haematocrit, urea and electrolytes, liver 
function tests, fasting glucose, fasting lipids and thyroid function tests).  Urine 
was tested for protein and blood and a urine pregnancy test performed before 
isotope administration in all women of childbearing potential.  Subjects were 
weight stable for at least 3 months prior to participation in the study.  
Anthropomorphic tests were performed on each subject including resting 
metabolic rate (Deltatrac), height, weight, waist-hip ratio, skin fold thickness, 
blood pressure and pulse rate.  Subjects attended the clinical research centre at 
approximately 0800 hrs after consuming a standardised meal and snack the 
previous evening and fasting overnight from midnight.  The meal contained 15 
kcal/Kg lean body mass (LBM) calculated from the formula  
 
LBM = (0.3281 x weight/Kg) + ((0.33929 x height/cm) – 29.5336) 
 
and delivered energy from carbohydrate, fat and protein in the proportions 50%, 
30% and 20% respectively, figures approximating to a healthy, eu-caloric diet 
(although perhaps somewhat different to that actually consumed by an average 
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Western population).  The snack was of identical macronutrient composition but 
comprised 5kcal/Kg calculated lean body mass.   
 
All subjects refrained from vigorous physical activity or alcohol for at least 36 
hours and from caffeine or smoking (2 smokers in each group) for 12 hours prior 
to the study.  Subjects taking drugs known to affect the SNS such as 
antidepressants, diuretics, α- or β-blockers, false transmitters, cocaine, cannabis, 
sibutramine or amphetamines were not recruited nor were those with a history of 
significant (> 5%) weight loss in the 3 months prior to the experiments.  The 
presence, proven or suspected, of pathological states such as obstructive sleep 
apnoea which are known to be capable of affecting SNS activity were carefully 
noted but as degrees of sleep disturbance are so prevalent amongst the morbidly 
obese and would tend to lead to increased rather than decreased SNS activity, 
subjects with suggestive features were not excluded on the basis of this alone.  
Known history of phaeochromocytoma, other SNS disease such as the Steele-
Richardson syndrome or reflex sympathetic dystrophy and history of chemical or 
surgical sympathectomy were excluded from taking part in these experiments. 
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Table 4.1:  Baseline characteristics of study subjects 
 
 
TABLE 4.1.  BASELINE CHARACTERISTICS * 
CHARARACTERISTIC LEAN OBESE 
 (N=11) (N=11) 
Age (years) 33.3 ± 2.86 38.4 ± 2.50 
Sex – no. (%)   
Male 6 (54%) 5 (45%) 
Female 5 (45%) 6 (54%) 
Body Mass Index (Kg.m-2) 23.1 ± 0.24 44.2 ± 0.84 
Blood Pressure‡   
Systolic - mmHg 120.3 ± 2.89 135.3 ± 3.68 
Diastolic - mmHg 75.5 ± 3.17 89.6 ± 3.35 
Weight – Kg 67.9 ± 2.38 135.7 ± 9.23 
Height – cm 171.2 ± 2.89 171.7 ± 2.02 
 
 
Legend to Table 1 
 
* Values are mean ± SEM.   
 
‡ Both systolic and diastolic blood pressures were significantly higher in the 
obese group (p<0.008 and p<0.01 respectively).  Otherwise, there were no 
significant differences between the groups except in weight/BMI. 
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Protocol 
 
Subjects attended the Clinical Research Centre at 0800hrs after the overnight fast 
and standard meal and snack the previous evening discussed above.   
 
Arterial blood was obtained from a radial artery catheter inserted under aseptic 
conditions using local anesthesia (lidocaine, 1% w/v).  Venous blood from 
subcutaneous abdominal adipose tissue was obtained from an indwelling catheter 
in a branch of the superficial epigastric vein (Frayn et al, 1993) and that draining 
deep forearm tissue (principally muscle) was drawn from a retrogradely placed 
forearm venous cannula as previously described (Coppack et al, 1996).  All lines 
were maintained with a constant rate saline infusion of 30mls/h and left for at 
least 45 mins prior to sampling.   
 
In order to determine tissue norepinephrine uptake, a constant infusion of tracer 
amounts (10 nCi.kg-1 .min-1) of levo-[ring-2,5,6-3H]-norepinephrine (40–80 
Ci/mmol; New England Nuclear, Boston, MA) was used.  This infusion was 
continued for at least 60 min to ensure steady state plasma concentration before 
blood sampling commenced. 
 
Abdominal subcutaneous adipose tissue blood flow (ATBF) was measured by the 
133Xe dispersion technique (Larsen et al, 1966, Jansson & Lonroth 1995) and 
forearm blood flow was determined by mercury strain-gauge plethysmography 
(Hokanson, Bellevue, WA) (Greenfield et al, 1963). 
 
After 4 pairs of arterial and venous blood samples from each site in the fasting 
state had been obtained, the subject then ingested a meal containing 15kcal/Kg 
lean body mass with the same macronutrient profile as the previous evening.  
Post-prandial measurements were taken at 60, 80, 100 and 120 minutes after the 
start of meal ingestion as shown in Figure 4.1 below. 
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Figure 4.1:  Experimental Design 
 
 
 
 
Legend to Figure 4.1:   
 
Time course of isotope administration and equillibration, post-absorptive 
measurements (blood sampling, forearm plethysmography and adipose tissue 
blood flow (ATBF) estimation), meal ingestion, and finally post-prandial 
measurements (blood sampling, forearm plethysmography and ATBF estimation ) 
are shown.  Keys are presented in the Figure and the protocol is described further 
in the text. 
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Analyses  
 
Blood was collected directly into cooled, heparinised containers and were 
centrifuged within a few minutes before being frozen at -700C until analysis.  
Plasma norepinephrine concentration, 3H-norepinephrine specific activity and 
epinephrine concentrations were determined as described previously (Eisenhofer 
et al, 1986). 
 
Calculations  
 
We applied Esler’s (Esler et al, 1984) tracer balance approach which is based on 
the concept that the rate of entry of the SNS neurotransmitter, norepinephrine 
(NE), into venous blood (norepinephrine spillover, NEspillover) is an index of local 
sympathoneuronal activity over a wide range of firing rates (Esler et al, 1990).   
 
Thus, at steady state isotope concentrations, systemic (whole body) 
norepinephrine spillover (NE Systemic spillover) was calculated as  
 
NE Systemic spillover = [3H]-NE isotope infusion rate (dpm/min) 
[3H]-NE specific activity (dpm/nmol) 
 
and local NE spillover as NEspillover =  ATPF x ([NE]v - [NE]a) + Tissue NEclearance  
 
where Tissue NE clearance =  (3H[NE]a – 3H[NE]v)  X  [NE]a     
3H[NE]a 
 
and 3H[NE]a and 3H[NE]v are the tritiated norepinephrine counts in arterial and 
venous samples respectively, [NE]v and [NE]a represent venous and arterial 
norepinephrine concentrations respectively and ATPF is adipose tissue plasma 
flow.   
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Local spillovers were also determined using Chang’s (Chang et al, 1991) 
modification of these calculations which has been advocated (Rongen et al, 2000) 
as being less vulnerable to changes in tissue perfusion.  Further details of the 
methods, calculations and assumptions used in this study are presented in Chapter 
II.   
 
Terminology 
 
Direct and absolute quantification of SNS activity in vivo would require 
measurement of many factors including the temporal pattern and frequency of 
action potentials together with the quantity of neurotransmitter release.  It is not 
possible to measure all these factors together in vivo in man.  We have measured 
global (systemic) and regional ‘norepinephrine spillover’, the best available index 
of SNS activity but have used the term ‘sympathetic outflow’ rather than 
‘sympathetic nervous system activity’ throughout the text in acknowledgement of 
these issues.   
 
Statistical Analysis 
 
Values are presented as means ± SEM.  Differences between the 2 groups were 
assessed by ANOVA (SPSS ver. 10, SPSS inc Chicago, Ill.).  Data were 
logarithmically transformed where necessary to normalise the distribution.  
Correlations were assessed using Spearman’s Rank Correlation Coefficient.  
Results were considered significant at p < 0.05.   
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RESULTS 
 
 
Adipose tissue norepinephrine spillover 
 
Local norepinephrine release from sympathetic nerves in adipose tissue was 
significantly lower in the obese subjects than in lean controls in both fasting 
(0.33± 0.09 vs. 0.58± 0.11 pmol.100g-1.min-1) and post-prandial (0.38± 0.15 vs. 
1.08± 0.22 pmol.100g-1.min-1) states (p=0.041 and p=0.008 respectively by 
ANOVA after logarithmic transformation).  This is shown in Figure 4.2.   
 
The transition to the post-prandial state was not associated with any significant 
increase in sympathetic outflow to adipose tissue in the obese group (p=0.657 by 
ANOVA).  However, in marked contrast to this, post-prandial adipose tissue 
norepinephrine spillover increased in the lean subjects by over 80% (p=0.013 by 
ANOVA).  These data are also shown in Table 4.2 and Figures 4.2 and 4.4.   
 
These differences were little affected by recalculation using Chang’s index 
(RaChang,) (Chang et al, 1991, Rongen et al, 2000), and remained statistically 
significant suggesting that the observed changes were not attributable to changes 
in blood flow (Table 4.2).   
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Figure 4.2: Systemic and Adipose tissue SNS outflow 
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Legend to Figure 4.2  
 
† represents a significant difference (p<0.05) between lean and obese groups. 
 
‡ represents a significant difference (p<0.05) between fasting and fed states 
within either lean or obese groups.   
 
Bars represent systemic (left) and adipose tissue (right) SNS outflow in the lean 
(filled black) and obese (hatched) subjects.  For each individual, 4 fasting and 4 
post-prandial values are averaged.  Values shown are means ± SEM.   
 
‘Systemic SNS outflow’ is the rate of secretion of norepinephrine into the 
circulation, measured in nmol per minute.  ‘Adipose tissue sympathetic nerve 
outflow’ is the release rate of norepinephrine into venous blood draining 100g 
adipose tissue per minute.   
 
Systemic SNS outflow was higher in the obese in both fasting and fed states 
whereas adipose tissue SNS outflow was significantly lower in the obese and 
failed to respond to feeding. 
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Table 4.2:  Other results 
 
 
TABLE 4.2.  OTHER RESULTS 
 Arterial NE concentration (pmol.l-1) 
 Fasting Fed 
Lean 1,249.6 ± 107† 1,653.7 ± 123†,‡ 
Obese 1,996.5 ± 226 2,371.6 ± 138‡ 
 Arterial Epinephrine concentration (pmol.l-1) 
 Fasting Fed 
Lean 259.3 ± 22† 218.3 ± 62 
Obese 149.6 ± 26 169.8 ± 37 
 Adipose tissue NE spillover (pmol.100g-1.min-1) 
 Fasting Fed 
Lean 0.58 ± 0.11† 1.08 ± 0.22†,‡ 
Obese 0.33 ± 0.09 0.38 ± 0.15 
 Adipose tissue NE appearance rate § (pmol.100g-1.min-1) 
 Fasting Fed 
Lean 1.38 ± 0.26† 1.87 ± 0.331†,‡ 
Obese 0.80 ± 0.22 1.09 ± 0.40 
 Forearm muscle NE spillover (pmol.100g-1.min-1) 
 Fasting Fed 
Lean 2.04 ± 0.26 4.01 ± 0.42‡ 
Obese 2.80 ± 0.42 4.55 ± 1.16‡ 
 Forearm muscle NE appearance rate § (pmol.100g-1.min-1) 
 Fasting Fed 
Lean 6.66 ± 0.59† 11.38 ± 0.90‡ 
Obese 9.85 ± 1.00 10.00 ± 1.30 
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Legend to Table 4.2 
 
Values are means of 4 fasting (t-30, -20, -10, 0) or fed (t+60, +80, +100, +120) 
sampling points ± SEM.  Statistical significance is tested by repeated measures 
ANOVA. 
 
† represents a significant difference (p<0.05) between lean and obese groups. 
‡ represents a significant difference (p<0.05) between fasting and fed states 
within either lean or obese groups.   
 
§ Appearance rate (Chang Index) is spillover with a correction for changes in the 
fractional extraction of NE as a result of changes in blood flow (see methods for 
details).   
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Systemic spillover and its relationship to Blood Pressure 
 
In marked contrast to the lower sympathetic outflow to adipose tissue, systemic 
SNS outflow in the fasting state (Figure 1) was significantly greater (p<0.02, by 
ANOVA) in the obese (5.03± 0.84 nmol.min-1) than in the lean (2.67± 0.33 
nmol.min-1) subjects.  This difference was accentuated by meal ingestion when 
SNS outflow increased in both groups (p<0.05 by ANOVA) to 7.32± 1.0 
nmol.min-1 and 3.68± 0.44 nmol.min-1 respectively, and remained significantly 
higher in the obese (p=0.007 by ANOVA).   
 
Significant correlations existed between fasting total body norepinephrine 
spillovers and both systolic and diastolic blood pressures (Rs=0.57, p<0.006 and 
Rs=0.676, p<0.001 respectively).  This relationship is shown in Figure 4.3.   
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Figure 4.3:  Relationship between Blood Pressure and Whole Body NE Spillover  
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Legend to Figure 4.3 
 
Correlation between whole body NE spillover (nmol/l) and systolic (◊) and 
diastolic (▲) blood pressure.  Spearman rank correlation coefficients were highly 
significant for both relationships (p<0.006 and p<0.001 respectively).  R squared 
values for the relationships are presented adjacent to the regression lines. 
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Arterial plasma catecholamine concentrations 
 
Although concentrations of epinephrine, secreted by the adrenal medulla, were 
significantly greater in the lean subjects in the fasting state (p<0.02, Table 4.2), 
there was no significant difference in the post-prandial state (p=0.77) and no 
significant response to the meal in either group.   
 
In contrast, arterial concentrations of norepinephrine (Table 4.2) reflected 
systemic release and thus were significantly higher in the obese in both fasting 
(p=0.02 by ANOVA) and fed (p<0.02 by ANOVA) states, increased in both 
groups in response to meal ingestion (p<0.05 by ANOVA) and, like systemic 
SNS outflow, showed positive correlations with both systolic and diastolic blood 
pressures in both fasting and fed states (p<0.05 for both).   
 
Forearm muscle norepinephrine spillover 
 
Although the release of norepinephrine from forearm muscle exceeded that of 
adipose tissue in both groups (p<0.0001 by ANOVA) and increased in both 
groups in response to meal ingestion (p<0.05 by ANOVA), there were no 
significant differences between the lean and obese groups in either the fed or 
fasting state (see Figure 4.4 for comparison of systemic, muscle and forearm 
muscle NE spillover at each time point before and after eating). 
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Figure 4.4:  Systemic, Muscle and Adipose Tissue NE Spillover at each time point.   
 
 
-30 0 30 60 90 120
0.0
0.5
1.0
1.5
time
AT
 N
E 
sp
ill
ov
er
(p
m
ol
.1
00
g-
1 .
m
in
-1
)
0
2
4
6
8
M
us
cl
e 
N
E 
sp
ill
ov
er
(p
m
ol
.1
00
g-
1 .
m
in
-1
)
0
2
4
6
8
10
12
Sy
st
em
m
ic
 N
E 
sp
ill
ov
er
(n
m
ol
.m
in
-1
)
*
*
*
*
 97
 
Legend to figure 4.4: 
 
Graphs of adipose tissue (bottom panel), muscle (middle panel) and systemic 
(upper panel) NE spillover at each experimental time point (error bars represent 
SEM).  Hatched lines joining triangular markers (▲) represent obese subjects and 
continuous lines joining square markers (■) are lean controls.  The vertical 
hatched line represents the time of meal ingestion (t=0).  Significant differences 
between lean and obese groups are denoted by asterisk (٭) and vertical arrows (↕).   
 
Whereas systemic NE outflow was greater in the obese subjects, local SNS 
outflow to adipose tissue was reduced in the obese group.  These differences in 
adipose tissue and systemic spillovers between the two groups were significant 
both before and after the meal (p<0.05 by ANOVA). 
 
Adipose tissue NE spillover increased in the lean (p=0.013) but not the obese 
groups (p=0.657) in response to meal ingestion.   
 
Systemic and muscle NE spillovers increased in both groups in response to eating 
(p<0.05 by ANOVA) but systemic NE spillover remained significantly higher in 
the obsese (p=0.007 by ANOVA).   
 
Muscle norepinephrine spillover did not differ between groups either before or 
after meal ingestion.   
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DISCUSSION 
 
The principal findings of the current study are that there is a local defect in 
sympathetic outflow to adipose tissue in obesity both in fasting and the fed states.  
This local adipose tissue defect is in contrast to the increased systemic 
sympathetic outflow in obesity and the lack of any significant difference in 
skeletal muscle.  Whereas systemic sympathetic responses to feeding are intact in 
obese subjects, those regulating adipose tissue are impaired or absent.   
 
These divergent abnormalities of sympathetic outflow, further evidenced by the 
dissociation between epinephrine derived from the adrenal medulla and systemic 
sympathetic outflow, illustrate the principle of heterogeneity in SNS outflow to 
different tissues and organs (Vaz et al, 1997, Esler et al, 1984, Cox et al, 1995).   
 
Consistent with Landsberg’s hypothesis (Reaven et al, 1996) relating obesity 
hypertension to high SNS outflow driven by hyperinsulinaemia, and with other 
studies of systemic SNS outflow in obesity (Vaz et al, 1997), there were 
significant correlations in our study between total body norepinephrine spillover 
and both systolic and diastolic blood pressures suggesting that obesity associated 
hypertension might be mediated via adrenergic mechanisms in addition to the 
known effects of insulin resistance and/or hyperinsulinaemia per se (Johnston et 
al, 1992).   
 
Catecholamines not only regulate lipolysis within adipose tissue but also 
influence many other adipose tissue functions including leptin (Trayhurn et al, 
1996, Lu et al, 1998) and adipocytokine (Orban et al, 1999) production, cell 
differentiation and apoptosis (Valet et al, 1998), and uncoupling protein (UCP) 
expression (Yoshitomi et al, 1998).  The importance of this SNS dependent 
regulatory system was elegantly demonstrated in a study (Youngstrom & Bartness 
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1998) in which experimental sectioning of sympathetic nerves to hamster white 
adipose tissue resulted in a 200% increase in the number of adipocytes.   
 
Until now, it has been thought that resistance of adipose tissue to the actions of 
catecholamines (Reynisdottir et al, 1994, Schiffelers et al, 2001, Arner 1999, 
Hoffstedt et al, 1997, Dodt et al, 2000) may be responsible for the observed 
pathophysiology of adipose tissue in obesity such as the increased cell number, 
reduced lipolysis per unit mass of adipose tissue (Klein et al, 1988), and increased 
leptin production (Maffei et al, 1995).  However, we now demonstrate that any 
resistance to catecholamines is further compounded by reduced sympathetic 
outflow, at least to the adipose depot we examined, in obesity.  Further studies 
will be required to establish whether these apparent abnormalities in innervation 
may explain how abnormal glucose and NEFA metabolism may be encountered 
in individuals at risk of diabetes despite them having preserved responses in vivo 
to infused catecholamines, matched weight and similar insulin sensitivity and 
insulin levels to control subjects (Frobes et al, 2006).  Other studies by the same 
group (Kousta et al, 2002) have demonstrated delayed or impaired metabolic and 
thermogenic responses to mixed meal ingestion in subjects with previous 
gestational diabetes which are potentially consistant with our finding of blunted 
meal stimulated sympathetic responses in adipose tissue in obese subjects who 
also are at risk from, but do not currently have, diabetes. 
 
Several (Cox et al, 1995, Patel et al, 1999, Fagius & Berne 1994), but not all 
(Matsumoto et al, 2001), groups have demonstrated increased systemic SNS 
outflow in response to meal ingestion in lean humans and a reduction of SNS 
outflow in response to underfeeding in lean subjects has also been described 
(Gohler et al, 2000, Young & Landsberg 1997).  The current study, whilst 
confirming these findings, reveals for the first time a complete absence of this 
increase in post-meal SNS outflow to adipose tissue in obese subjects.   
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Certain limitations are inherent in the methods used in this study.  Norepinephrine 
rate of entry into blood is an indirect measurement of the rate of release of 
neurotransmitter at the synaptic cleft and other factors such as firing frequency, 
receptor disposition and post-receptor signal transduction will undoubtedly have a 
bearing on the effect of the SNS upon adipose tissue.  Nevertheless, the spillover 
methodology that we have used has been shown to be correlated to local electrical 
activity in animal preparations (Esler et al, 1990) and is widely considered to be 
the best available method for studying local SNS outflow in vivo (Grassi & Esler 
1999).  In addition, the present study has only investigated subcutaneous 
abdominal adipose tissue and, given the regional heterogeneities of both the SNS 
and of adipose tissue, it would be important for future studies to examine other 
adipose tissue depots.  It is not possible on the basis of our results to determine for 
certain whether the observed defects in SNS outflow are primary or secondary to 
obesity.  However, it has previously been demonstrated that low 24h 
norepinephrine excretion presaged future weight gain (Tataranni et al, 1997) and 
that subcutaneous abdominal adipocyte resistance to catecholamines was at least 
partially reversed by weight loss (Reynisdottir et al, 1994).  Whichever the case, 
reduced sympathetic outflow to adipose tissue would certainly appear to be a 
maladaptive response to obesity whether or not it contributes to its causation, as it 
would tend to perpetuate rather than counteract the condition (Macdonald 1995).  
Whether or not a reduction in sympathetically mediated lipolysis may constitute a 
defence against the development of diabetes by reducing ‘lipotoxicity’ (Unger 
2002) is perhaps teleologically plausible but this remains an issue which is subject 
to considerable debate and one which can not be resolved on the basis of the 
current data. 
 
Selective β3-adrenoceptor agonists have shown initial promise as a novel class of 
anti-obesity agent (Weyer 1999) despite the fact that no clinical studies have 
investigated the function of sympathetic nerves within adipose tissue, the 
principal location of this receptor subtype.  The defects we report in adipose tissue 
SNS outflow suggest that pharmacological correction may provide a rationale for 
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restoring adipocyte function and ultimately reducing adipocyte mass.  On the 
other hand, our demonstration of raised systemic SNS outflow and its positive 
correlation with blood pressure in obesity emphasizes the need for such agents to 
act specifically to avoid unwanted cardiovascular sympathomimetic effects.   
 
We conclude that in human obesity, regional sympathetic outflow to adipose 
tissue is reduced whereas sympathetic outflow is increased.  Although 
sympathetic neural responses to feeding are intact overall, those specifically 
regulating adipose tissue are impaired.  The increases in sympathetic outflow may 
contribute to hypertension, whereas hypofunction of sympathetic nerves 
innervating adipose tissue may contribute to body fat accumulation in obesity via 
a variety of specific local mechanisms including abnormal lipolysis and 
disordered adipocytokine secretion.   
 
We therefore proceeded to investigate the possible role of SNS innervation of 
adipose tissue in co-ordinating NEFA and adipokine secretion with studies 
assessing the pulsatile release of these substances from within the same 
subcutaneous abdominal adipose tissue depot.  We aimed to test the hypothesis 
that SNS innervation of this tissue is involved in qualitative as well as quantitative 
control of lipolysis and adipokine secretion.  Specifically, we hypothesised that 
release of free fatty acids and cytokines would be pulsatile.  If this were shown to 
be the case, we reasoned that pulsatile release would be entrained to either SNS or 
insulin pulses.  We therefore studied the effects of euglycaemic 
hyperinsulinaemia NEFA and leptin concentrations reasoning that, under 
hyperlinsulinaemic clamp conditions, any effects due to spontaneous endogenous 
insulin pulses would be attenuated.   
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CHAPTER V 
 
 
 
 
 
 
 
OSCILLATIONS OF FATTY ACID AND GLYCEROL 
RELEASE FROM HUMAN SUBCUTANEOUS 
ADIPOSE TISSUE IN VIVO 
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INTRODUCTION 
 
It is increasingly recognized that metabolic processes do not operate at steady 
rates. Oscillations in glycolytic flux, synchronized across cells, have long been 
recognized (Dano et al, 1999). Pulsatile secretion of hormones is also well 
established, and for insulin, for example, there is a clear oscillatory pattern with a 
characteristic period of 12–13 min observable in systemic plasma (Lang et al, 
1979, Hansen et al, 1982). Among the metabolic processes regulated by insulin is 
adipose tissue lipolysis.  Recently, rapid oscillations in lipolysis have been 
observed in omental adipose tissue in dogs (Getty et al, 2000).  These oscillations 
appeared to be independent of insulin, however, and were partially blocked by 
propranolol.  More recent work in dogs has shown that oscillations of lipolysis, 
detected in systemic plasma non-esterified fatty acid (NEFA) concentrations, are 
superimposed on a steady background level of NEFA, and only the oscillatory 
component is blocked by specific blockade of the β3-adrenoceptor, which is 
responsible for lipolysis in dogs (Hücking et al, 2003).  In humans, adipose tissue 
lipolysis, as measured by microdialysis of interstitial glycerol, is not affected by 
propranolol after an overnight fast (Arner et al, 1990).  This seems surprising but 
might be understandable if β-adrenergic activation were responsible for only a 
small component of lipolysis; rapid oscillations might be lost with the limited 
time resolution of microdialysis.  If pulsatile lipolysis were detectable in humans, 
it might considerably alter our view of NEFA release and its interaction with 
insulin action and glucose metabolism.  Therefore, we have sought evidence for 
pulsatility of lipolysis in human adipose tissue.   
 
The subcutaneous upper-body adipose tissue makes the largest contribution to the 
systemic plasma NEFA pool (Guo et al, 1999), so we measured arterio-venous 
differences for the products of lipolysis, NEFA and glycerol, across the 
subcutaneous abdominal fat depot every 2 min at steady state.  Adrenergic 
stimulation of lipolysis in humans is brought about mainly by β1-and β2-
adrenceptors (Barbe et al, 1996), so it is not possible to block it systemically 
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without causing cardiovascular side effects.  We therefore measured plasma 
norepinephrine concentrations in arterial and adipose tissue venous plasma as an 
index of systemic and local sympathetic activity and sought relationships between 
these measurements and lipolysis.  Because it seems intrinsically likely that 
oscillatory insulin concentrations will affect lipolysis, we also used a constant 
insulin infusion with the euglycaemic hyperinsulinaemic clamp technique to 
remove this possible stimulus.  
 
Rapid oscillations of insulin secretion are seen in obese as well as normal-weight 
subjects (Hansen et al, 1982) but are attenuated in relatives of patients with type 2 
diabetes (O’Rahilly et al, 1988) and absent in type 2 diabetes (Matthews 1996).  
They are somewhat restored with weight loss (Matthews 1996).  To obtain some 
preliminary information on the effects of obesity on any lipolytic pulsatility 
observed, we included subjects with a wide range of adiposity. 
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METHODS 
 
Nine healthy subjects (five men), covering a range of adiposity levels (BMI 19.7–
50.8, median 23.8 kg/m2), were recruited.  Their ages ranged from 21 to 61years 
(median 43).  The subjects were healthy and receiving no medication.  The 
protocol was approved by the Oxfordshire Clinical Research Ethics Committee 
and the East London and City Ethics Committee, and all subjects gave written 
informed consent.   
 
Subjects were studied after an overnight fast.  A 10-cm, 22-gauge Hydrocath 
catheter (Becton Dickinson, Oxford, U.K.) was introduced over a guidewire into a 
superficial vein on the anterior abdominal wall and threaded toward the groin so 
that its tip lay just superior to the inguinal ligament.  This provided access to the 
venous drainage from the subcutaneous abdominal adipose tissue, which was 
uncontaminated by muscle drainage, with a relatively minor contribution from 
skin (Frayn & Coppack 2001).  A retrograde cannula was placed in a vein 
draining the hand, which was warmed in a hot-air box maintained at 60°C to 
obtain arterialised blood (n=4) or into the radial artery (n=5).  The term 
‘arterialised’ is used to mean blood drawn by either method in this study.  The 
cannulae were kept patent by a slow infusion of 0.9% (wt/vol) saline.  After a 30-
min resting period, blood was taken with careful timing in order to ensure 
simultaneous sampling from the arterialised and adipose tissue venous lines and 
was repeated every 2 min for 60 min.  After this 60-min sampling period, a 
hyperinsulinaemic-euglycemic clamp was established by infusing insulin, using a 
primed-constant infusion protocol (DeFronzo et al, 1979), with the final infusion 
rate 35 mU. m-2. min-1.  The arterialised blood glucose concentration was 
maintained at 5 mmol/l by measurement of glucose using a reflectometer 
(Hemocue, Sheffield, U.K.) at 5-min intervals.  Once the blood glucose 
concentration was stable, blood sampling was again started simultaneously from 
the arterialised and adipose tissue venous lines, and this was repeated every 2 min 
for 60 min.  Clamps were not performed in three subjects.   
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Adipose tissue blood flow (ATBF) was measured during the entire experiment by 
registering the washout of 133Xe injected into the subcutaneous abdominal adipose 
tissue as previously described (Samra et al, 1995).  Blood samples were taken into 
heparinised syringes.  A portion of each blood sample was rapidly deproteinized 
with 7% (wt/vol) perchloric acid for glycerol determination.  Samples were kept 
on ice, and plasma was separated rapidly by centrifugation at 4°C.  One aliquot 
was stored with preservative at -70°C for subsequent norepinephrine analysis.  
Plasma glucose was measured within 24 h on fresh plasma to avoid the variable 
loss of glucose on freezing (Clark et al, 1990).  Plasma NEFA and blood glycerol 
concentrations were measured on samples stored at -20°C.  Plasma NEFA, 
glucose concentrations, and blood glycerol concentrations were measured using 
enzymatic methods on an IL Monarch centrifugal analyzer (Instrumentation 
Laboratory, Warrington, U.K.).  Plasma insulin was measured using a double-
antibody radioimmunoassay (Pharmacia and Upjohn, Amersham, U.K.).  Plasma 
norepinephrine was measured by high-performance liquid chromatography with 
electrochemical detection (Forster & Macdonald 1999) on samples stored at -
70°C. 
 
Data analysis.  
 
Glycerol and glucose were not measured in some samples for practical reasons, so 
for these measurements, n = 6.  Given that some subjects did not undergo the 
clamp and some adipose venous samples were not taken, a total of 2,190 potential 
data points were available for NEFA, glycerol, and norepinephrine.  In fact 2,119 
measurements were available (97% of potential total).  Sixteen individual missing 
values were filled by interpolation for analysis of pulsatility.  We sought evidence 
for pulsatility in arterialised and adipose tissue venous concentrations, as well as 
in the veno-arterialised difference for plasma NEFA and blood glycerol 
concentrations, which we took as a simple measure of the release from adipose 
tissue.  We did not attempt to calculate absolute flux rates (veno-arterialised  
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difference x blood flow) because, as described in ‘Results’, measurements of 
ATBF over 2-min intervals turned out to be unreliable.  For norepinephrine, there 
was generally net uptake across adipose tissue, and we calculated arterio-venous 
differences.  For ATBF, Mediscint software (Oakfield Instruments, Eynsham, 
U.K.) was used to record counts per second (cps) over 20s intervals.  We took 
these data into Microsoft Excel and calculated averages over 2-min periods to 
correspond with blood samples and over 10-min periods to calculate mean ATBF 
values.  ATBF is proportional to the (negative) slope of the log(cps) versus time 
plot.   
 
Evidence for pulsatility was sought as follows.  The program ‘Cluster 7’ 
(http://mljohnson.pharm.virginia.edu/pulse_xp/downloads.php) (Veldhuis & 
Johnson 1986) was used following the guidelines supplied with the program.  
This program has been used previously for similar studies (Hücking et al, 2003) 
and validated for this purpose against an alternative program, ULTRA.  The 
program searches for peaks and nadirs defined by changes above and below mean 
baseline that are outside of the limits expected from analytical variation.  
Analytical variation was measured as described below.  The default settings of the 
program were not altered, except that the minimum number of points needed to 
define peaks and nadirs (default setting 2) was changed as follows.  For most 
measurements, we set 2 for the number for a peak and 1 for a nadir.  This was 
done because our samples were at 2-min intervals, and we discovered that we 
were looking at some events with a period ~6–7 min, so often only 1 point 
defined a nadir (or peak). In addition, the half-life of plasma NEFA in humans, 
for instance, is ~3min (Bonadonna et al, 1990, Meyer et al, 1997), so a peak 
might convert to a nadir within a few minutes.  We tested the effect of choosing 
2/2 points (peak/nadir) against 2/1 with several sets of data.  The latter made the 
program more sensitive at finding some peaks but did not consistently alter the 
characteristics of the peaks found (width, interval, etc.).   
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The half-life of plasma norepinephrine in normotensive subjects is ~2 min 
(Silverberg et al, 1978, Young et al, 1980), so for norepinephrine concentrations, 
we set the number of points at 1/1.  Then, for each subject, ‘Cluster 7’ calculated 
the number of significant peaks discovered and their characteristics.  This was 
done separately for the fasting and clamp periods (i.e., 30 points each).   
 
We tested the reliability of this approach in a number of ways.  First, we applied 
‘Cluster 7’ to 30 repeated analyses of plasma NEFA from one fasting sample, and 
similarly to 30 repeated analyses of blood glycerol.  In the latter case, 30 separate 
aliquots of one blood sample were extracted with perchloric acid (as described 
earlier) for analysis.   
 
We also created “mock” veno-arterialised differences for NEFA by subtracting 
one subject’s arterialised concentrations from the next subject’s venous NEFA 
concentrations and tested these for pulsatility.  We created two mock datasets 
(subject A venous minus subject B arterialised, subject A venous minus subject C 
arterialised) for each real dataset (subject A venous minus subject A arterialised).  
This was done to reduce the impact of apparent pulses seen when pairing data 
from mismatched subjects (e.g., lean man with obese woman, etc.).  Second, we 
attempted to validate the observed pulsatility using the technique of cross-
correlation analysis.  Cross-correlation was also used to test for significant 
temporal relationships between variables.  In cross-correlation, two datasets are 
lined up and correlated to each other.  One dataset is then “moved” one time point 
relative to the other (2 min with our data), and the correlation is repeated; this is 
repeated several times.  If there are significant temporal relationships between the 
datasets, significant correlations will be observed with a “lag” (number of points 
moved) corresponding to the time delay between maximal coincidence.  If there is 
a similar baseline trend in both variables (e.g., downward drift with time), then 
spurious significant cross-correlations will be generated.  To avoid this, we 
transformed the data for cross-correlations by “differencing” (replacing each point 
with the difference between it and the previous point).  We argued that if we 
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applied cross-correlation analysis to independently measured variables, it would 
test whether the variations we observed were simply random or were indeed 
related to some underlying process.  Cross-correlations were performed using 
SPSS for Windows (release 11.5.0; SPSS, Chicago, IL).   
 
The within-batch analytical variation of the methods was assessed for ‘Cluster 7’.  
For plasma NEFA, the coefficient of variation (CV) was 1.4% based on the 30 
replicate measurements (each in duplicate) of a plasma sample described above.  
We used a conservative value of 3% for ‘Cluster 7’.  For blood glycerol, the CV 
was 7.2%, again based on the 30 replicate measurements (each in duplicate) 
described above.  We used a value of 10% for ‘Cluster 7’.  For plasma insulin and 
norepinephrine, we used a value of 5%, based on experience of variation between 
duplicates. 
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RESULTS 
 
 
Plasma and blood concentrations.  
 
Plasma and blood concentrations, averaged over the 60-min fasting and clamp 
periods in each individual are shown in Table 5.1.  As expected, there was marked 
output of both NEFA and glycerol from subcutaneous adipose tissue in the fasting 
state, and this was suppressed to a large degree during the clamp.  Arterialised 
plasma norepinephrine concentrations were not altered by the clamp.  
 
ATBF.  
 
Detailed analysis of ATBF showed that estimates over 2-min periods have a CV 
~50%.  It is not, therefore, possible to generate reliable results on ATBF using 
‘Cluster 7’.  Thus, we did not further analyze ATBF for evidence of pulsatility.  
Mean ATBF was not altered by the clamp (Table 5.1). 
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Table 5.1:  Mean concentrations in blood and plasma 
 
 
 
Arterial NEFA 
(µmol/l) 
Venous NEFA 
(µmol/l) 
Arterial Glycerol 
(µmol/l) 
Venous Glycerol 
(µmol/l) 
Fasting 521 ± 88 (9) 1,198 ± 161 (8) 62.9 ± 13.8 (6) 213.1 ± 27.4 (5) 
Clamp 103 ± 59 (7) 211 ± 166 (6) 28.9 ± 8.0 (5) 59.6 ± 17.8 (5) 
P* 0.002 0.004 0.054 0.003 
 
Arterial NE 
(nmol/l) 
Arterial Insulin 
(pmol/l) 
Arterial Glucose 
(mmol/l) 
ATBF  
(ml·min−1 100 g−1) 
Fasting 0.65 ± 0.16 (5) 46 ± 12 (9) 5.15 ± 0.12 (6) 3.6 ± 0.6 (9) 
Clamp 0.62 ± 0.22 (4) 294 ± 17 (6) 4.75 ± 0.12 (6) 4.0 ± 0.9 (7) 
P* NS 0.000 NS NS 
 
Legend to Table 5.1:   
 
Data are means ± SE (n). NEFA, norepinephrine (NE), glucose, and insulin were 
measured in plasma, and glycerol was measured in whole blood.  
 
*P value for fasting vs. clamp (paired t test).  Arterial, arterialised; Venous, 
adipose tissue venous. 
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Evidence for pulsatility 
 
Analysis with ‘Cluster 7’, as described in ‘Methods’, showed inconsistent 
evidence for pulsatile behaviour of arterialised NEFA and glycerol 
concentrations.  Not all subjects showed significant pulses, and the estimated 
period was extremely variable from person to person.  However, there was much 
more consistent evidence for pulsatile release of NEFA and glycerol from the 
subcutaneous abdominal adipose depot, as measured by the veno-arterialised 
difference: seven of nine and five of six subjects showed more than one peak for 
NEFA and glycerol release, respectively (Table 5.2). The period was ~12–14 min.   
 
Norepinephrine showed clear evidence of repeated peaks in every subject for 
arterialised, adipose venous, and the arterio-venous difference, with a period~6–8 
min (Table 5.2).  Arterialised insulin concentrations showed clear pulsatility in all 
subjects, as expected, with a typical period of 12 min (Table 5.2). 
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Table 5.2:  Analysis of pulsatility using ‘Cluster 7’ during the fasting period 
 
 
Measurement 
Subjects 
available 
(n) 
>1 peak 
found 
(n) 
Median 
no. of 
peaks 
Median inter- 
 peak interval 
(Range)/min 
NEFA 
(arterialised) 
9 5 2 15.4 (8–30) 
NEFA 
(adipose venous) 
9 6 3 11.5 (8–24) 
NEFA 
(V-A difference) 
9 7 3 12.0 (10–17) 
Mock NEFA 
(V-A difference) 
18 10 2* 14 (9–28)† 
Glycerol 
(arterialised) 
6 3 2.5 12.7 (12–22) 
Glycerol 
(adipose venous) 
6 0   
Glycerol 
(V-A difference) 
6 5 2 14 (6–30) 
Norepinephrine 
(arterialised) 
5 5 6 7.1 (6.3–11) 
Norepinephrine 
(adipose venous) 
4 4 6 8.0 (6.3–13) 
Norepinephrine 
(V-A difference) 
4 4 6.5 6.0 (5.6–8.0) 
Glucose 
(arterialised) 
6 0   
Insulin 
(arterialised) 
9 9 4 12 (8–14) 
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Legend to Table 5.2 
 
V-A difference, veno-arterialised difference (adipose tissue venous minus 
arterialised concentration). Mock NEFA (V-A difference) created by subtracting 
one subject’s arterialised concentration from another subject’s venous (see 
Methods).  Median interpeak interval and range (minutes) presented for datasets 
in which > 1 peak was found. 
 
* Number of peaks detected less for “mock” than for real data (P < 0.05) 
† significantly greater variation in peak interval compared with true NEFA (V-A 
difference) (P < 0.01).   
 
 
To test whether the apparent pulsatility was indeed real for NEFA and glycerol, 
we examined cross-correlations between independent measurements, arguing that 
random fluctuations in the data would not result in significant cross-correlations.  
For this, we used ‘differenced’ data to eliminate baseline trends as described in 
‘Methods’.  We examined the cross-correlation of arterialised with adipose 
venous NEFA concentrations in nine people.  Five showed significant positive 
cross-correlations with no lag (P < 0.05 in two subjects, P <0.01 in one subject, 
and P < 0.001 in two subjects).   
 
For arterialised and adipose venous norepinephrine (four subjects available), three 
subjects showed significant cross-correlation with no lag (P < 0.05 in two subjects 
and P < 0.01 in one subject).   
 
Finally, to examine completely independent metabolic variables, we looked at the 
veno-arterialised differences for NEFA and glycerol.  Data were available in six 
subjects.  In three subjects, there were significant positive cross-correlations with 
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no lag (P < 0.05 in one subject and P = 0.001 in two subjects), and in two others, 
there were significant positive cross-correlations with lag ~10 min (P < 0.05). 
 
We attempted to use cross-correlation analysis to show the physiological origin of 
the pulsatility observed.  We cross-correlated veno-arterialised differences for 
NEFA and glycerol with arterialised norepinephrine and insulin concentrations.  
No consistent patterns were observed for norepinephrine.  There was a tendency 
to a positive cross-correlation between veno-arterialised NEFA and arterialised 
insulin concentrations.  Of seven people analysed, six showed positive cross-
correlations (of whom four were at P = 0.05), but one showed a significant 
negative cross correlation (P < 0.02). 
 
There was no obvious relationship between pulsatility and BMI.  Pulses were 
observed in both lean and obese subjects (Figs. 5.1 and 5.2).  If the subjects were 
divided into tertiles of BMI, the median number of pulses for NEFA veno-
arterialised difference was the same (three) in the lowest tertile (median BMI 21.1 
kg/m2) and the upper tertile (median BMI 37.3 kg/m2). 
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Figure 5.1:  V-A differences for NEFA in the fasting state 
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Legend to Figure 5.1:   
 
Representative traces for NEFA release from subcutaneous adipose tissue 
expressed as veno-arterialised (V-A) difference. The data are veno-arterialised 
differences for NEFA in the fasting state from three subjects, with BMI (from top 
to bottom) 50.8, 23.8, and 21.1 kg/m2. The pictures are the graphical output from 
‘Cluster 7’. The error bars represent analytical variation (a conservative estimate, 
see Methods). The top line in each panel shows the interpretation of peaks and 
troughs by ‘Cluster 7’. 
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Figure 5.2:  Arterialised plasma Insulin concentrations in the Fasting State 
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Legend to Figure 5.2:  
 
Representative traces for arterialised plasma insulin concentrations. 
The data are from the same three subjects as the data in Figure 5.1.  For 
explanation, see Figure 5.1. 
 
 
 
Checks for reliability.  
 
We applied ‘Cluster 7’ to 30 repeated measurements of plasma NEFA and blood 
glycerol from a single blood sample, as described in Methods.  The program did 
not detect any pulses, and there was no cross-correlation detected between NEFA 
and glycerol measurements.  ‘Cluster 7’ was also applied to the “mock” NEFA 
veno-arterialised differences created by subtracting one subject’s arterialised 
concentrations from the next subject’s venous concentrations (Table 5.2).  
‘Cluster 7’ detected fewer pulses in the “mock” NEFA veno-arterialised 
differences than in the true data (P < 0.05, Mann Whitney test), and the 
characteristics of the pulses found were far less consistent (Table 5.2), with 
significantly greater variation in the reported peak width (P = 0.006) and peak 
interval (P =0.004) (F tests from SPSS). 
 
Hyperinsulinaemic clamp.  
 
During insulin infusion, there was surprisingly more consistent evidence for 
pulsatile behaviour of arterialised NEFA and glycerol concentrations, with all 
subjects showing more than one peak during the period of observation and with 
reasonably consistent periods of ~12–14 min (Table 5.3).  There was again 
consistent evidence for pulsatile release from the subcutaneous abdominal adipose 
depot, as measured by the veno-arterialised difference (six of seven and six of six 
subjects showing more than one peak for NEFA and glycerol, respectively).  The 
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period was again ~10–15 min.  As in the baseline period, norepinephrine showed 
clear evidence of repeated peaks in every subject for arterialised, adipose venous, 
and the arterialised-venous difference, with a period~7–10 min.   
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Table 5.3: Analysis of pulsatility using ‘Cluster 7’ during the hyperinsulinemic-
euglycemic clamp 
 
 
Measurement 
Subjects 
available 
(n) 
>1 peak 
found 
(n) 
Median 
no. of 
peaks 
Median inter- 
 peak interval 
(Range/min) 
NEFA 
(arterialised) 
7 7 4 12 (8–14) 
NEFA 
(adipose venous) 
7 7 3 13 (10–36) 
NEFA 
(V-A difference) 
7 6 4 15 (10–20) 
Glycerol 
(arterialised) 
6 6 2.5 13 (10–32) 
Glycerol 
(adipose venous) 
6 1 1 18 — 
Glycerol 
(V-A difference) 
6 6 3 11.5 (9–17) 
Norepinephrine 
(arterialised) 
4 4 6.5 7.10 (6.9–22) 
Norepinephrine 
(adipose venous) 
4 4 6 9.5 (7–11.5) 
Norepinephrine 
(V-A difference) 
4 4 7 7.03 (6–8) 
 
 
Legend to Table 5.3:   
 
V-A difference, veno-arterialised difference (adipose tissue venous minus 
arterialised concentration).  See also legend to Table 5.2. 
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Once again, we applied cross-correlation using ‘differenced’ data during the 
clamp period to assess the reliability of the observed pulsatility.  Cross-
correlations were generally not so consistent as in the fasting state, but that was to 
be expected given the smaller concentrations measured.  For the cross-correlation 
of arterialised with adipose venous NEFA concentrations, there were data from 
seven people, three of whom showed significant positive cross-correlations with 
no lag or a lag of 2 min (P = 0.05 in one subject, P < 0.01 in one subject, and P < 
0.001 in one subject).  For the veno-arterialised differences for NEFA and 
glycerol, data were available in six subjects.  In two, there were significant cross-
correlations with no lag or 2-min lag (P = 0.05 in one and P < 0.001 in the other). 
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DISCUSSION 
 
Our main finding was that there were multiple pieces of evidence for pulsatile 
release of NEFA and glycerol from human subcutaneous adipose tissue in vivo.  
In contrast, we found inconsistent evidence for pulsatility of systemic NEFA and 
glycerol concentrations, even though this has been found for NEFA in dogs 
(Hücking et al, 2003).  This may imply that in humans, the different adipose 
depots that contribute to the systemic plasma NEFA pool are not co-ordinated in 
their pulsatility.  We must also consider, however, that an even more precise 
NEFA assay, perhaps applied over a longer period, might have revealed 
pulsatility of systemic concentrations.  In terms of NEFA and glycerol release, we 
also have to remember that the transit time for blood through the tissue bed is 
finite and that simultaneous blood sampling (arterialised and adipose venous) 
might not be absolutely appropriate.  However, we believe the transit time is 
probably short in relation to the time it takes to draw a sample: blood flow is high 
in relation to tissue fluid content.  
 
We sought evidence for the main regulator of lipolytic pulsatility, but our results 
do not give firm conclusions in this respect.  While the period of pulsatility of 
NEFA release was strikingly similar to that of insulin concentrations, pulsatility 
of NEFA release was maintained even at the suppressed levels seen during the 
hyperinsulinaemic clamp, when insulin concentrations were steady.  This seems 
to rule out insulin as the main stimulus.  It would have been interesting to clamp 
insulin at fasting concentrations using somatostatin, but at this stage of 
investigation, we did not want to alter the secretion of other peptide hormones 
potentially involved.  Although there would have been some residual endogenous 
(and potentially pulsatile) insulin secretion during the clamp, this would have 
been minor compared with the exogenous insulin.   
 
 124
Taking plasma norepinephrine concentrations as an index of sympathetic nervous 
system activity, there was clear and consistent evidence for pulsatility, and it 
would seem likely in principle that this could be a major driver of lipolytic 
pulsatility, as in dogs (Getty et al, 2000, Hücking et al, 2003). However, the 
period of norepinephrine pulsatility was consistently shorter than that for 
lipolysis, and no strong cross-correlations were observed between the two 
variables.  At the whole-body level, there is a correlation between plasma 
norepinephrine concentration and sympathetic nerve activity recorded in the 
peroneal nerve in the resting state (Wallin et al, 1981).  However, subsequent 
studies have shown a regional inhomogeneity of sympathetic nervous system 
responses to interventions such as feeding, where increased norepinephrine 
spillover is observed in some tissues or organs but not others (Cox et al, 1995).  
The lack of a relationship between oscillations in plasma norepinephrine and in 
veno-arterialised differences for glycerol or NEFA indicates that any pulsatility in 
sympathetic nervous system outflow to abdominal subcutaneous adipose tissue is 
not in synchrony with the oscillations seen in arterial norepinephrine.  This is not 
too surprising, since the major source of arterial norepinephrine is likely to be 
spillover from sympathetic nerves innervating the vasculature, and one would 
expect any physiological variation in norepinephrine release to be related to 
variations in blood pressure rather than in metabolic variables such as adipose 
tissue lipolysis. 
 
The alternative explanation is that there is some communication between 
adipocytes that leads to co-ordinated lipolysis.  This type of communication is 
well established in other cell types.  Yeast cells in suspensions show co-ordinated 
oscillations in glycolytic flux (Dano et al, 1999).  Pancreatic islets in perifusion 
systems or in a perfused pancreas will show co-ordinated oscillations in 
glycolysis, intracellular Ca2+ concentrations, and insulin secretion (Cunningham 
et al, 1996, Kennedy et al, 2002, Gilon et al, 2002).  However, it is difficult to 
imagine how signals could diffuse between adipocytes that may be several 
centimetres apart sufficiently rapidly to produce the periodicity observed here.   
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One concern in interpreting such data is the detection of spurious pulsatility.  Our 
checks with repeated measurements of one sample gave us confidence that 
‘Cluster 7’ will not always detect pulses, as did the lack of pulsatility found in 
plasma glucose concentration.  It was also clear in the fasting state that 
arterialised NEFA and glycerol concentrations gave less consistent pulsatility than 
did the corresponding veno-arterialised differences.   
 
We also tried to test validity of the reported pulses by various types of 
randomisation. For instance, we took each subject’s data (e.g., for arterialised 
NEFA concentrations) and randomised the time points (data not shown).  We also 
created mock veno-arterialised differences by subtracting one subject’s 
arterialised concentrations from another subject’s venous concentration.  
However, we found that such randomisation usually led to ‘Cluster 7’ detecting 
some pulses, albeit significantly less consistent in character than with the original 
data.  The reason for this must be that a truly pulsatile dataset contains values that 
are significantly above or below mean values (i.e., by more than analytical 
variation), and even after randomisation, these values will sometimes by chance 
associate to give peaks or nadirs.   
 
We consider the data and statistical tests suggest real pulses were present, 
however, because of the strong independent evidence from cross-correlation 
analysis.  The significant cross-correlations observed between veno-arterialised 
differences for NEFA and glycerol, for instance, can only easily be explained by 
true pulsatile lipolysis in the subcutaneous abdominal adipose depot.   
 
We had hoped to test the pulsatility of ATBF, but when the data were examined in 
detail, it became clear that estimates of ATBF over 2-min intervals from 133Xe-
washoutcurves are highly variable and not satisfactory for pulsatility analysis.  It 
remains a possibility that the pulsatility of NEFA and glycerol release that we 
observed in fact represents pulsatility of ATBF superimposed on a constant rate of 
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lipolysis.  It will be difficult to test this with existing methodologies as the time 
resolution is inadequate.  We believe it is unlikely to be the explanation because it 
would leave open the question of what drives pulsatility of ATBF.  Insulin itself 
does not regulate ATBF (Karpe et al, 2002).  In the fasting state, local β-
adrenergic blockade does not alter ATBF and the major regulator appears to be 
the nitric oxide pathway (Ardilouze et al, 2004).  Adrenergic stimuli only become 
the predominant regulator of ATBF in response to carbohydrate ingestion (Karpe 
et al, 2002, Ardilouze et al, 2004).  Of course, even if our observations were a 
reflection of pulsatility of ATBF, the observation of pulsatile release of NEFA 
and glycerol still stands, although the interpretation as a reflection of pulsatile 
lipolysis would need re-evaluation.   
 
The nature of the analysis we have performed does not permit us to conclude 
whether there is regular oscillation or irregular pulsatility, but to distinguish these 
two would require longer periods of observation during which it would be 
extremely difficult to maintain a metabolic steady state.   
 
We did not observe any differences in pulsatility of lipolysis between lean and 
obese subjects.  As outlined above, insulin pulsatility is retained in obesity but 
lost in type 2 diabetes.  It would be interesting to extend these studies to diabetic 
patients and also to patients with disorders of lipid metabolism in future work.   
 
We conclude that there is pulsatile release of NEFA and glycerol from human 
subcutaneous adipose tissue in vivo.  We are unable to pinpoint the stimulus for 
this pulsatility, although insulin seems to be excluded because of the retention of 
pulsatility during a hyperinsulinaemic clamp.  Pulsatility of NEFA release is 
maintained in obese subjects, although we have not yet examined patients with 
type 2 diabetes.  Our results have implications for understanding the regulation of 
lipolysis in humans and raise questions as to the nature of pulsatile release of 
other adipose tissue products such as leptin.  Leptin is known to have a diurnal 
rhythm entrained by meal ingestion.  Defects in leptin production or action are 
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rare but well recognised causes of obesity in animals and humans.  We therefore 
sought direct evidence of pulsatile leptin production in humans. 
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CHAPTER VI 
 
 
 
 
 
 
 
OSCILLATIONS IN LEPTIN RELEASE FROM 
ADIPOSE TISSUE IN THE FASTING STATE AND IN 
RESPONSE TO EUGLYCAEMIC-
HYPERINSULINAEMIA 
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INTRODUCTION 
 
 
Adipose tissue was once thought to be a metabolically inert fat repository.  
However, in recent years it has become clear that it subserves myriad functions 
including but not limited to fertility, hormonal modulation, immunity, systemic 
inflammation, thermogenesis and insulin resistance.  It has even been ventured 
that it functions as an endocrine ‘organ’ with all the co-ordination and regulation 
of structure and function that this term implies in other endocrine organs 
(Mohamed-Ali et al, 1998, Lawrence & Coppack 2000).  This concept arose in 
part following the positional cloning of leptin by Friedman’s group in 1994 
(Zhang et al, 1994), a landmark in the understanding of adipose tissue biology.   
 
Leptin is a peptide produced in human white adipose tissue which has important 
effects in the maintenance of body weight through NPY and non-NPY mediated 
effects on appetite and also through its effects on energy expenditure (Coll et al, 
2007, Ahima et al, 2006, Stephens et al, 1995, Erickson et al, 1996).  Although 
the absence of leptin is known to be associated with extreme and reversible 
obesity (Farooqi et al, 1999), most obese subjects are not deficient in leptin but 
instead have elevated circulating leptin concentrations (Farooqi & O’Rahilly 
2006).  However, in the obese, elevated leptin concentrations do not have the 
anorexogenic or metabolic effects that might be expected.  The concept of obesity 
being a leptin resistant state has therefore been advanced (Eikelis et al, 2007, 
Scarpace & Zhang 2009).   
 
Leptin resistance  
 
Experimental data in animals suggests that this resistance to leptin action may be 
induced by 16 days of high (45%) fat feeding (Trayhurn et al, 1995).  These data 
suggest that leptin resistance may not be an obligatory feature of obesity per se 
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but may be induced at some point before or during the development of the obese 
state.  Treatment of obesity with leptin has not, with the exception of patients with 
documented leptin gene mutations, been considered worthwhile due to this 
resistance.   
 
Many hormones (e.g. LH, insulin) have pulsatile patterns of release and defects in 
their co-ordinated pulsatile secretion are found in hormone resistant states, an 
example being the loss of insulin pulses during the progression of insulin 
resistance to type 2 diabetes (Porksen et al, 2002).  Such defects have even been 
detected in non-diabetic relatives of patients with type 2 diabetes suggesting that 
abnormalities of pulsatility may be encountered early in the pathogenesis of 
syndromes of hormone resistance (O’Rahilly et al, 1988).   
 
It has been suggested (Saad et al, 1998) that ‘obesity is associated not only with 
higher leptin levels but also with blunted diurnal excursions and dampened 
pulsatility..... this abnormal rhythmicity may contribute to leptin resistance in 
obesity’.   
 
Leptin pulsatility and the SNS 
 
Serum leptin levels in humans and other animals undergo circadian variability 
with levels highest at night and after meal ingestion and lowest in the morning 
and when fasting (Sinha et al, 1996, Schoeller et al, 1997).  Superimposed upon 
this circadian pattern, distinct pulses have been detected although the frequencies 
reported vary widely between 3.25 (Sinha et al, 1996), 3.6 (Saad et al, 1998), 7 
(Koutkia et al, 2003), 10 (Ahmad et al, 2001), 30 (Licinio et al, 1998) and 32 
(Licinio et al, 1997) pulses per 24 hours.  By reanalysing their data originally 
sampled at 7 minute intervals at simulated 14, 21, 28, 35, 42, 49 and 56 minute 
intervals, Licinio (Licinio et al, 1998) demonstrated elegantly how much the 
sampling frequency used will affect the number of pulses detected.  Using these 
derived datasets, the observed 24 hour pulse frequency declined from 30 with the 
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raw data to 11.5, 8, 6, 3, 4, 1.5 and 0 respectively.  Much of the variance evident 
in the reports cited above may therefore be explicable in terms of divergent 
methodologies and sampling protocols.  Pulsatile concentrations are most evident 
at meal times and during sleep (Mingrone et al, 2005) but the potential extrinsic 
oscillator has not been ascertained.  Using cross-correlation techniques, some 
have pointed to a relationship between insulin concentration (Saad et al, 1998), 
possibly with a time lag of as long as 275 minutes (Koutkia et al, 2003).  Others 
(Wellhoener et al, 2000) have suggested that insulin action in terms of insulin-
stimulated glucose disposal is responsible on the basis of hypoglycaemic-clamp 
techniques.  Others consider that neither insulin, corticosteroid action (Himms-
Hagen 1999), nor an intact pituitary gland (Kousta et al, 1998), appears 
responsible.  One report has concluded that leptin pulses may be entrained to SNS 
variability (Himms-Hagen 1999).   
 
In support of the concept of SNS regulation, connections to candidate brain 
regions have been suggested by retrograde neuronal tracer studies which have 
shown that pseudorabies virus injected into WAT is transported to the 
intermediolateral cell group and thence on to the nucleus of the solitary tract 
(which is known to be involved in voluntary food intake) and thence to the 
paraventricular nucleus which stimulates lipolysis.  In addition, the 
suprachiasmatic nucleus (SCN), a hypothalamic region involved in circadian 
rhythmicity also appears to innervate white adipose tissue suggesting a possible 
mechanism whereby circadian signals could be transmitted to adipose tissue via 
its SNS innervation (Bartness & Song 2007).  These observations concord well 
with evidence for leptin excursions being primarily linked to food intake and time 
of day (Sinha et al, 1996, Schoeller et al, 1997).  Further data supporting a role 
for the SNS in mediating leptin pulsatility has come from experimental axonal 
interruption studies that have attenuated leptin pulses by disconnection of the 
afferent SNS innervation of adipose tissue (Niijima 1999) and from studies that 
show that beta agonist therapy may affect leptin production (Ricci et al, 2005).   
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Pulsatility as a marker of adipose tissue co-ordination as an ‘organ’ 
 
Variability in the plasma concentration of a hormone or cytokine may be 
regulated by an external oscillator although the possibility that circadian 
oscillations may be generated by genetic mechanisms intrinsic to adipose tissue 
with or without external modification (Zvonic et al, 2006) has recently been 
advanced.  There is little agreement as discussed above as to where the external 
oscillator, if any, lies although either insulin, the SNS or both have some evidence 
in support of them in this role.   
 
Whatever its origin, variability in plasma concentrations does not necessarily 
imply co-ordinated secretory pulses.  Changing binding characteristics (e.g. to 
leptin soluble receptors or specific or non-specific (e.g. albumen) binding proteins 
in plasma), changes in the rate of clearance, hydrolysis or receptor mediated 
uptake as well as changes in production (Gavrila et al, 2003) may lead to 
variability in arterialised or venous plasma concentrations over time.  Conversely, 
for similar reasons, the absence of co-ordinated pulsations in venous or 
arterialised plasma does not ipso facto rule out the presence of co-ordinated 
output from adipose tissue.  Evidence for co-ordinated pulsation would support 
the view of adipose tissue as an ‘organ’ rather than simply a collection of similar 
cells.  Although mathematical modelling techniques such as deconvolution 
analysis may be used in an attempt to estimate production from plasma 
concentrations and decay and distribution characteristics, they are inherently less 
satisfactory than direct measurement of output where this is possible.   
 
In summary, although most studies report diurnal and prandial variability of leptin 
concentrations, the presence, periodicity and control of leptin release directly 
from adipose tissue has not been characterised.  Nor has the question of whether 
leptin resistance may be related to defective pulsatility been fully resolved. 
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We therefore sought evidence for the pulsatile production of leptin in individuals 
of differing body weight using adipose tissue venous cannulation and veno-
arterial difference methodology.  We sought to determine whether leptin release 
or concentration is in fact pulsatile and, if so, whether the patterns of release 
differed between lean and obese individuals suggesting that this might explain 
observed differences in leptin action.  Finally, we sought evidence that the release 
of leptin from adipose tissue might be entrained by insulin pulses and thus would 
be attenuated under hyperinsulinaemic-euglycaemic clamp conditions as a result 
of blunting of insulin pulses. 
 
Our hypothesis was that leptin production deomonstrates co-ordinated pulsatility 
and that leptin pulses would continue despite attenuation of spontaneous insulin 
pulsatility.  We reasoned that, if proven, this would lead to proposal of a further 
hypothesis that disorders of leptin pulsatility might affect tissue responses and 
therefore contribute to the leptin resistance seen in obesity.  
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METHODS 
 
Eight healthy subjects (five men), covering a range of adiposity levels (BMI 20.5–
50.8, median 23.8 kg/m2), were recruited.  Their ages ranged from 21 to 61years 
(median 43).  The subjects were healthy and receiving no medication.  The 
protocol was approved by the Oxfordshire Clinical Research Ethics Committee 
and the East London and City Ethics Committee, and all subjects gave written 
informed consent.  Subjects were studied after an overnight fast.   
 
The methods used were identical to those in Chapter V above and will not 
therefore be reiterated in detail.  Subjects were cannulated using the techniques 
described in chapter II ‘Core Methods’.   
 
Sampling proceeded at 2 minute intervals for 60 minutes from abdominal 
subcutaneous and arterial (n=5) or arterialised (n=3) blood.  A hyperinsulinaemic-
euglycemic clamp was established by infusing insulin, using a primed-constant 
infusion protocol (DeFronzo et al, 1979), with the final infusion rate 35 mU. m-2. 
min-1 as before.  Once the blood glucose concentration was stable, blood sampling 
was again started simultaneously from the arterialised and adipose tissue venous 
lines, and this was repeated every 2 min for 60 min.  Clamps were not performed 
in five subjects for technical reasons.  Samples were kept on ice, and plasma was 
separated rapidly by centrifugation at 4°C.  Plasma leptin analysis was performed 
using a commercially available enzyme linked immunosorbent assay (ELISA) 
method with a sensitivity of 2 ng/ml.  Standard curves were constructed and 2 
replicates were used for each measurement.  Intra-assay coefficient of variation 
was reported as 6.3% and the mean difference between replicates was less than 
2%.  Adipose tissue blood flow (ATBF) was measured as described in Chapter II 
‘Core Experimental Methods’.  Of all potential leptin samples, 97% were 
available for analysis (those missing were due to technical difficulties e.g. 
blocked cannula).  Missing values were filled by interpolation of the mean value 
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of adjacent results before data analysis.  There were no instances of consecutively 
missing data points.  Data were not available for some subjects during the 
hyperinsulinaemic-euglycaemic clamp and veno-arterial differences were not 
obtained from some subjects due to technical problems with cannulation.   
 
We sought evidence for pulsatility as described above in Chapter V.  We used 
similar tests of reliability to examine whether the pulse detection programme 
‘Cluster 7’ (Veldhuis & Johnson 1986) was detecting real pulses or simply 
random variability.  These tests of robustness included creation of “mock” veno-
arterialised differences for leptin by subtracting one subject’s arterialised 
concentrations from the next subject’s venous leptin concentrations which were 
then tested for pulsatility.   
 
In addition, we created further ‘control’ data by randomisation of the time order 
of both venous concentration and veno-arterialised differences in an attempt to 
determine whether ‘pulses’ detected in ‘Cluster 7’ represented truly co-ordinated 
pulses or whether variability for any one of a number of reasons was more likely.  
For adipose tissue venous leptin concentrations, the random number generator in 
‘Microsoft Excel’ was used to create a random number between 0 and 1 and these 
numbers were put alongside the true time-ordered results.  Columns were then 
sorted according to increasing randomly generated number so that the time order 
of the true results became randomised.  Data were then re-analysed using ‘Cluster 
7’ to attempt to detect pulses.  For data presented in this chapter, the default 
settings of 2 points each to define a peak or a nadir were used within ‘Cluster 7’ 
due to the longer half life of leptin (24.9 ± 4.4 minutes) compared to NE or NEFA 
in plasma (Klein et al, 1996). 
 
Statistical methods and assumptions are as for Chapter V above and data are mean 
± SD except where otherwise stated.  
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RESULTS 
 
 
POST-ABSORPTIVE STATE 
 
Venous Concentrations 
 
Fasting leptin levels were higher in the more obese subjects as expected ranging 
from mean values of 1.18 to 27.5 ng/ml as BMI increased from 20.5 to 50.8 
Kg.m-2 (p<0.005).  This relationship is demonstrated in Figure 6.1.   
 
 
Figure 6.1:  Relationship between adipose tissue venous leptin concentration 
(ng/ml) and Body Mass Index (BMI, Kg.m-2) 
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Legend to Figure 6.1 
 
Shows the significant increase in mean plasma leptin (ng/ml) for subjects of 
increasing BMI (Kg.m-2).  The correlation co-efficient (non-parametric 
Spearman’s test as samples from a non-normal distribution) was p<0.005.   
 
 
 
Variability in adipose tissue venous leptin concentrations was apparent in all 8 
subjects and 2-6 (3.25 ± 1.39) peaks and 2-6 (3.50 ± 1.41) troughs were detected 
by the ‘Cluster 7’ programme as pulses (Table 6.1).  There was no relationship 
between the number of peaks and troughs and body mass index.  Figure 6.2 below 
shows the graphs generated using this programme with the settings described in 
Methods.   
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Figure 6.2:  Post-absorptive Venous leptin concentration (ng/ml) vs. time  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend to Figure 6.2 
 
Shows raw outputs of venous leptin concentrations (ng/ml) vs. time (min) from 8 
subjects as detected using ‘Cluster 7’.  The horizontal line above each leptin-time 
plot represents peaks or troughs identified by ‘Cluster 7’.  
Subject 1 Subject 2
Subject 3 Subject 4
Subject 5 Subject 6
Subject 7 Subject 8
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Table 6.1:  Adipose tissue venous leptin in the post-absorptive state 
 
 
Subject 1 2 3 4 5 6 7 8 
Mean leptin 5.50 27.50 14.70 1.18 23.55 1.27 2.64 6.05 
AUC 253.9 1621.5 862.8 69.9 1413.3 76.0 158.5 360.3 
Peaks (n) 2 3 2 4 3 6 4 2 
Troughs (n) 2 3 2 5 3 6 4 3 
 
 
Legend to Table 6.1 
 
Individual adipose tissue venous leptin values (ng/ml) for 8 subjects (numbered 
1,2…8) showing mean adipose vein concentration, area under the leptin-time 
curve (AUC) and number (n) of peaks and troughs determined by ‘Cluster 7’ over 
60 minutes prior to insulin clamp. 
 
 
V-A Differences 
 
Similarly, ‘Cluster 7’ detected between 3 and 5 pulses in v-a differences in the 
post absorptive state in all subjects (Table 6.2).  Again, the number or peaks (3.6 
± 0.54) and troughs (4.0 ± 0.7) detected by ‘Cluster 7’ did not differ between lean 
and obese subjects.  Figure 6.3 shows the graphs generated using the pulse 
detection programme with the settings described in ‘Methods’. 
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Figure 6.3:  Leptin v-a differences (ng/ml) in the post-absorptive state 
 
 
Subject 8
Subject 4 Subject 5
Subject 7
Subject 6
 
 
Legend to Figure 6.3 
 
Shows the raw ‘Cluster 7’ outputs with pulse detection (horizontal line) of leptin 
v-a difference (ng/ml) vs. time (minutes) from 5 subjects in the post-absorptive 
state using the settings described in ‘Methods’.   
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Table 6.2:  V-a differences (ng/ml) for 5 subjects’ ‘true’ leptin datasets  
 
 
Subject 4 5 6 7 8 
Mean v-a 
difference 
0.328 7.174 0.00163 0.457 0.876 
AUC of v-a 
difference 
18.32 432.3 0.3 28.84 56.8 
Peaks 3 4 4 3 4 
Troughs 4 4 4 3 5 
 
 
Legend to Table 6.2 
 
Shows mean veno-arterial difference (ng/ml) and area under the curve or veno-
arterial difference in leptin (ng/ml) for 5 subjects in the post absorptive state.   
 
 
CLAMP STUDIES 
 
 
Venous leptin concentrations did not increase significantly before vs. during 
euglycaemic hyperinsulinaemia (9.15 ± 12.5 ng/ml vs. 12.48 ± 12.29 ng/ml, 
p=0.21) but there was a non-significant trend towards increased v-a differences 
(2.54 ± 4.01 vs. 4.35 ± 4.89 ng/ml, p=0.07).  The area under the leptin venous 
concentration curve (AUC) also showed a trend towards increase which just failed 
to reach statistical significance (153.8 ± 241.6 vs. 256 ± 285.6, p=0.05).  There 
was no significant difference between the number of venous leptin peaks before 
(4.33 ± 1.53) or during (3.33 ± 1.15) the euglycaemic hyperinsulinaemic clamp.  
Neither was there a difference in the number of venous leptin troughs before (4.3 
± 1.53) or during (4.3 ± 1.15) the insulin clamp (p=1.0)  
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Figure 6.4:  Adipose tissue venous leptin concentrations (ng/ml) in 3 subjects 
during euglycaemic-hyperinsulinaemic clamp 
 
 
Subject 6
Subject 5
Subject 7
 
 
Legend to Figure 6.4:   
Shows the raw ‘Cluster 7’ outputs of adipose tissue venous leptin concentrations 
(ng/ml) in 3 subjects during euglycaemic-hyperinsulinaemic clamp conditions 
using the settings described in ‘Methods’.  
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Table 6.3: Adipose tissue venous leptin concentrations (ng/ml) during euglycaemic-
hyperinsulinaemic clamp for 3 subjects 
 
 
Subject 5 6 7 
Mean 
leptin 
26.09 2 9.73 
Leptin 
AUC 
1562.3 120.15 579 
Peaks 4 2 4 
Troughs 5 3 5 
 
 
Legend to Table 6.3 
 
Shows mean leptin concentrations (ng/ml) and area under the curve of leptin 
concentrations (Leptin AUC, ng/ml) for 3 subjects under conditions of 
euglycaemic hyperinsulinaemia.   
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V-a leptin differences (ng/ml) during euglycaemic-hyperinsulinaemic clamp 
 
There was a trend towards an increase in leptin v-a differences in response to 
insulin (2.54 ±  4.01 before vs. 4.35 ±  4.89 ng/ml after insulin, p=0.07 (paired t 
test, 2 tailed) which just failed to reach statistical significance.  This data is shown 
in Figure 6.5 and Table 6.4.  The number of v-a difference peaks did not differ 
before (3.66 ± 0.33) or during (3.66 ± 2.33) the insulin clamp (p=1.0).  Neither 
was there a difference in the number of troughs in v-a differences before (3.66 ± 
0.58) and during (4.66 ± 1.53) the insulin clamps (p=0.47) ( paired t test, equal 
variance not assumed). 
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Figure 6.5:  Leptin v-a differences (ng/ml) before (left) and during (right) 
euglycaemic-hyperinsulinaemic clamp 
 
Subject 6
Subject 5
Subject 7
 
 
Legend to Figure 6.5:   
 
Graphical output from ‘Cluster 7’ for 3 subject’s leptin v-a differences (ng/ml) 
before (left) and during (right) euglycaemic-hyperinsulinaemic clamp are shown 
over a 60 minute period after reaching steady state conditions and using the 
settings for ‘Cluster 7’ described in ‘Methods’.   
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Table 6.4:  Leptin v-a differences (ng/ml) during the insulin clamp for 3 subjects 
 
 
Subject 5 6 7 
Mean leptin v-a 
difference 
9.98 1.17 1.9 
Leptin v-a 
difference AUC 
585.7 73.9 110.31 
Peaks 4 2 5 
Troughs 5 3 6 
 
 
Legend to Table 6.4: 
 
Mean leptin veno-arterialised differences for 3 subjects during steady state 
conditions of euglycaemic hyperinsulinaemia. 
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‘CONTROL’ DATASETS  
 
In order to test whether or not these data were robust, we went on to create control 
datasets against which to test the true datasets so that we could be sure that what 
‘Cluster 7’ was detecting was true pulsatility rather than random biological 
variability.   
 
As described in ‘Methods’, mock datasets were created by either randomising the 
time order of plasma concentrations or v-a differences or by creating falsely 
paired v-a differences subtracting one subject’s arterial concentration from the 
other subject’s venous concentration. 
 
 
Mock venous leptin datasets 
 
Each of the control datasets for the 5 subjects studied demonstrated between 2 and 
4 apparent peaks (3.2 ± 0.84) and between 3 and 4 apparent troughs (3.8 ± 0.45).  
The mean number of peaks (p=0.46) and troughs (p=0.54, t test, 2 sample, not 
assuming equal variance) did not differ significantly from the number using 
correctly time ordered datasets i.e. although ‘pulses’ were detected by ‘Cluster 7’ 
in all subjects’ venous leptin concentrations and v-a differences, a similar number 
of pulses was also detected when the ‘true’ datasets were converted into control 
datasets both by false pairing and randomisation of their time order.   
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Mock v-a difference datasets 
 
Again, mock or ‘control’ datasets were constructed as described in ‘Methods’.   
 
1) False pairs 
 
Variability was evident in the mock datasets and once again ‘Cluster 7’ 
recognised between 3-7 peaks (4.16 ± 1.47) and troughs (4.16 ± 1.60) in each 
subject.  The number of peaks (p=0.411, t test assuming unequal variance) and 
troughs (p=0.825, t test assuming unequal variance) did not differ between the 
true and the mock v-a difference datasets.   
 
Because this raised the possibility that ‘Cluster 7’ was detecting peaks that were 
due to the inherent variability of the data rather than due to the presence of true 
pulsatility, we went on to investigate this further with additional mock datasets.  
These were created by randomising the order of true v-a differences and then 
testing the resultant dataset with ‘Cluster 7’. 
 
2) Random order v-a datasets 
 
Randomised datasets were created in Microsoft Excel by using the random 
number generator to generate a random number between 0 and 1 in a column 
adjacent to the true time ordered values for leptin v-a differences.  The values 
were then sorted according to increasing random number value to generate 
random time ordered leptin v-a differences.  Again, 2-5 peaks (3.2 ± 1.3) and 2-6 
troughs (3.8 ± 1.64) were found in each subject after randomisation of the time 
order of their v-a leptin differences.  The number or peaks (p=0.55) and troughs 
(p=0.81, 2 tailed 2 sample t test) did not differ significantly between the true 
dataset and the randomised time order dataset in each subject.   
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3) Change in assay CV using cluster 
 
As a result of discovering that cluster was detecting pulses in mock datasets, we 
investigated the possibility that apparent pulses were being detected because we 
underestimated the assay CV for leptin and we therefore changed the detection 
criteria of ‘Cluster 7’ to assume a more conservative assay CV of 10% which 
comfortably exceeded estimates of the assay CV of 6.3% which were based on 
repeated QC replicates as described in ‘Methods’.   
 
This would allow for the fact that greater apparent CV would occur when an 
arterial value with its own CV were subtracted from a venous value with an 
inherent CV and also for variable CV at different.  This had no significant effect 
on the pulse detection using cluster in the subjects studied.   
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DISCUSSION  
 
 
We used direct adipose tissue venous sampling and a-v difference methodology 
seeking evidence of pulsatile leptin secretion.  Using these methods, we studied 
release of leptin from subcutaneous abdominal adipose tissue in humans of 
differing body composition.  We are not aware of any previous studies using this 
methodology to investigate secretion rather than venous concentration in man nor 
are we aware of the use of 2 minute sampling in order to be able to detect 
oscillations with a frequency that might be expected if pulsatility were, for 
example, entrained to insulin or SNS pulsations with inter-peak intervals in the 
order of 7-15 minutes (see Chapter V results).  As expected, leptin levels and 
leptin production as assessed using veno-arterial differences was greater in the 
more obese subjects.  In accordance with previous reports (Boden et al, 1997), the 
effect of euglycaemic insulin infusion was to increase the secretion of leptin 
although our results just failed to reach statistical significance for v-a difference 
(p=0.07) and area under the leptin curve (p=0.05).  This may be explicable given 
previous reports suggesting a time lag between insulin and leptin excursions 
(Koutkia et al, 2003) or by the loss of power we experienced as a result of small 
numbers of completed clamp studies.  The trend to increase we did see in v-a 
differences measured in adipose tissue venous effluent render any insulin 
mediated increase in leptin concentrations to be more likely to be due to changes 
in the rate of production, at least from the human subcutaneous adipose tissue 
depot than to a reduction in clearance.  It has previously been shown that apparent 
insulin-mediated effects are blunted during hypo-glycaemic hyperinsulinaemia 
suggesting that glucose uptake per se rather than insulin binding may be the 
trigger for leptin release under these conditions (Wellhoener et al, 2000).   
 
Although our data revealed variability in the secretion and v-a differences of 
leptin, our application of mock datasets to act as controls gave us reason to doubt 
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that this represented truly co-ordinated pulses.  This is despite the fact that a 
commonly accepted programme for pulsatility detection suggested that the 
concentrations and production contained more variability than could be accounted 
for by assay variability alone.  The strength of our method was that rapid (2 
minute) sampling over 1 hour allowed us to look for rapid oscillations but also 
constrained us in that it only permitted us to make observations over this short 
time period.  Oscillations with periods already reported in the literature variously 
between 3.25 (Sinha et al, 1996), 3.6 (Saad et al, 1998), 7 (Koutkia et al, 2003), 
10 (Ahmad et al, 2001), 30 (Licinio et al, 1998) and 32 (Licinio et al, 1997) 
pulses per 24 hours are perfectly consistent with our negative findings in that no 
more than one oscillation with an inter-peak interval similar to those reported in 
these studies would occur in its entirety over our sampling period.  Our methods 
were not designed to examine any form of diurnal variability, meal response or 
circadian rhythm: such influences on leptin production have been long established 
(Sinha et al, 1996) and repeatedly observed (Licinio et al, 1998, Mingrone et al, 
2005).  We did not ‘smooth’ our data using techniques such as ‘differencing’ or 
passage thorough ‘filtering’ algorithms to remove unstable baseline characteristics 
or oscillations taking place over a longer period than we were measuring because 
the ‘Cluster 7’ programme methodology is thought to be inherently robust to such 
effects (see below).   
 
‘Cluster 7’  
 
As stated in its product literature (Veldhuis & Johnson 1986), ‘Cluster 7’ is less 
prone than previous methods to the effects of inconsistent pulse frequency 
estimates, fluctuating baseline hormone concentrations, variable pulse amplitudes, 
lack of consistent definition of what exactly constitutes a peak and a trough or 
lack of an explicit statistical basis for the analysis.  Definition of a peak requires 
that a region of significant increase be associated with nadirs on both sides.  A 
nadir is defined as a decrease followed by an increase, with all else representing a 
peak.  In performing the analysis, the operator specifies individual test cluster 
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sizes for the nadir and peak (i.e., number of points to be used in testing nadirs 
against peaks), a minimum and maximum intra-series coefficient of variation, a t 
statistic to identify a significant increase, and a t statistic to define a significant 
decrease.  The programme does assume that measurement error (essentially assay 
CV) is distributed in a Gaussian fashion although it is robust to skewed 
distribution.  In determining the CV for the assay, the programme can either 
calculate it based on the variability of replicate assay results on the clusters of 
values used to define a particular peak or trough or can be set to use the measured 
CV of the assay as a whole based on the testing of replicated assays of a typically 
larger number of data points.  On theoretical grounds, which they demonstrate 
mathematically, and with support from ‘stress testing’ the programme on data 
series of different hormones with known pulsatility, the authors conclude that a 
constant ‘external’ CV performs better and we therefore adopted this method 
analysing our results.  The authors state that the program ‘should provide the 
following advantages in pulse analysis: 1) consistent pulse detection despite 
drifting base-line hormone concentrations; 2) lack of requirement for uniform 
pulse amplitudes within the series under analysis; 3) an ability to use multiple-
point criteria to delineate significant nadirs or peaks; 4) a statistically explicit 
definition of significant increases and decreases in the data series and hence 
accurate demarcations of peak width; 5) sensitivity to assay precision within the 
actual experimental data series; and 6) substantial freedom from variable false-
positive errors associated with a wide range of intra-assay coefficients of 
variation. Thus, we suggest that cluster analysis may be applicable to 
investigations of a wide variety of endocrine pulse signals.’  
 
Variability vs. Pulsatility 
 
Several potential mechanisms may account for variability without truly co-
ordinated pulsatility.  These include time dependent changes in soluble receptor 
mediated clearance, in renal leptin clearance (the predominant method (Cumin et 
al, 1996)) or in other factors such as adipose tissue blood flow.  Adipose tissue 
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blood flow changes are known, for example, to affect patterns of NEFA export 
from adipose tissue by promoting re-esterification when the products of lipolysis 
are able to accumulate locally (Burns et al, 1978).  For this reason, we had 
intended to measure leptin flux- that is the product of v-a difference and blood 
flow as this, using the Fick principle (Zierler 1961), would have given us true 
rates of production.  As reported in Chapter V, we found our methods for ATBF 
quantification were not able to resolve changes any more rapidly than over 
approximately 20-30 minute periods of observation so this was not possible in 
practice.  We might however suppose that if blood flow were truly pulsatile, the 
product of a variable and a pulsatile number (e.g. sinusoidal) series might be 
expected to produce a variable rather than truly pulsatile number, mathematically 
at least.   
 
Detecting pulses in biological data is inherently problematic because of factors 
such as noise (which may or may not be Gaussian), unpredictable frequency, 
assay variability, biological variability (caused by haemolysis or degradation in 
the syringe and tubing or during storage), variability introduced by the very act of 
sampling (e.g. changes in blood flow due to the negative pressure applied to draw 
the sample), infrequent sampling (e.g. failing to find the apex of true peaks), 
statistical tests prone to what is in effect multiple hypothesis testing, moving 
baseline characteristics of the data, variable size of peaks, superimposition of 
slower (e.g. circadian) and faster (e.g. pulsatile) variability and the sometimes 
unknown plasma kinetics of the substance under study which may be multiple 
(e.g. receptor mediated and renal clearance) and concentration dependent.   
 
In the case of adipose tissue, there are a number of adipose tissue depots 
(including the brain which may make a significant contribution to whole body 
leptin production (Eikelis et al, 2004) and random variations in the secretion from 
each could at times be in phase and summate and at others be out of phase with 
each other and not summate.  The signal detected will depend upon many factors 
including the site and the frequency used.  Insulin pulsatility serves as a good 
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illustration of these concepts.  Insulin has an ultradian rhythm detectable with, for 
example, hourly blood sampling.  It also has meal time excursions which may be 
similarly detectable.  However, insulin also has a superimposed faster component 
of pulsatility with a period of approximately 5-15 minutes which is far better 
detected with sampling every 1-2 minutes directly from the portal vein than with 
less frequent sampling from peripheral veins.  Each of these components is likely 
to have biological relevance and require different study designs to resolve.  The 
diurnal variation may be related to diurnal changes in insulin sensitivity and the 
mealtime excursions are clearly related to carbohydrate disposal.  The most rapid 
component is lost early in the pathogenesis of insulin resistance (O'Rahilly et al, 
1988) and may thus be important in understanding this condition.  
 
Conclusions 
 
We conclude that although ‘Cluster 7’ and similar programs offer a number of 
distinct advantages in deciding whether variability within a time ordered dataset 
can be explained by assay variability alone, it does not confer the ability to 
disentangle co-ordinated pulsatility from other causes of variation such as 
biological variability or random noise.  Thus, a cautious approach should be taken 
when interpreting claims to have detected pulsatility using methods such as 
‘Cluster 7’.  This is not to imply criticism of the use of the programme itself 
which is explicit and effective about what it does: it makes a probabilistic 
decision about whether a data point differs from those preceding and following it 
as a result of assay variability and defines an operator specified number of 
successive significant excursions in a positive or negative direction as a peak or a 
trough respectively.  Using a series of control constructs derived from re-pairing 
or re-ordering the real data, we conclude that leptin concentrations show greater 
variability than can be accounted for by assay variability alone but that pulses 
detected by ‘Cluster 7’ are not more co-ordinated than random re-arrangements of 
the data.  We did not find convincing evidence of differences (other than in 
amplitude and mean levels) between the characteristics of leptin production 
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assessed by v-a differences and adipose tissue venous concentrations between 
lean and obese subjects.  We therefore reject our hypothesis that pulses of leptin 
production are subject to co-ordinated regulation and would be abnormal in 
obesity.   
 
Our results are consistent with the concept that leptin acts as a medium to long 
term signal related to repletion of fat stores rather than as a minute to minute 
signal where pulsatility might be thought to be of greatest importance.  For this 
reason, it is perhaps not altogether surprising that we failed to find convincing 
evidence of co-ordinated pulsatility.  We advance our use of control datasets as a 
method by which truly co-ordinated hormone or cytokine pulsatility may be 
distinguished from any of the other reasons that variability may be encountered in 
time ordered sequences of biological datasets.   
 
We sought next to examine the anatomy of the SNS within adipose tissue in order 
better to understand the consequences of the study in Chapter IV suggesting 
defective release of norepinephrine from SNS terminals within this tissue in 
obesity.  We hoped that a greater understanding of the anatomy might give clues 
to the likely functional consequences of our findings.  Specifically, we wished to 
confirm that SNS axons were present in human abdominal subcutaneous white 
adipose tissue and to determine whether they were predominantly peri-vascular in 
distribution or whether they made direct contact with adipocytes spatially distant 
from blood vessels.   
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CHAPTER VII 
 
 
 
 
 
 
 
MORPHOLOGICAL STUDIES ON THE SNS 
INNERVATION OF ADIPOSE TISSUE IN MAN 
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INTRODUCTION 
 
 
From function to structure 
 
It has been known for over a century that the SNS is able to control the formation 
and dissipation of lipid stores through activation of its receptors within white 
adipose tissue (Dogiel 1898).  Its ability to do this does not primarily depend upon 
changes in the concentration of circulating catecholamines as removal of their 
primary source, the adrenal medulla, does not attenuate the lipolytic response to 
experimentally induced hypoglycaemia (Nishizawa & Bray 1978, Spiegelman & 
Flier 2001).  Local release of catecholamines within adipose tissue itself is further 
implied by studies comparing the effects of infusion of either glucose or the same 
amount of the glucose utilisation blocker, 2 deoxyglucose which produces a state 
of acute functional neuroglycopaenia (Bartness & Bamshad 1998).  Whereas 
infusion of glucose results in decreased firing rates of SNS axons innervating 
epididymal WAT, the same amount of intravenous 2 deoxyglucose results in 
increased firing rates in the same tissue bed.  The mechanism by which 
catecholamines are delivered to the vicinity of adipocytes is significant because of 
the different concentrations, and as a consequence, the different receptor-
mediated effects that may result.  Whereas alpha 2 receptor activation (decreasing 
lipolysis) has been reported to predominate at low catecholamine concentrations, 
beta 3 activation and increased net lipolysis occurs at higher concentrations 
(Carmen & Victor 2006, Lafontan & Berlan 1995)  If even the response to a 
metabolic emergency (hypoglycaemia) where circulating catecholamines are 
present in high concentration is mediated primarily by catecholamines released 
from SNS axons within adipose tissue, it must therefore follow that the routine 
autonomic control of lipolysis will also be dependent on local adipose tissue 
innervation rather than circulating catecholamines.  Such an arrangement prevents 
the organism having to endure the effects of widespread catecholamine secretion 
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(the ‘fight or flight’ response) whenever lipolysis is required e.g. after overnight 
fasting.  Whether high local catecholamine levels are achieved primarily by direct 
synaptic contact between SNS axons and adipocytes or alternatively via diffusion 
of Norepinephrine from the microvasculature is not currently clear (Wirsen 1964, 
Slavin & Ballard 1978, Rebuffe-Scrive 1991, Bartness & Bamshad 1998).  Other 
functions of the SNS within adipose tissue including the possibility that it may 
also be able to influence lipolysis indirectly through regulation of adipose tissue 
blood flow are discussed below. 
 
Catecholamines, ATBF and lipolysis 
 
Direct stimulation of SNS axons in a dissected adipose tissue depot bathed in 
physiological medium causes lipolysis which is prevented by ganglionic blockade 
(hexamethonium) or SNS fibre destruction (6 hydroxydopamine) (Correll 1963).  
However, this does not necessarily reflect the situation in the intact animal where 
blood flow and capillary permeability may be simultaneously affected by the 
actions of the SNS.  Both of these are important as they will influence local 
concentrations of released NEFA which are a potent end product inhibitor of 
lipolysis (Burns 1978).  In conditions of increased lipolysis and increased blood 
flow, net export of NEFA will ensue.  However, with increased lipolysis and 
reduced blood flow, there would be the potential for futile cycles of lipolysis and 
re-esterification using energy but not resulting in net release of NEFA into the 
circulation.  Such futile cycling has the potential to be a significant determinant of 
the overall energy economy of the organism with obvious consequences for the 
understanding of some obese states (Hammond et al, 1987).  Wirsen (Wirsen 
1965), in an early series of studies in adipose tissue biology noted that 
norepinephrine infusion in general causes initial alpha-mediated constriction of 
vessels in addition to lipolysis with vasodilatation later ensuing.  Infusion of 
catecholamines, alpha and beta adrenoceptor blockade and other manipulations of 
the SNS alter adipose tissue blood flow in animals and man (Rosell 1969, Ballard 
1973, Ballard 1978, Dodt 1999).  Under such influences, ATBF may vary by as 
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much as ten fold from 3-30 mls/100g/min adipose tissue depending on species, 
location of the depot and the prevailing metabolic circumstances (Ballard 1978).  
These and other data serve to illustrate the complexity of the regulation of adipose 
tissue by the SNS and suggest that blood vessels as well as, or even instead of, 
adipocytes are innervated by the SNS and that changes in flow and capillary 
permeability to albumen which permits removal of the products of lipolysis may 
be just as important as simple up-regulation of lipolysis per se (Rosell 1975).   
 
SNS and fat cell differentiation  
 
A number of animal studies suggest a role for the SNS innervation of adipose 
tissue in longer term energy homeostasis.  There is evidence that the SNS may be 
involved in regulating differentiation and recruitment of pre-adipocytes (Giordano 
et al, 1998) and also in promoting trans-differentiation of adipocytes with 
predominantly white characteristics to those with the classical morphology and 
function of brown adipocytes (Himms-Hagen et al, 2000).  This raises the 
intriguing possibility that the SNS may be closely involved in the longer term 
regulation of adipose tissue morphology and function as well as, or even instead 
of, in the minute-to-minute control of lipolysis.  If this is indeed the case, 
understanding the nature of the SNS innervation of white adipose tissue may also 
underlie some of the observed inter-species and inter-depot differences in adipose 
tissue behaviour (Bartness & Song 2007).   
 
Domestic fowl for example exhibit little if any catecholamine responsiveness 
(Carlson et al, 1964) whereas hibernating mammals such as the Siberian hamster 
demonstrate exquisite sensitivity to catecholaminergic stimulation, presumably 
related to the need to repeatedly and rapidly store and then mobilise adipose tissue 
during periods of fasting and re-feeding.  Thus, denervation of a Siberian hamster 
fat pad whilst leaving the contralateral pad intact as an internal control leads to a 
doubling of the size of that fat pad.  This appears to be due to an increase in the 
number of adipocytes rather than to an increase in any individual cell’s lipid 
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storage (Youngstrom & Bartness 1998).  Denervation  additionally attenuates the 
lipolytic response to other stimuli such as fasting, oestrogens or changes in the 
light-dark cycle (Bartness & Song 2007).  Conversely, the increased visceral 
adiposity of Cushing’s syndrome has been suggested to derive from enhanced 
glucocorticoid-mediated catecholamine insensitivity (Rebuffe-Scrive 1991).  Such 
observations, if interpreted to mean that one of the functions of the SNS is to act 
as a brake on adipose depot hyperplasia (Turtzo & Lane 2002), have obvious and 
far reaching potential consequences in our understanding of the development and 
maintenance of obesity.   
 
Adipose tissue anatomy 
 
Anatomical studies of adipose tissue have a long history although much detail 
remains unresolved (Bartness 2007, Bartness and Bamshad 1998).  Animal 
studies have demonstrated what are thought to be SNS axons within adipose 
tissue, particularly in fasted animals (perhaps because the smaller adipocytes 
permit visualisation of axons otherwise concealed between cells) although the 
methodologies have only permitted tentative differentiation between vascular and 
direct innervation (Slavin & Ballard 1978) or have not been clear about 
innervation of WAT vs. innervation of regions with the characteristics of BAT 
within WAT.  It has frequently been observed that the apparent innervation 
density appears highly variable even within the same adipose tissue depot 
(Bartness & Song 2007).  Those studies that have reported direct contact either 
histochemically (Ballard 1974, Diculescu & Stoica 1970, Rebuffe-Scrive 1991, 
Slavin & Ballard 1978) or in electron microscopic (e.m.) studies (Slavin & 
Ballard 1978) generally report direct contact with only a minority of adipocytes.  
The only semi-quantitative estimate available from animal studies of the number 
of adipocytes that are actually innervated by SNS terminals reported a figure of 
3% despite rich innervation of surrounding vascular tissue (Slavin & Ballard 
1978).  If such patchy and sparse direct innervation is truly the case, it would raise 
the intriguing possibility that either there is a metabolically active pool of 
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adipocytes with SNS connections (Ballard 1974) or alternatively that, through 
some kind of electrochemical coupling as observed in differentiating adipocytes 
in vitro (Yanagiya et al, 2007) these cells act as pacemakers for the entire adipose 
depot.   
 
Descending innervation 
 
The origin of descending SNS innervation might provide a clue to its function.  If 
SNS fibres do more than simply regulate the provision of oxygenated blood to 
adipose tissue, its fibres might be expected to originate in areas of the brain 
involved in energy homeostasis.  Anterograde and retrograde tracer studies 
reviewed recently (Bartness 2007) have demonstrated that the SNS afferents to 
adipose tissue do indeed arise from brain regions known to be involved in appetite 
and weight regulation and seasonal fat storage.  This would support the 
hypothesis that their influence is not limited to the regulation of vascular tone per 
se.  The high degree of co-localisation of SNS axons destined for adipose tissue 
and MC4 receptors has been proposed to explain how MC4 mutations change 
body weight more than pair feeding experiments would predict (Raposinho et al, 
2003).  This data suggests a role for the SNS in mediating the energy expenditure 
effects of MC4 mutations, the commonest monogenic form of obesity yet 
described (Farooqi et al, 2003). 
 
Methodological considerations 
 
Dogiel in 1898 was the first to report staining of nerves innervating WAT (Dogiel 
1898).  However, early studies using methylene blue lacked specificity for SNS 
fibres and conversely may have missed direct innervation of adipocytes in freely 
fed animals due to obscuration within a tightly packed adipose tissue matrix.  It is 
difficult to be certain that the direct innervation reported in some studies (Ballard 
et al, 1974, Diculescu & Stoica 1970, Rebuffe-Scrive 1991, Slavin & Ballard 
1978) has not been affected by the methodological difficulties inherent in 
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studying a tissue which is largely removed by standard histological techniques.  A 
further potential difficulty in determining whether there is direct innervation of 
white adipose tissue lies in the ‘contamination’ of white adipose tissue with cells 
with a more ‘brown’ phenotype.  Brown adipose tissue is densely innervated by 
the SNS and discrimination between white and brown adipose tissue is usually 
considered straightforward (see Colour Plate 7.1 for example).  However, it is 
now clear that trans-differentiation between white and brown adipocytes does 
occur (as judged by UCP-1 staining), that the characteristics used in making these 
distinctions are not necessarily ‘all or nothing’ in nature and that brown and white 
adipose tissue are mixed in the same depots (Cinti 2009) (see also Colour plate 
7.3).  Even in adult humans thought to possess very little brown fat, patients with 
catecholamine-secreting tumours (phaeochromocytoma) have increased amounts 
of brown type fat in the perinephric adipose tissue depot (Lean et al, 1986).  
Similarly, infusion of catecholamines has been shown to increase the ‘brown’ 
characteristics of white adipose tissue in laboratory animals (Himms-Hagen et al, 
2000).  For these reasons, one of the main criteria used in distinguishing brown 
from white adipose tissue, innervation density, risks being a circular argument.  
Other discriminating features such as mitochondrial organisation have a degree of 
potential subjectivity.  No previous study has used combined vascular and 
neuronal staining with three dimensional image reconstruction to examine in 
detail the precise anatomical relationship between neuronal and vascular elements 
in adipose tissue. 
 
The role of SNS innervation of Adipose Tissue in Man 
 
Studies of adipose tissue in animals may not be easily transferable to humans who 
have, at most, small amounts of brown adipose tissue and do not share with 
animals certain SNS dependent adipose tissue functions such as BAT 
thermogenesis and hibernation.  The need for a human study is further 
underpinned by evidence suggesting that abnormal SNS activity within adipose 
tissue in man may be associated with clinical obesity.  Our own studies outlined 
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in Chapter IV suggest that adipose tissue SNS activity is both reduced in human 
obesity in the post-absorptive state and also that it fails to respond normally to 
meal ingestion.  Others have shown with microdialysis techniques that intraneural 
stimulation of WAT in obese women does not trigger lipolysis in subcutaneous 
WAT, whereas the same stimulation produces a profound increase in lipolysis in 
their lean counterparts (Dodt et al, 2000).  Lipolysis in denervated limbs in 
patients with spinal cord injury is also impaired compared with contralateral 
unimpaired limbs (Karlsson et al, 1997).  It is hard to understand the true 
significance of these observations without data confirming that SNS axons do 
indeed innervate adipose tissue in man. 
 
In conclusion, it seems likely that the SNS is organised in such a way as to be able 
to deliver catecholamines at high concentration into the vicinity of adipose tissue 
adrenergic receptors.  SNS effects, whether related to lipolysis or to pre-adipocyte 
differentiation and recruitment may potentially occur either through direct 
synaptic contact, through diffusion of catecholamines into adipose tissue from 
microvascular innervation or from changes in local NEFA concentration mediated 
by changes in blood flow or endothelial permeability to binding proteins such as 
albumen.  Species differences exist in relation both to adipose tissue function (e.g. 
hibernation and thermogenesis) and innervation (e.g. lack of catecholamine 
induced lipolytic response in domestic fowl (Carlson et al, 1964)).  No study has 
reported data on the existence or pattern of SNS innervation in white adipose 
tissue in man despite data suggesting to abnormal SNS activity within this tissue 
in the obese state. 
 
Our hypothesis therefore was:   
 
a) That techniques could be developed to visualise SNS axons within 
human adipose tissue for the first time  
b) That SNS axons would co-localise with blood vessels rather than exist 
independently  
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METHODS 
 
 
Samples 
 
Human adipose tissue samples were obtained from human visceral and 
subcutaneous adipose tissue during routine surgical procedures after approval 
from the East London Regional Ethical Committee [P01/039] having obtained 
fully informed consent from each subject.  Animal material (rat and mouse) was 
used from tissue banks and from the discarded carcasses of animals kept and 
sacrificed by individuals with appropriate licenses during unrelated experiments 
thought unlikely to affect adipose tissue.  None of the human subjects were 
known to have HIV, cancer or other conditions which would make serious 
abnormalities in adipose tissue likely.   
 
Samples were kept in physiological saline and collected direct from the operating 
theatre or freshly killed animal before being placed in 4% paraformaldehyde for 
overnight fixation.  Tissue was then frozen on dry ice (we found that liquid 
nitrogen tended to fracture the delicate tissue) and sectioned to between 10 and 
100µm thickness at -10 to -50 deg C before preparation for immuno-fluorescence 
microscopy.  Thin sections yielded the clearest staining but the blood vessels and 
tissue were prone to fracture and less three-dimensional information was available 
with confocal microscopy than with thicker sections of up to 100 µm.  Both 
human and animal adipose tissue was used to determine optimal staining 
techniques.  Variations of tissue sectioning, antibody specificity, slide 
preparation, and imaging were used to determine the best methods of obtaining 
reliable and consistent staining with optimisation of signal to noise ratio.  
Permutations of the methods used to optimise visibility of SNS axons and 
endothelia included variations on the thickness of sections, time in 
paraformaldehyde, temperature of the cryostat and inclusion or omission of 
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antigen retrieval.  In addition, incubation of sections with primary antibodies in 
sequence or together, use of primary antibodies raised in rabbit, sheep and goat, 
use of polyclonal rather than monoclonal primary antibodies, use of differing 
dilutions of the primary antibodies and variation of the length of primary antibody 
incubation were all used in reaching the optimised techniques described below.   
 
Primary antibodies 
 
The primary antibodies used were tyrosine hydroxylase (TH) at an optimal 
dilution of 1:10 and Q BEND-10 (CD 34) at optimal dilution of 1:50.  Incubation 
times were varied from 30 minutes to 8 hours overnight.  Longer times were in 
general found to yield more abundant SNS staining, although at the cost of 
increased non specific background immuno-fluorescence and were generally used 
as the non-specific background noise could be recognised as occurring on non-
neuronal or vascular structures.  We reasoned that it would be more important to 
avoid under-recognition of TH immuno-reactivity within the adipose elements 
than to avoid some element of unwanted noise that could later be compensated for 
in analysis.  Rat aorta obtained from a tissue bank was used as a positive control 
for both primary antibodies containing both endothelial and SNS elements.  
Restriction of staining to tubular structures with the characteristics of vascular 
elements was used as an internal negative control for Q-BEND-10 and to beaded 
neuronal structures with the typical characteristics of SNS axons for anti-TH 
primary antibodies.  This approach was confirmed by using PGP, a pan-neuronal 
marker in initial experiments to show that TH immuno-reactivity was limited to a 
subsection of all neuronal elements stained within the section.   
 
TH 
 
Mouse monoclonal IgG2a Kappa Anti-Human Tyrosine Hydroxylase (Novo 
Castra Laboratories, Newcastle upon Tyne, UK) was the primary antibody used to 
identify SNS axons within human adipose tissue.  This antibody is raised against a 
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pro-karyotic recombinant protein corresponding to a portion of the carboxyl-
terminal end of the tyrosine hydroxylase molecule.  TH is the rate limiting 
enzyme in the biosynthesis of norepinephrine within SNS axons (catalyzing the 
conversion of the amino acid L-tyrosine to dihydroxy-phenylalanine (DOPA) 
which is a precursor for dopamine, itself a precursor of norepinephrine).  TH is 
not known to be present in adipose tissue outside of catecholaminergic neuronal 
tissue.   
 
CD 34 
 
Mouse monoclonal IgG-1 anti-Human CD 34 (QBEND-10, Chemicon 
International Temecula, CA 92590) was used to stain vascular endothelia.  The 
antigen is predominantly associated with the baso-luminal surfaces of endothelial 
membranes.  QBEND-10 also immuno-precipitates a glycoprotein with a relative 
MW 110kD expressed on haematopoietic cells and on the established myeloid 
leukaemic cell line KG1A.   
 
Slide preparation 
 
Sections were picked up on coated slides and dewaxed in xylene (x2) and 
dehydrated in alcohol (x2).  Endogenous peroxidase activity was removed using a 
solution containing 97 mls methanol and 3 mls H2O2 for 15 minutes.  The slides 
were rinsed again in tap and then distilled water at room temperature before 
immersion in 20% acetic acid for 10 minutes.   
 
Antigen exposure was enhanced by microwaving the slides on full power for 18 
minutes in buffer solution (900 mls distilled water and 100 mls citrate buffer 
titrated to pH=6.0 with 0.1M NaOH) and then washed in Tris buffered saline.  We 
found that, particularly when using thinner sections, omission of this step yielded 
better staining.  Background (non-specific) immuno-fluorescence was blocked 
with normal horse serum (50µl of normal horse serum to 5 mls antibody diluent, 
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not removed from the slide).  Sections were then washed in TBS and incubated 
with biotinylated secondary reagent from an Elite Kit.  Avidin complex solution 
(fluoroscein avidin DCS 1:200 diluted in TBS and left to stand for 30 mins) was 
then added for 20 minutes, washed off and then DAB solution was applied for 5 
minutes.  This was followed by washing in running tap water for 5 minutes, brief 
air drying and mounting in Vectashield mounting medium.  The slides appeared 
to be stable for several days if kept at +4 deg C especially if the cover slip was 
sealed with nail varnish to prevent desiccation.   
 
Observation was carried out using a fluorescent confocal laser scanning 
microscope (LSM510 Meta; Carl Zeiss) equipped with 10x dry, 20x dry, and 40x 
oil objectives.  Stacks of images at regular intervals along the optical axis were 
collected by exciting the tissue using multiple colour laser lines and collecting 
emitted light through appropriate narrow band-pass filters.  Each image was 
produced from an average of 8 frames after which the acquired images were 
processed to produce a surface-rendered 3-dimensional model using LSM Image 
Browser software (available from 
http://www.zeiss.de/C12567BE0045ACF1/Contents-
Frame/CAA2EF638EC5F0D3C1256ADF0050E2F1).   
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RESULTS  
 
 
The colour plates below are representative of the images obtained using the 
methods outlined above in both human and animal adipose tissue depots.  The 
findings are not presented in a quantified manner for the reasons discussed in 
‘discussion’ below but are based on observation of many sections.   
 
The principal findings were that there is evidence of SNS innervation of both 
visceral and subcutaneous adipose tissue in man although the axons appear to 
travel in association with blood vessels and none were encountered independently 
of endothelial staining.  We propose that fracturing of blood vessels during the 
slide preparation and issues relating to plane of focus could potentially have been 
responsible for the apparent observation of independent SNS axons in older 
studies that did not use three-dimensional image reconstruction techniques or 
endothelial staining.   
 
We did not find evidence to support the notion that adipocytes situated close to 
SNS axons would be smaller than other adipocytes due to the pro-lipolytic effects 
of the SNS.   
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Colour Plate 7.1:  Rat inguinal adipose tissue x 10.   
 
 
 
 
Legend to Colour Plate 7.1:   
 
Interface between brown and white adipose tissue showing the different pattern of 
innervation, that in WAT being confined to vessels (relatively large vessels with 
dense innervation shown, labelled A).  This demonstrates the classical distinction 
between multi-lobular, densely innervated brown adipocytes below (B) and 
larger, uni-lobular white adipocytes above.   
A  
B 
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Colour Plate 7.2:  Human subcutaneous adipose tissue x 40.   
 
 
 
 
Legend to Colour Plate 7.2: 
 
Without vascular staining, it is hard to determine whether or not these typical SNS 
axons (labelled C) are associated with a blood vessel.  The use of endothelial 
counterstaining permitted us to conclude that all SNS axons we encountered were 
in close association with a blood vessel.   
C 
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Colour Plate 7.3:  Rat Perinephric Brown Adipose Tissue x 20 
 
 
 
 
Legend to Colour Plate 7.3:   
 
This demonstrates an area of predominantly brown adipose tissue with dense 
innervation around virtually all of the small multi-lobular cells.  However, it can 
be seen that there are ghosts of larger cells with a more typical white adipocyte 
morphology (labelled D).  This demonstrates the complexity in labelling a region 
brown or white adipose tissue.  The ability of individual adipocytes to have more 
or less brown adipose characteristics is discussed in the text.   
D 
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Colour Plate 7.4:  Human Subcutaneous White Adipose Tissue x 40  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend to Colour Plate 7.4:   
 
Although not seen clearly in this 2 dimensional representation, the neural 
structures (labelled E, red) were seen clearly to be vascular with three 
dimensional analysis (TH red, QBEND-10 green). 
E 
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Colour Plate 7.5:  Mouse inguinal adipose tissue (x 10).   
 
 
 
 
Legend to Colour Plate 7.5:   
 
This low power image demonstrates the rich latticework of blood vessels carrying 
SNS innervation (labelled F).  Where nerves appear to be independent of vessels, 
further 3 dimensional imaging reveals a fractured vessel (e.g. top right of picture) 
or one out of the plane of focus (TH red, QBEND-10 green).   
F 
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Colour Plate 7.6:  Mouse inguinal adipose tissue (x 10).   
 
 
 
 
Legend to Colour Plate 7.6:   
 
Further view of the above at a different plane of section using the three 
dimensional image reconstruction software described in ‘Methods’.  It is apparent 
in this region that most, if not all, adipocytes are closely apposed to at least one 
SNS axon, especially when the images are viewed using three-dimensional 
techniques (TH red, QBEND-10 green). 
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Colour Plate 7.7:  Mouse inguinal adipose tissue (x 10).   
 
 
 
 
 
Legend to Colour Plate 7.7:   
 
Magnified view of part of the material shown in Colour Plate 7.6 demonstrating 
the close anatomical relationship between blood vessels and SNS axons (labelled 
G) and the widespread presence of fractured blood vessels (labelled H).  As 
discussed in the text, much of the substance of adipose tissue may be lost in 
histochemical tissue preparation (TH red, QBEND-10 green). 
 
G 
H  
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Colour Plate 7.8:  Human visceral white adipose tissue x 40.   
 
 
 
 
Legend to Colour Plate 7.8:   
 
Demonstrating vascular innervation within a rich latticework of vessels in human 
visceral (omental) adipose tissue (TH red, QBEND-10 green). 
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DISCUSSION 
 
 
SNS axons exist within WAT 
 
We used double immuno-fluorescence techniques and confocal microscopy to 
identify the anatomical relationship between endothelia and SNS axons in human 
white adipose tissue.  We demonstrate directly for the first time in man that SNS 
fibres are present throughout both subcutaneous and visceral adipose tissue depots 
although nerve fibres were only encountered in relation to blood vessels.  
Although perhaps expected, this conclusion was by no means inevitable given 
well established species differences in the innervation of white adipose tissue in 
animals.  Many SNS dependent adipose tissue functions in animals are not shared 
in man such as hibernation and the use of brown adipose tissue for thermogenesis 
and therefore there is no a priori reason to have expected that sympathetic 
innervation would be similar.   
 
Strengths and limitations of methods used 
 
The main advantages of the techniques we used were related to the optimisation 
of double labelling immuno-fluorescence techniques, the use of three dimensional 
image reconstruction allowing us to observe the course of a single axon through 
the tissue for some distance and the use of QBEND-10 counterstaining to 
distinguish blood vessels from other cellular structures in the spaces between 
adipocytes.  We were thus able to examine in three dimensions the anatomical 
relationships between vascular endothelia and SNS axons.  Like all histological 
studies of adipose tissue, we were constrained by the fact that the lipid within 
adipocytes is removed by the staining process and by the fact that much of the 
structural integrity of the tissue may be lost as a result.  We were not able using 
our endothelial stain to determine whether a particular blood vessel was an artery, 
arteriole, capillary, venule or vein or between arterioles situated at the opening of 
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arteriovenous anastomoses or capillary beds.  Specific innervation of such 
structures might imply a predominant role in vascular innervation with effects on 
either lipolysis or fat cell recruitment and differentiation being secondary either to 
diffusion of catecholamines throughout adipose tissue or due to en passant 
synapses of axons primarily innervating blood vessels with adjacent adipocytes.  
It was, however, possible to distinguish capillaries from larger vascular structures 
on the basis of size either in relation to the scaling bar of the reconstruction or in 
relation to residual red blood cells in the lumen. 
 
We consistently observed that not all vascular elements carried varicose TH 
immunoreactive neural structures.  It may be that only larger vessels on the 
arterial side of the vascular tree carried SNS axons but our techniques did not 
permit us to examine this point specifically.  Further studies with H&E 
counterstaining will be needed to determine whether these vessels were indeed 
arterioles and if so, whether all arterioles carry SNS axons or whether this 
function may have been limited to a defined subset.  Adipocytes are large cells 
(sometimes larger than 100µm in diameter) and thus it is difficult to section the 
tissue thickly enough to see whole cells whilst at the same time permitting 
sufficient antibody-antigen interaction and sharp focus with the confocal 
microscope.  Tracking a single adipocyte with multiple sections was not feasible 
due to edge effects and the fact that a particular adipocyte will not tend to have 
any particular features that would help distinguish it from adjacent adipocytes.  
Thus our techniques did not enable us to quantify precisely the exact proportion 
of adipocytes that are immediately adjacent to an SNS axon although further 
refinement of the methods might well permit this in the future.   
 
What can be inferred from this about adipose innervation? 
 
In some species (e.g. ferret), gap junctions have been described which could 
potentially serve as a coupling mechanism so that the electrical stimulation of one 
adipocyte could be transmitted to its neighbours (akin to a ‘pacemaker’ cell).  If 
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this were the case, it might be expected that groups of similarly sized adipocytes 
would be arranged in clusters.  However, no such electrochemical coupling could 
be inferred from this observational study where it appeared that the size of any 
one cell could not be inferred from the size of its neighbours.  Neither was it 
obviously the case that adipocytes adjacent to SNS fibres were smaller than others 
in their locality as might be expected if the function of the SNS innervation of 
adipose tissue were to bring about the direct control of lipolysis in a 
subpopulation of adipocytes.  This anatomical observation accords well with 
evidence in Siberian hamsters suggesting that SNS denervation of a fat pad causes 
a change in the size of the fat pad via changes in fat cell number without 
influencing fat cell size (Youngstrom & Bartness 1998).  Further studies will be 
needed to address the question of what determines adipocyte size and, for the 
moment at least, the answer to this question remains elusive.   
 
SNS axons appear vascular 
 
We did not find evidence to support the notion that there is both SNS innervation 
of blood vessels and also a distinct sub population of SNS axons that directly 
innervate white adipocytes.  Our use of vascular counterstaining and three 
dimensional image reconstruction afforded the opportunity to track individual 
nerve fibres through the adipose tissue so that we could determine for some 
distance the origin and course of the nerve.  We frequently observed situations 
where, for example, an SNS axon has become detached from a fractured blood 
vessel during tissue preparation and speculate that such fracturing might account 
for at least some of the previous reports of SNS axons visualised as being distinct 
from vascular innervation.  The other possible explanation for previous reports 
that we periodically encountered was a situation where a blood vessel carrying an 
SNS axon coursed just below the plane of focus with the axon precisely in the 
plane of focus.  Without the ability to visualise this in three dimensions, it could 
have appeared that the nerve was coursing through the tissue without an 
accompanying blood vessel.   
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Functionally, such a distinction may well be unnecessary.  Changes in adipose 
tissue blood flow and/or vascular permeability have a profound influence on 
whether there is net export of the products of lipolysis (NEFA and glycerol) from 
adipose tissue to the general circulation or whether the accumulation of NEFA 
itself inhibits net lipolysis (Burns et al, 1978).  In the latter circumstances, the 
potential for energy dissipation in futile cycles of lipolysis and re-esterification is 
realised.  Such futile cycling has the potential both to generate heat and also to 
regulate the storage and release of lipid and thus body weight (Hammond et al, 
1987).   
 
It is possible therefore to reconcile SNS effects on lipolysis with essentially 
vascular innervation but other SNS functions such as trophic effects (Youngstrom 
& Bartness 1998) still need to be explained if this model is to be plausible.  In 
fact, it has been established that differentiating pre-adipocytes are found in close 
proximity to vascular stem cell progenitors (Nishimura S et al, 2007) and this 
inter-relationship appears necessary for adipose tissue hyperplasia.  Given this, 
one might even expect SNS innervation to be peri-vascular within adipose tissue 
rather than independent of it if this is an important role.   
 
In conclusion, our finding of TH immunoreactivity limited to neural elements 
carried on vascular structures appears fully consistent with the known vascular, 
lipolytic and trophic roles of the SNS within adipose tissue.   
 
Further studies 
 
Our aim was to develop a technique adequate to study differences in innervation 
of white adipose tissue both within and between specific human adipose tissue 
depots under differing conditions.  Much valuable insight has been gained by 
studies in the Siberian hamster, a species chosen for its ability to store and then 
mobilise large amounts of adipose tissue during hibernation, seemingly signalled 
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by changes in the light-dark cycle.  These and other studies have told us a great 
deal about the response of adipose tissue depots to changing circumstances (cold, 
hunger, preparation for and emergence from hibernation etc) and clearly establish 
SNS innervation of white adipose tissue as a major mediator not only of lipolysis 
(both in its own right and as a facilitator of other signals such as oestrogen) but 
also of adipocyte recruitment, differentiation and trans-differentiation.  Future use 
of our methods may enable studies to be carried out examining the effect on 
adipose tissue of, for example, agents which modulate SNS activity (beta 
stimulants and blockers), disorders of lipolysis such as HIV associated adipose 
redistribution syndrome (HARS) and the effects of changing body weight in 
different adipose tissue depots.   
 
Issues of Quantification 
 
Having established that SNS axons are indeed visible in human adipose tissue 
although apparently always in association with blood vessels, the next step will be 
to develop methods of quantification which will enable comparisons of different 
adipose tissue depots under differing experimental or environmental conditions.  
This does however present a considerable challenge.  Whilst, for example, 
measuring the length of SNS fibres per high power field would be perfectly 
feasible, subjective bias could easily be introduced by choice of the plane of focus 
or whether or not to count an axon that is only faintly seen just below the plane of 
sharp focus.  Then the question arises as to whether to count more than one axon 
on a blood vessel separately or not without knowing what the biological 
consequences of this are, if any, and how to allow for differing adipocyte size 
under varying experimental circumstances (e.g. should the denominator be per 
unit area or volume of a section or per adipocyte or per blood vessel).  Alternative 
strategies might be to count the area of a slide staining positively for TH but this 
would then depend on the brightness and contrast settings used in image 
reconstitution and it is not at all clear what the biological relevance of surface area 
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of a neuron is.  Then there are difficulties in quantification of neural structures 
without cell bodies in a tissue that is largely removed during the slide preparation.   
 
For these and other reasons, no previous investigators have, to our knowledge, 
attempted histological quantification during immuno-fluorescence studies of 
adipose tissue SNS innervation.  The only quantification we are aware of to date 
has been subjective grading on a scale of 1-5 for the apparent innervation density 
(Giordano A et al, 1996). 
 
In summary, we demonstrate SNS innervation within white adipose tissue for the 
first time in man although in this study it appeared that SNS axons were 
invariably linked to blood vessels.  Our methods should lend themselves to future 
use in examining human adipose tissue depots under different prevailing or 
experimental conditions.   
 
We did not find evidence in support of a distinct subset of SNS axons which 
coursed through adipose tissue independent of blood vessels.  We can not entirely 
discount the possibility that this was because of their loss during tissue 
preparation although the fact that the nerve integrity was sometimes preserved 
despite fracture of the blood vessel it was associated with would suggest that this 
is unlikely.  We also can not completely discount the possibility that had our 
subjects been fasting for some time, depletion of adipocyte lipid droplets may 
have rendered such nerves visible, a phenomenon that has been suggested to 
occur in animal studies (Bartness & Bamshad 1998).  However, in view of the 
fact that changes in vascular permeability and flow are capable of regulating 
lipolysis via end product inhibition (Burns et al, 1978) and also the fact that 
adipose tissue blood flow appears abnormal in human obesity, and that we can 
account for the known trophic effects of the SNS without direct adipocyte 
innervation (Nishimura et al, 2007), we would advance the hypothesis that the 
SNS mediates its effects on lipolysis predominantly via the vasculature.   
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We did not find evidence that adipocytes adjacent to SNS axons formed a distinct 
morphological subtype by virtue of, for example, size as would be expected if its 
main function were limited to stimulating and co-ordinating lipolysis.  We suggest 
that this concords well with physiological studies showing that the SNS exerts 
regulatory influence on pre-adipocyte recruitment and differentiation and that, 
given common lineage with vascular progenitor cells lying in close proximity to 
blood vessels, the SNS is anatomically placed to fulfil this function without 
exclusive (non vascular) innervation.  We were not able to determine with our 
methods whether or not  SNS axons synapse in an en passant fashion with 
adipocytes whilst coursing along blood vessels although electron microscopic 
studies have previously suggested this to be the case. 
 
Further studies are needed to resolve whether the SNS innervates decision points 
on the vascular tree which would suggest that vascular regulation is its main 
purpose or whether there is any evidence in man to support the electrochemical 
coupling of mature adipocytes which would suggest that direct adipose tissue 
regulation is possible despite the relatively sparse innervation of the tissue by the 
SNS.   
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CHAPTER VIII 
 
 
 
 
 
 
 
GENERAL DISCUSSION and CONCLUSION 
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We have used both established and novel techniques to study the role of the 
sympathetic nervous system in adipose tissue anatomy and physiology in man.   
 
The first study, reported in Chapter III, confirmed that our venous sampling 
techniques were able to demonstrate the metabolic characteristics of abdominal 
subcutaneous white adipose tissue as well as that of two other quantitatively and 
qualitatively different tissues, forearm skeletal muscle and skin.  This study 
revealed differences in the metabolic characteristics of these tissues in vivo both 
in the post-absorptive state and in response to glucose infusion.  We went on to 
demonstrate with the studies reported in Chapter IV that there are abnormalities of 
SNS outflow within this quantitatively important abdominal subcutaneous adipose 
tissue depot both in the fasting state and in response to meal ingestion.  These 
abnormalities would tend to favour increased fat storage in this depot and, if not 
matched by changes in omental fat, relative redistribution of lipolysis towards 
central depots, a situation known to be associated with the development of insulin 
resistance and other features of the metabolic syndrome.    
 
This finding of defective adipose tissue norepinephrine spillover in the fasting 
state in obese subjects is vulnerable to the assertion that a variable (here, 
norepinephrine spillover) measured per unit mass of tissue may spuriously be 
changed in a condition in which adipocyte volume is known to be increased.  In 
other words, it is possible that the fasting differences simply reflect the fact that 
there are fewer adipocytes per unit volume (and therefore, per unit mass) of 
adipose tissue in obesity, each potentially receiving the same autonomic nerve 
traffic.  The failure of the norepinephrine spillover to respond normally to mixed 
meal ingestion in obesity is, however, fully consistent with our hypothesis of 
defective innervation as the denominator of adipose tissue mass remains constant.  
Tissue heterogeneity was evident in the apparently normal responses of forearm 
muscular tissue to the same change in metabolic conditions.  There has been much 
debate over whether the SNS is overactive in obesity leading to hypertension (the 
‘Landsberg’ hypothesis (Reaven et al, 1996)) or whether its under-activity might 
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be responsible for the increased tendency for lipid deposition in adipose tissue in 
obesity (the 'MONA LISA’ hypothesis (Bray & York 1998)).  Our studies 
demonstrate how regional heterogeneity in SNS function may reconcile these two 
seemingly opposed positions.  Whilst SNS outflow to adipose tissue appears 
defective and demonstrates ‘metabolic inflexibility’ in terms of transition to the 
fed state in obesity, whole body SNS activity is increased in both metabolic states, 
consistent with the well known association between obesity and hypertension.  
Further studies are underway to examine regional SNS outflow in post obese 
individuals.  A number of the obese subjects who participated in the studies 
reported in Chapter IV have subsequently undergone bariatric surgery and some 
(currently 5) have been restudied at a lower, stable body mass.  Our reasoning for 
these studies is that abnormalities of SNS function that persist in the post-obese 
state have the potential to have had a causative role in the development or 
maintenance of the obesity.  Conversely, if the apparent abnormalities of SNS 
outflow normalise after weight loss, it may be that they simply reflected the obese 
state itself and were not responsible for its development.  Either way, the 
relevance of our current findings to understanding important elements of the 
pathophysiology of established obesity (abnormal regional lipolysis, hypertension 
etc.) would remain.   
 
We report in Chapter V that NEFA export from adipose tissue appears to be 
pulsatile.  Attenuation of insulin pulses using a euglycaemic-hyperinsulinaemic 
clamp technique reduces the amplitude but does not reduce the frequency of 
NEFA pulses from the subcutaneous abdominal adipose tissue depot studied.  
This suggests a co-ordination of lipolysis which depends, at least in part, on 
factors other than insulin pulses.  Further studies using different techniques will 
be needed to establish whether or not the SNS acts as the external oscillator.  Our 
methods for measuring ATBF did not permit time resolution of less than around 
20-30 minutes for SNS outflow and therefore could not address this question 
directly.  Our positive and novel finding in respect of the pulsatility of NEFA 
export from adipose tissue is in a way strengthened by the negative results in 
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relation to leptin release.  By developing and using control datasets, we were able 
to show that commercially available pulse detection algorithms may detect 
apparent pulsatility in datasets characterised by biological or other inherent 
variability.  Our conclusions about NEFA export were robust to this evaluation 
and less tentatively advanced as a result.   
 
We have shown for the first time (Chapter VII) that SNS axons do indeed 
innervate human white adipose tissue although TH immuno-reactivity appeared 
confined to axons coursing through it in association with blood vessels.  The 
distribution of these fibres suggests that lipolytic regulation and/or co-ordination 
by the SNS is brought about indirectly either through changes in blood flow (and 
presumably therefore end product inhibition of lipolysis (Burns et al, 1978)) or, 
alternatively, through some kind of coupling of adipocytes allowing propagation 
of SNS impulses throughout the tissue from adipocytes lying in close proximity to 
vascular axons.  An alternative explanation of these data is that the SNS may have 
a more important role in the recruitment and differentiation of adipocyte 
precursors in man than it does in the minute to minute quantitative regulation of 
net lipolysis and would tend to suggest that co-ordination of pulsatile secretion is 
likely to depend on neither the SNS nor insulin pulses.  Nevertheless, such a 
conclusion would be consistent with the notion that the SNS primarily regulates 
fat cell number rather than fat cell volume (Youngstrom & Bartness 1998), at 
least in animals.   
 
Many questions remain unanswered by our studies.  Having developed 
histological techniques to study the SNS innervation of white adipose tissue in 
man, it will be important to determine whether the functional abnormalities we 
have found are reflected in structural changes in obese subjects as well as in other 
states of adipose tissue dysfunction (e.g. HIV adipose redistribution syndrome 
(HARS), lipodystropies and PPAR-γ polymorphisms).  Further work will be 
required to develop robust and reproducible histological methods of quantification 
for such studies.   
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Human studies are complex practically and ethically and, particularly in those 
studies where difficult cannulation techniques and very frequent sampling were 
combined, the numbers of subjects completing some of these studies declined as a 
result.  Nevertheless, there are important differences between human and animal 
adipose tissue function which mean that conclusions derived in one species may 
not necessarily be directly transferable to the other.  We have demonstrated that 
such studies can be done and their application to different experimental and 
pathological situations will, we hope, provide the basis for greater understanding 
of this tissue.  Future studies to develop these concepts might include the 
following: 
 
a. Further investigation of what appears to be an incretin-like effect on 
adipose tissue blood flow which is increased by orally ingested but not 
intravenously injected glucose administration.  This might include 
measuring ATBF in subjects before and after bariatric surgery, with and 
without diabetes and in response to incretin (e.g. exenetide or GLP-1) 
administration. 
 
b. Studies of adipose tissue NE spillover after bariatric surgery are already 
underway as discussed above 
 
c. The use of similar techniques to those used in Chapter IV to study 
individuals predisposed to the development of insulin resistance as a result 
of predominant visceral fat accumulation (e.g. Asian vs. Caucasian 
subjects and viscerally obese men vs. women with predominant gluteo-
femoral lipid deposition).  Visceral fat accumulation is known to be a risk 
factor for the development of insulin resistance.  Defective lipolysis in the 
abdominal subcutaneous adipose tissue depot may lead to relative 
redistribution of lipolysis towards visceral depots.  We would advance the 
hypothesis that subcutaneous abdominal NE spillover will be blunted in 
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subjects with, or at greater risk of, visceral adiposity in comparison to that 
of weight matched controls. 
 
d. Extension of the adipose tissue cannulation techniques to study different 
adipose tissue depots e.g. gluteal adipose tissue in lean and obese subjects 
with varying fat distribution.  The hypothesis would be that, in subjects 
with gluteo-femoral rather than visceral adiposity, SNS outflow will not 
be reduced in the gluteo-femoral depot.  This might have the consequence 
of redistributing lipolysis towards this depot rather than to visceral fat 
stores under circumstances of reduced SNS outflow to the subcutaneous 
abdominal depot. 
 
e. In order to strengthen our findings in relation to the pulsatile release of 
NEFA from adipose tissue, studies using constant rate infusion of stable 
isotope-labelled fatty acids could be undertaken.  We would reason that 
any pulsatility encountered in the concentrations of infused stable isotopes 
either suggests that our methods and use of control datasets have not 
excluded spurious pulsatility or, alternatively, that oscillations in plasma 
NEFA clearance are a better explanation than co-ordinated regulation of 
NEFA production from adipose tissue. 
 
f. A somatostatin ‘pancreatic’ clamp technique with basal insulin 
replacement could be used to strengthen our conclusion that NEFA 
pulsatility does not depend on spontaneous insulin pulses.   
 
g. Beta-adrenoceptor blockade could be used to examine the effects this 
might have on NEFA pulsatility.  The use of stable isotope techniques 
may help disentangle changes due to the inevitable cardiovascular effects 
of non-selective beta-adrenoceptor blockade from those due to blockade of 
adrenoceptors within adipose tissue itself. 
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h. Further development of quantitative techniques for our anatomical studies 
of human white adipose tissue may permit examination of its innervation 
in different pathological states including obesity and HARS and also 
develop our understanding of whether differences in the size and lipolytic 
behaviour of different adipose tissue depots is due predominantly to 
receptor/post receptor differences, differences in the release of NE in the 
tissue or instead to changes in the anatomical distribution of SNS axons 
within adipose tissue depots. 
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